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Abstract  
Dentine sensitivity continues to be a problem for patients who experience painful 
symptoms associated with the condition and there is a clear clinical need for the 
development of new treatments to manage the problem. Currently available 
treatments often require frequent application or do not produce the required 
alleviation of symptoms. The aim of this thesis was to establish if self-assembling 
peptides (SAPs) combined with nanohydroxyapatite seed crystals could be an 
effective treatment for the occlusion of human dentine tubules and so potentially 
alleviate the symptoms of dentine sensitivity.  
Nanohydroxyapatite (nanoHA) seed crystals were produced via hydrothermal 
synthesis and characterised using x-ray diffraction, dynamic light scattering, 
scanning electron microscopy and transmission electron microscopy. This 
confirmed the presence of highly crystalline rod shaped crystals with a median 
size of 45 nm (longest axis). A steady state in vitro nucleation and crystal growth 
assay (IVNCG) was used to determine the minimum nanoHA seed crystal 
density in agarose required to generate a total phosphate mass (indicative of 
quantity of mineral formed) comparable to that produced by the poly-L-glutamic 
acid positive control after 5 days exposure to buffers containing calcium and 
phosphate ions at physiological concentrations, pH and temperature. A transition 
in crystal morphology and composition, reflecting a shift from an OCP-like 
towards a HA-like chemistry and appearance, was seen on increasing nanoHA 
seeding density from 20 µg/mL to 30 µg/mL. SAPs (P11-13 and P11-14, 
complementary pair) were then combined with nanoHA seed crystals to produce 
a novel hybrid material. Its ability to support HA crystal growth was assessed 
using the IVNCG, without success, due to precipitation of the hybrid material. A 
novel precipitation assay was developed and used alongside a 1H NMR study to 
determine the cause of the observed precipitation. Precipitation was found to be 
associated with interaction and aggregation of the P11-13 peptide with nanoHA 
in the presence of calcium ions at the same concentration as those used in the 
IVNCG assay, possibly through calcium bridging.  
SAP/nanoHA hybrid material and P11-4 were applied to human dentine samples 
and their ability to reduce dentine permeability assessed using a fluid filtration 
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method after initial application and following 7 days incubation in artificial saliva 
(AS). Surprisingly, following treatment with the hybrid material, dentine 
permeability increased after 7 days in AS, possibly due to P11-13 interaction with 
the dentine tubule wall (as suggested by the 1H NMR experiments) resulting in 
compression of the non-slip layer. In contrast, P11-4 treated dentine showed a 
decrease in permeability after 7 days incubation in AS which was statistically 
insignificant compared to the positive control (I Bond universal, Kulzer)(p>0.05). 
The reduction in fluid flow was attributed to the formation of a 10 µm thick layer 
of crystals, believed to be HA, present 20 µm down the tubule and seen in the 
SEM analysis.  
In conclusion the P11-13/14 self-assembling peptides combined with nanoHA 
treatment produced no evidence of human dentine tubule occlusion and actually 
resulted in an increase in fluid flow through dentine. P11-4 treatment, in contrast, 
resulted in reduced dentine permeability and should be considered a candidate 
for further development as a dentine sensitivity treatment. 
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Chapter 1 - Introduction 
1.1 General Introduction 
The successful long-term treatment of dentine sensitivity remains a clinical 
challenge. Dentine sensitivity is defined as a short sharp pain arising from 
exposed dentine tubules in response to stimuli, typically thermal, evaporative, 
tactile, osmotic or chemical, which cannot be ascribed to any other dental defect 
or pathology (Holland et al., 1997). There are a wide range of available 
treatments to prevent the painful response to the stimuli produced on the surface 
of open dentine tubules but to date no treatment has been defined as “gold 
standard”. For a treatment to be defined as gold standard it would be required to 
produce the following effects: non-irritant to the pulp, easily applied, rapid in 
action, effective for a long time, without staining effects, relatively painless on 
application and economically viable (Kimura et al., 2000). As no treatment can 
claim to meet all of these desirable criteria, research into new materials using 
different treatment methodologies is ongoing.  
In the work presented in this thesis, a rationally designed self-assembling 
peptide/nanoHA hybrid material was optimised and assessed to determine its 
efficacy in promoting occlusion of dentine tubules in human dentine samples. 
The self-assembling peptide (SAP) component of the hybrid material was 
comprised of peptides P11-13 and P11-14 which have been rationally designed 
such that when combined in equimolar ratio under physiological conditions and 
at sufficient peptide concentration, they follow a hierarchical self-assembly 
process producing a 3-dimensional fibrillar network (Kyle et al., 2012). The P11-
13/14 SAPs when combined with nano-sized hydroxyapatite (HA) have been 
shown to be effective in favouring the growth of nanoHA seed crystals (Sayed, 
2013).  
The following thesis will test the hypothesis that the self-assembling 
peptide/nanoHA hybrid material is effective in occluding human dentine tubules. 
The rationale behind the proposed self-assembling peptide/nanoHA hybrid 
material dentine sensitivity treatment is that a solution of P11-13 seeded with 
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nanoHA and a second solution of P11-14 seeded with nanoHA would be applied 
separately to the dentine surface one after the other. The first nanoHA seeded 
peptide solution would penetrate in to the dentine tubules. The subsequent 
addition of the second nanoHA seeded peptide solution would then initiate the 
self-assembly process, resulting in the formation of a SAP gel, not only on the 
dentine surface, but within the dentine tubules. The nanoHA seed crystals 
contained within and supported by the SAP gel could then grow, promoting the 
occlusion of the dentine tubules. To optimise the SAP/nanoHA hybrid material 
with respect to its crystal growth potential, a high throughput in in vitro nucleation 
and crystal growth (IVNCG) assay was validated and utilised.  
To assess the SAP/nanoHA hybrid material with respect to its ability to reduce 
fluid flow through human dentine, a fluid filtration device was developed and 
validated. The fluid filtration device was based on the work of Reeder et al.  
(1978) and allowed for the measurement of dentine permeability with respect to 
fluid flow through the dentine. The optimised SAP/nanoHA hybrid material was 
applied to human dentine samples and the permeability of the dentine assessed 
after initial application and after 7 days incubation in AS solution, using the fluid 
filtration device. P11-4 SAP, the active ingredient in the commercially available 
Curodont dental regeneration/protection clinical products, was also tested in the 
same system to provide a comparison. 
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Chapter 2 - Literature Review 
The following chapter will provide a review of the literature relevant to the work 
presented in this thesis. The review is not exhaustive but provides a background 
source of literature detailing the anatomy and development of the tooth, along 
with an introduction to hydroxyapatite and its synthesis, including a brief 
introduction to the thermodynamics and kinetics of mineral formation. The clinical 
challenge of dentine sensitivity is described along with a review of current 
treatments and measurement techniques used in the development of new 
treatments. The final section provides an introduction to biomimetic peptide-
based treatments used in dental applications. Each subsequent chapter in this 
thesis contains a separate introduction which provides a more focussed and 
detailed review with respect to the topic covered in that chapter.  
2.1 Anatomy and Development of the Dental Tissues 
2.1.1 Tooth Anatomy  
To understand the causes of dentine sensitivity and develop new treatments to 
address the problem, an understanding of the anatomy of the tooth and its 
tissues is required. Enamel covers the entire crown of the tooth protecting the 
underlying dentine. Enamel provides the hardness of the tooth’s crown with a 
Young’s modulus of 94 ± 5 GPa which is smaller than steel (approximately 200 
GPa) but significantly larger than dentine (20 ± 2 GPa) (Xu et al., 1998). The 
hardness of enamel confers wear-resistance properties which are required for 
the mastication of food (Lin and Douglas, 1994). Enamel, although displaying 
remarkable hardness properties, is brittle and requires the underlying dentine, 
which has a much lower Young’s modulus to act as a cushion for loading 
transmission to prevent tooth failure (Lin and Douglas, 1994; Imbeni et al., 2005). 
The bulk of the tooth is composed of dentine, overlaid by enamel, while the inner 
core of the tooth contains a chamber where the pulp (the living part of the tooth) 
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resides. Below the tooth crown, the roots are covered in a thin mineralised tissue 
layer called the cementum, see Figure 2-1. 
 
Figure 2-1 Schematic showing the main tooth tissues modified from 
Blausen.com (2014). 
2.1.2 Enamel 
Mature enamel is the most mineralised tissue in the body consisting of >95% 
apatite material by weight (LeFevre and Manly, 1938). The structure of enamel 
is complex and results in a highly mineralised tissue which can withstand the 
mechanical and abrasive forces required throughout the lifetime of the organism 
(Fincham et al., 1999). As the tooth emerges from the oral cavity, the ameloblast 
layer, which is responsible for the formation of enamel, is lost, resulting in enamel 
being a non-vital and acellular tissue that cannot undergo cell-mediated 
regeneration (Nanci, 2013a), in contrast to bone, and dentine. Enamel can be 
said to have 3 levels of hierarchical structure (Ang et al., 2012). The first level of 
structure are the apatite nanocrystals approximately 60 nm wide with a thickness 
of 25 nm (Daculsi and Kerebel, 1978) and a length of at least 100 µm (Daculsi 
et al., 1984). These crystals are organised together to form rods (or prisms) 
approximately 3-4 μm in diameter which form the 2nd level of structure, and are 
thought to run from the enamel-dentine junction to the near surface of the tooth 
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enamel which is on average 2.5 mm thick (Oliveira et al., 2010) . The regions 
between the rods are occupied by interrod (inter-prismatic) enamel which can be 
distinguished from rod enamel as its crystals are orientated at 60° compared to 
the rod (White et al., 2001). The final level is the grouping of rods into Hunter and 
Schreger bands which  can be seen under light microscopy due to changes in 
direction between cohorts of adjacent rods (Homma, 1990).  
2.1.3 Dentine 
Dentine, composed of 70% inorganic material, 20% organic material and 10% 
H2O, makes up the bulk of the tooth tissue (Linde and Goldberg, 1993). Dentine 
is a mineralised tissue which has tubules running in parallel from the pulp to the 
enamel-dentine junction. Each of these tubules contains an odontoblast process 
which forms a layer at the pulpal-dentine interface (Ireland, 2006). Human 
dentine is a complex structure and can be of 3 different types: primary, secondary 
and tertiary dentine (Kuttler, 1959).  
Primary dentine makes up the majority of the tooth and lines the pulp chamber; 
it is also known as circumpulpal dentine (Nanci, 2013b). Primary dentine is not 
itself a homogenous layer and is made up of intertubular dentine and peritubular 
dentine (Goldberg et al., 2011). Intertubular dentine makes up the bulk of the 
primary dentine with the peritubular dentine lining the tubular lumen (inside 
space of the tubule) (Fearnhead, 1957). Intertubular dentine is comprised of a 
tightly woven network of type I collagen fibrils with apatite crystals deposited 
throughout while peritubular dentine is more highly calcified with less collagen 
present compared to intertubular dentine (Nanci, 2013b).  
Once the tooth becomes functional in the mouth, the formation of secondary 
dentine begins (Arana-Chavez and Massa, 2004). The thickness of secondary 
dentine increases with age and results in the size of the pulp chamber decreasing 
over time (Solheim, 1992). There is little compositional difference between 
primary and secondary dentine but secondary dentine does differ 
morphologically as the curvature of the tubules is more accentuated due to the 
growth of the dentine into the pulp chamber, which results in a reduction of the 
space for the odontoblasts (Goldberg et al., 2011).  
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The final type of dentine that can be present is tertiary dentine, also known as 
reactive dentine due to the fact that its formation is triggered through stimuli such 
as attrition, caries or dental procedures (Stanley et al., 1966; Smith et al., 1995).  
2.1.4 Dental Pulp 
The dental pulp is located in the central chamber of the tooth and is a soft 
connective tissue that supports the dentine and contains the “living” part of the 
tooth. The dental pulp can be split into 4 distinct zones (Nanci, 2013b).  
The first zone is called the odontoblast layer and is found at the periphery of the 
pulp chamber. The odontoblasts form a lining around the pulp chamber and have 
extended processes that reach into the dentine. The second zone is called the 
cell-free zone and as its name suggests, this zone contains little to no cells 
although there are areas occupied by blood capillaries, nerve fibres and the 
processes of fibroblasts (Gotjamanos, 1969; Trowbridge and Kim, 1994). The 
third zone is the cell-rich zone which contains the fibroblasts whose function is 
to maintain the pulp matrix (Nanci, 2013b) as well as perivascular cells, 
undifferentiated mesenchymal cells (Sloan and Smith, 2007) and postnatal 
human dental pulp stem cells (Gronthos et al., 2000). These cells are thought to 
ensure that the odontoblasts are repaired or regenerated if stimuli results in 
odontoblast damage/death (Smith et al., 1995). The final zone is the pulp core 
which contains the major blood vessels and the nerves of the pulp (Nanci, 
2013b). The nerve fibres (which when stimulated produce pain) have been 
shown to extend beyond the cell-free zone close to the odontoblast lining the 
pulp chamber (Dahl and Mjör, 1973).  
2.2 Tooth Development 
In humans, at around 37 days after conception, bands of thickened epithelium, 
called the primary epithelium bands, begin to form around the presumptive upper 
and lower jaws which initiate tooth development (Nanci, 2013c). The primary 
epithelium bands then grow into the neural crest derived mesenchymal forming 
the dental lamina which corresponds to the future position of the teeth (Pispa 
and Thesleff, 2003). Dental placodes then form which are localised thickenings 
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of the epithelium. These are thought to initiate which tooth type will form (incisor, 
canine, premolar, molar) (Mikkola, 2007).The mesenchyme then condenses 
around the ingrowing epithelium producing the tooth bud (Tucker and Sharpe, 
2004). As the bud grows further into the mesenchyme, it drags along the dental 
lamina and wraps around the condensing mesenchyme producing a cap sitting 
on a ball of mesenchyme; this is known as the cap stage, see Figure 2-2 (Tucker 
and Sharpe, 2004). The cap on the ball of condensed mesenchyme is known as 
the dental organ but will eventually produce the enamel of the tooth while the 
condensed mesenchymal ball will become the dental papilla which will form the 
dentine and pulp (Nanci, 2013c). As the development of the tooth continues, it 
begins to take on the shape of a bell as the condensing mesenchyme deepens 
into the neural-crest derived mesenchyme, producing the bell stage (Nanci, 
2013c). Towards the end of the bell stage, once the condensing mesenchyme is 
completely enclosed by the growing epithelium, the epithelial cells closest to the 
dental mesenchyme differentiate into enamel producing ameloblasts while the 
adjacent dental mesenchyme differentiates into dentine producing odontoblasts 
(Ruch et al., 1995).   
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Figure 2-2 Schematic of tooth development describing the stages of tooth 
development. Thickening stage occurs through oral epithelium 
growth into the mesenchyme. Mesenchyme then thickens in response 
to ingrowing epithelium resulting in the bud stage. As the epithelium 
grows deeper into the mesenchyme it wraps around the condensing 
mesenchyme producing the cap stage. The epithelium continues to 
grow into the mesenchyme producing a bell shape of condensed 
mesenchyme, differentiation of the epithelium cell occurs at the point 
of contact between the epithelium and condensed mesenchyme 
producing a layer of odontoblasts on the condensed mesenchyme 
and a layer of ameloblasts above the odontoblasts which go on to 
produce the enamel and dentine respectively. Image reproduced with 
permission from Tucker & Sharpe (2004). 
2.2.1 Amelogenesis 
During the bell stage of tooth development, the process of amelogenesis 
(enamel formation) begins. The formation of enamel can be described as 
proceeding in 3 stages: pre-secretory stage, secretory stage and the maturation 
stage (Leblond and Warshawsky, 1979).  
During the pre-secretory stage, the ameloblasts develop a protein synthesis 
apparatus which will enable the production and secretion of the organic matrix of 
enamel during the secretory stage (Nanci and Smith, 1999). The predominant 
protein present in the forming organic enamel matrix is amelogenin and its 
cleavage products, which constitute around 90% of the total organic enamel 
matrix although this can deviate depending on the amelogenesis stage (Termine 
et al., 1980). The amelogenin protein is alternatively spliced and subject to post-
secretory degradation generating a wide spectrum of amelogenin proteins 
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(Gibson et al., 1991). Amelogenins are mostly proteins 20-25 kDa (SDS 
molecular weight), primarily hydrophobic and rich in the amino acids proline 
(25%), glutamic acid (14%), leucine (9%) and histidine (7%) (Eastoe, 1960). The 
second most abundant protein present in the protein enamel matrix is called 
ameloblastin, which accounts for around 10% of the matrix composition. 
Ameloblastin is relatively large when compared to amelogenin, with a molecular 
weight of approximately 65 kDa (Nanci, 2013d). Ameloblastin is essential for the 
formation of enamel and has been shown to be responsible for the maintenance 
of the ameloblasts' phenotype and may facilitate the attachment of the 
ameloblasts to the matrix surface (Fukumoto et al., 2004). The final major 
component of the protein enamel matrix is called enamelin and contributes 
approximately 1% of the total matrix composition. Enamelin is the largest 
structural protein found in the protein enamel matrix with a molecular weight of 
approximately 186 kDa (Nanci, 2013d). Enamelin has been found to be essential 
to ensure ameloblast integrity and for the formation of enamel (Hu et al., 2014). 
Prior to the secretory stage, the ameloblasts begin to actively secrete enamel 
proteins which produce a thin layer of enamel containing no prisms. The 
ameloblasts then move away from the already formed dentine surface and form 
the Tomes' process at the enamel facing end of the cell (Nanci, 2013d).  
The formation of the Tomes’ process signals the beginning of the secretory 
stage. The Tomes’ process is a specialised structure at the secretory end of the 
ameloblast which controls the formation of enamel rods and enamel interrod 
material. Once the Tomes’ process has been formed, the secretion of enamel 
proteins occurs at 2 sites. The proximal site secretes proteins which form the 
interrod enamel, this process resulting in the formation of pits as the interrod 
enamel forms around the protruding distal part of the cell (Boyde, 1967). The pit 
is then filled with matrix secreted from the distal end site of the Tomes’ process, 
and this matrix participates in the formation of the enamel rods (Leblond and 
Warshawsky, 1979). The earliest mineral crystals present during enamel 
formation have been reported as long thin crystals with dimensions of 1.5 nm 
thickness and 15 nm width (Kerebel et al., 1979). Towards the end of the 
secretory phase, the amount of matrix protein decreases; this has been 
attributed to the withdrawal of protein following extracellular degradation 
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(Robinson et al., 1981). It is also the case that as the ameloblasts reach the 
surface limit of the tissue, they secrete progressively less protein (Robinson et 
al., 1988). Once the distal portion of the Tomes’ process is lost, the ameloblasts 
become shorter and produce enamel similar to the initial enamel that contained 
no rods, this makes up the last few increments of the enamel structure (the 
“aprismatic layer”) (Gwinnett, 1966). 
The final stage in amelogenesis is the maturation stage. Enamel hardens as the 
level of protein decreases and is replaced by tissue fluid, there is a rapid increase 
in the width and thickness  of the crystals. The study of the effect of bovine 
amelogenins on the growth of OCP crystals has shown that on removal of 
amelogenins, the crystal growth is primarily formed through the thickening of the 
individual crystals (width and thickness) (Iijima et al., 2001). It was reported that 
the loss of protein from the secretory stage crystal surfaces is the cause of this 
rapid mineral accumulation at the maturation stage, which suggests that the 
proteins exert control over the morphology of mineral crystals (Robinson et al., 
1989).  
2.2.2 Dentinogenesis  
Dentine is formed by odontoblast cells that have differentiated from the 
condensed mesenchymal cells of the dental papilla. The odontoblasts then begin 
the secretion of a matrix which will produce the first dentine layer called the 
dentine mantle (Arana-Chavez and Massa, 2004). This matrix consists of large-
diameter collagen type III fibres, known as Korff's fibres, which originate deep 
within the odontoblasts and extend towards the enamel organ (Nanci, 2013b).  
As the odontoblasts continue to grow in size, they begin to produce smaller type 
I collagen fibrils which position themselves parallel to where the dentinoenamel 
junction will form. This process results in the formation of the dental mantle 
(Nanci, 2013b). The odontoblasts produce small membrane bound vesicles, 
known as a matrix vesicles, which bud off and lie near the basal lamina and 
embed themselves in the organic matrix of dentine which consists of around 90% 
collagen, primarily type I but types III and V are also present in small amounts 
(Goldberg and Takagi, 1993). The collagen acts as a scaffold which provides a 
surface for the matrix vesicles to form upon (Nanci, 2013b). The mechanism by 
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which mineral is nucleated in dentine (and bone) has not be conclusively 
reported although there are theories as to how mineral nucleation is achieved. 
One widely accepted theory is that the mineral phase of dentine is initiated inside 
the matrix vesicle and as it grows it breaks through the vesicle and spreads a 
cluster of crystallites which interact and fuse with other erupting clusters of 
crystallites to produce a continuous mineral phase (Anderson, 1995). In dentine 
the formation of spherical matrix vesicles which imbed themselves within the 
surrounding collagen fibres has been reported (Eisenmann and Glick, 1972). The 
matrix vesicles have been shown to contain needle-like crystals suggesting that 
nucleation of calcium phosphate mineral occurs within these matrix vesicles 
(Eisenmann and Glick, 1972).  
A contradicting theory involves the non-collagenous proteins which are present 
in the dentine organic matrix with phosphophoryns being the most abundant 
(Dimuzio and Veis, 1978). Phosphophoryns have been reported to be capable 
of HA nucleation, have been found at the mineralising front and have been linked 
to the nucleation of HA crystals in vitro (Nawrot et al., 1976).  
The precise mechanism of mineral nucleation in dentine is therefore currently 
unclear although matrix vesicles or phosphophoryns are possible nucleating 
agents. Once the dentine mantle has been formed, the odontoblasts cease to 
produce matrix vesicles and instead begin to produce several non-collagenous 
matrix proteins (Arana-Chavez and Katchburian, 1998).  
The non-collagenous proteins include, but are not limited to, the previously 
described phosphophoryns, dentine matrix protein-1 and dentine sialoprotein. 
Dentine matrix protein-1 (DMP-1) is an acidic protein which has been shown to 
be capable of nucleating HA in vitro and control the morphology of the growing 
crystals into elongated rods (He et al., 2003). Dentine sialoprotein (DSP) has 
been shown in vitro to have a limited effect on HA nucleation and crystal growth 
(Boskey et al., 2000) but has been reported as a possible regulator of 
mesenchymal cell differentiation (Wan et al., 2016). The odontoblasts are always 
separated from the mineralising front by a layer of pre-dentine due to the 
mineralisation lag. As the odontoblasts move towards the pulp, one of the cell 
processes, known as a Tomes' fibre, becomes accentuated and is left behind, 
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while the dentine matrix will mineralise around this cell process resulting in the 
formation of the dentine tubules (Arana-Chavez and Massa, 2004). 
2.3 Hydroxyapatite 
The mineral phase of enamel and dentine is apatitic. “Apatite” is the general 
name given to a family of inorganic compounds which share a similar hexagonal 
crystal structure and crystal lattice point group P63/m (LeGeros, 1994). Apatite 
was first identified as a calcium phosphate salt in 1788 by Proust and Klaprota 
who also noted its similarity to bone (Smith, 1994). Calcium phosphate mineral 
can take the form of an apatite called hydroxyapatite which makes up the majority 
of the mineral content of vertebrates’ bone and teeth, although the composition 
of biological apatite can vary, see section 2.3.1, (Sadat-Shojai et al., 2013). The 
structure of apatite can be described by the general formula A4B6(MO4)6X2. In 
pure hydroxyapatite, calcium occupies 2 different sites, A and B, M is phosphorus 
and X is a hydroxyl group resulting in the formula Ca10(PO4)6OH2 (Kay et al., 
1964). Calcium’s occupation of two different sites is visible in Figure 2-3. 
 
Figure 2-3 Schematic representation of hydroxyapatite structure showing 
sites of hydroxyl, oxygen, calcium and phosphorus in the 
hydroxyapatite structure. Image reproduced with permission from 
Brunton et al.  (2013). (https://creativecommons.org/licenses/by/3.0/) 
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2.3.1 Biological Hydroxyapatite 
Biological hydroxyapatite is not pure as substitutions within the mineral structure 
can and do occur, for example bone is relatively rich in a carbonate and 
magnesium analogue of pure hydroxyapatite (Boskey, 2003), while dentine and 
enamel  have minor substituted components including, but not limited to, 
carbonate, magnesium and fluoride (Robinson et al., 1995). Biological 
hydroxyapatite is always nano-dimensional and nano-crystalline with dimensions 
of a few to hundreds of nano-meters. One reason for this biological preference 
is thought to be the result of natural selection as this size range can form specific 
interactions with proteins which can exert control over the morphology of the 
crystals formed (Dorozhkin, 2010).  
The substitutions within the crystal structure affect the resulting chemical 
properties of the mineral formed. The substitution of carbonate into the 
hydroxyapatite crystal structure can occur through the exchange of a hydroxyl 
ion (least common) (Elliott et al., 1985) or phosphate ion (most common) 
(LeGeros et al., 1967). The substitution of carbonate ions into the apatite crystals 
can result in a decrease in crystallinity due to a decrease in structural order 
caused by the replacement of the PO4 group with the smaller carbonate group 
which increases mineral solubility (LeGeros, 1981). The substitution of 
magnesium ions for calcium ions in the apatite has been shown to inhibit the 
growth of apatite crystals through stabilising the formation of tricalicum 
phosphate or amorphous calcium phosphate of the crystal surface resulting in 
smaller sized crystals (LeGeros, 1981). The inclusion of magnesium in brushite 
cement formulations has been shown to retard the formation of hydroxyapatite 
through stabilising the tricalicum phosphate precursor phase preventing the 
formation of HA which decreases the compressive strength in vivo and increases 
the reabsorption of the cement (Lilley et al., 2005). The substitutions of carbonate 
and magnesium which can occur in biological apatite have been shown to 
increase the dissolution of biological apatite under acidic conditions which is 
caused by the decrease in crystallinity associated with the substitution  (Legeros 
et al., 1995). Although when the organic component of the biological tissue was 
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present, dissolution under acidic conditions was reduced suggesting the organic 
component plays an important role in the protection of biological apatite under 
acidic conditions (Legeros et al., 1995).  
Fluoride ions can be incorporated into hydroxyapatite through substitution with 
the hydroxyl group (Young, 1974) and results in an apatite with reduced solubility 
under acidic conditions caused by the contraction of the apatite crystal structure 
caused by the electronegative fluoride ions substitution with the hydroxyl group  
(Buonocore and Bibby, 1945). Fluoride toothpastes, which result in the 
substitution of fluoride into enamel crystals, are extensively used to reduce 
enamel erosion and prevent the formation of enamel caries through producing 
an acid resistant fluorapatite layer on the tooth surface(Featherstone, 1999). 
2.3.2 Synthesis Methods 
It is generally accepted that hydroxyapatite nanoparticles are preferable to 
macro-sized particles when we are considering their use in hard tissue 
engineering. This preference is due to the poor bioresorbability and brittle 
characteristics of macro-sized particles compared to that of the nano-sized 
particles (Zakaria et al., 2013). The demand for nano-sized particles of 
hydroxyapatite has resulted in a steady increase in the number of publications 
related to the synthesis of hydroxyapatite nanoparticles (nanoHA). A recent 
review carried out by Sadat-Shojai et al. (2013) found an increase from 25 
publications in 1999 to 75 publications in 2011 indexed in Scopus, relating to 
methods of nanoHA synthesis (Sadat-Shojai et al., 2013). This trend displays the 
increasing interest in hydroxyapatite nanoparticles as well as the challenges of 
producing them. 
There are a number of different methods which can be used to synthesise 
nanoHA depending on the type of hydroxyapatite required, which in turn depends 
on its chosen application. Phase composition, purity, crystallinity, particle size, 
particle-size distribution, specific surface area, density and particle morphology 
can all be controlled through the synthesis methodology chosen (Abidi and 
Murtaza, 2014). Synthesis methods include but are not limited to sol-gel (Fathi 
et al., 2008), hydrothermal (Earl et al., 2006a), wet chemical precipitation (Abidi 
and Murtaza, 2014) and hydrolysis (Nakahira et al., 1999).  
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Hydrolysis of various calcium phosphate minerals, examples being 
CaHPO4.2H2O (Shih et al., 2004) and 3Ca3(PO4)2 (Durucan and Brown, 2000), 
using CaCO3 has been shown to be effective in the synthesis of nanoHA. The 
hydrolysis method can proceed under a range of temperature and pH values. 
The calcium phosphate mineral to be hydrolysed (see above) is mixed with 
CaCO3 at a Ca/P molar ratio of 1.67 and poured into a NaOH solution. The 
mixture then undergoes agitation at high temperature (below 100 °C) for a period 
of time. The reaction is then stopped through the addition of ice cold H2O. The 
resulting suspension is then washed and dried. The suspension can then be 
heat-treated to remove undesired phases. The resulting nanoHA produced can 
vary in phase purity and size although single phase crystalline nanorod HA has 
been reported (Shih et al., 2004).  
The sol-gel methodology of nanoHA particle synthesis often involves the 
formation of a triethyl phosphite colloid suspension in anhydrous ethanol with a 
small amount of H2O added to allow for hydrolysis (Liu et al., 2001). Once 
hydrolysis is complete, a stoichiometric (Ca/P molar ratio of 1.67) amount of 
calcium nitrate dissolved in anhydrous ethanol is added dropwise to the solution 
under constant stirring. The ethanol is then removed through drying at 60 °C 
resulting in a gel product. The gel is then heated in a furnace at various 
temperatures to produce the final nanoHA product. The processing of the sol-gel 
method product has been shown to have a significant effect on the resulting Ca/P 
ratio of the powders formed (Bilton et al., 2010).   
Wet chemical precipitation is a common method used and is relatively easy to 
carry out; it can be used to produce large quantities of product and at cheap cost 
(Berzina-cimdina and Borodajenko, 2012). A calcium solution, normally calcium 
hydroxide or calcium nitrate, is prepared along with a phosphate solution, 
normally orthophosphoric acid or di-ammonium hydrogen phosphate, and both 
are added dropwise to each other under continuous stirring which results in the 
precipitation of hydroxyapatite. Once the addition is complete the suspension 
can then undergo further processes such as aging, washing, drying and thermal 
treatment which, depending on the method used to achieve these processes, 
16 
 
can alter the final structure of the nanohydroxyapatite crystals produced (Sadat-
Shojai et al., 2013).  
A variation of the wet chemical precipitation method is the hydrothermal method 
which uses the same initial precipitation reaction but the suspension is then 
treated at high temperature and pressure to promote the 1-dimensional growth 
of crystals resulting in the production of nanorods (Earl et al., 2006a). One issue 
with this method compared to others is the cost as expensive equipment is 
needed to obtain the required temperatures and pressures (Sadat-Shojai et al., 
2013).  
2.3.3 Characterisation Techniques 
Once hydroxyapatite has been synthesised, characterisation of the resulting 
nanoparticles is required to determine if the reaction has been successful. There 
are a number of techniques that can be used to determine the composition, size, 
shape and size distribution of the nanoparticles produced. A few of the main 
techniques will be introduced below along with the information that the technique 
provides. 
Fourier transformed infrared spectroscopy (FTIR) provides information on the 
chemical bonds present in a material through exciting chemical bonds causing 
vibrations. The frequency at which a chemical bond absorbs energy is dependent 
on the strength of the bond, the atoms involved in the vibration and the vibrating 
bonds’ interactions with the surrounding environment. FTIR produces an 
absorbance or transmission spectrum which can be assigned to specific bonds 
within a material. FTIR can be used in hydroxyapatite nanoparticle 
characterisation to assess 2 main parameters: maximum absorption which 
indicates composition and peak width which provides information concerning the 
degree of order within the material (Berzina-cimdina and Borodajenko, 2012). 
The characteristic chemical groups present in the FTIR spectrum of synthesised 
hydroxyapatite are commonly PO43-, OH-, CO32- (Fathi et al., 2008). 
Dynamic light scattering provides information on the size distribution of particles 
suspended in solution (Müller et al., 2014). The technique involves the passing 
of a laser through a particle suspension. The laser light interacts with the particles 
and is scattered. The scattered light is detected and the angle at which the 
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photon was scattered relative to the laser beam is used to calculate the size of 
the particle. The measurement of particle size when analysing nanoparticles can 
overestimate the size due to the instruments measurement of hydrodynamic 
radius, that is its hydrated size (Bhattacharjee, 2016). Measurement of 
hydrodynamic radius produces size values larger than the true size of the 
particle. This effect is negligible when considering micron sized particles but can 
produce a significant effect when using nm sized particles (Kaasalainen et al., 
2017).  
X-ray diffraction (XRD) is a technique that is widely used to determine the 
structure of crystalline material. X-rays have wavelengths of approximately 10-10 
m which is the same order of magnitude as the distances between atoms in 
molecules. This results in the diffraction of x-rays when they interact with a 
molecule (Housecroft and Sharpe, 2008). The peaks produced in an x-ray 
spectrum can provide information on the crystal structure and composition 
(Bragg, 1913), as diffraction patterns from experiments can be compared to 
reference spectra (Sudarsanan and Young, 1969). The degree of crystallisation 
can also be determined from x-ray diffraction spectra since the more defined the 
peaks are, the more crystalline the sample is, due to the alignment of crystal 
plains within a highly crystalline sample (Abidi and Murtaza, 2014). 
Transmission electron microscopy (TEM) uses the same principles as a light 
microscope but utilises electrons instead of light. Electrons are accelerated then 
projected onto a thin sample (approx. 50 nm thick). As the electrons travel 
through the sample, they interact with the sample atoms in one of 2 ways. When 
an electron approaches the atom it can be deflected by the atoms nucleus 
(elastic scattering) and this deflection can divert the electron away from the 
detector. The second possible interaction is that the electron dislodges an 
electron in the specimen (inelastic scattering), producing a secondary electron 
of lower energy that does not reach the detector. Both of these interactions result 
in electron not forming the image. The electrons that reach the detector are used 
to form the final image (Dykstra and Reuss, 2003). This technique is used to 
determine the morphology of hydroxyapatite nanoparticles (Tao et al., 2007; 
Fathi et al., 2008). 
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Scanning electron microscopy (SEM) is similar to TEM although in SEM the 
electrons which interact with the sample are not the electrons that are used to 
produce the final image. The SEM performs a raster scan of the sample surface 
and detects secondary electrons which are produced from the beams interaction 
with the sample’s surface. These secondary electrons are detected and used to 
form an image of the samples surface. SEM can be used to determine 
morphology of hydroxyapatite nanoparticles (Kumta et al., 2005).  
Energy-dispersive x-ray spectroscopy can also be used in the characterisation 
of hydroxyapatite nanoparticles. This technique uses an electron beam that 
interacts with the sample in the same manner as in SEM and TEM. One of the 
possible outcomes of the electron beam interacting with the sample is that an 
electron from the beam will collide with an orbital electron of the sample and 
cause it to be dislodged. This results in an unstable electron configuration and 
an electron from a higher shell will fall back to fill the electron vacancy. The 
difference in energy between the electron vacancy and the higher energy level 
electron results in the emission of an x-ray with energy equal to the difference 
between the 2 levels. These energies are characteristic of the atom in which they 
occur and this can be used to determine the elemental composition of the 
sample. In hydroxyapatite particle synthesis, this is useful as it enables the 
determination of the calcium to phosphate molar ratio which if equaling 1.67 is 
consistent with hydroxyapatite (He et al., 2003). A comparison of the information 
provided by the characterisation methods used in this thesis and associated 
limitations is supplied in section 3.4. 
2.4 Mechanisms of Mineralisation  
Mineral crystal formation is a process whereby a system (solution which is 
saturated with respect to a mineral crystal phase) moves from a high energy 
state to a lower energy state through the formation of a crystal phase. The origin 
of the energy difference between the energy states is related to the solubility of 
the inorganic crystal phase that is produced. The solubility of an inorganic salt 
can be defined as the amount of pure solid that can dissolve in one litre of water. 
The change in energy that accompanies the dissolution of a solid into the 
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aqueous phase, the free energy of solution ∆GS, is described by     Equation 
2.4-1 with ∆GL, the free energy change for crystal lattice disruption. The 3 
negative terms are hydration ∆GH, ion pairing, ∆GIP and complex formation, 
∆GC. The sum of all 4 terms produces the free energy of solution ∆GS. If the 
resulting ΔGS is negative the system will move towards dissolution.  
∆𝐆𝐒 =  ∆𝐆𝐋 −  (∆𝐆𝐇 +  ∆𝐆𝐈𝐏 +  ∆𝐆𝐂)     Equation 2.4-1 
 
The solubility product Ksp is the product of the effective concentrations (activities) 
of ions at equilibrium with their corresponding solid phase, Equation 2.4-2. The 
Ksp of an inorganic salt is related to the free energy of solution ∆GS through 
Equation 2.4-3 with R being the gas constant and T the temperature. 
𝑲𝒔𝒑 =  [𝑿−]. [𝑴+]       Equation 2.4-2 
∆𝑮𝑺 =  −𝑹𝑻 𝒍𝒏(𝑲𝒔𝒑)   Equation 2.4-3 
 
The solubility product Ksp sets the thermodynamic point for the precipitation of a 
solid. The thermodynamic driving force for crystallisation is the supersaturation 
(SR) which is the difference between the activity product (AP) and the solubility 
product Ksp at equilibrium. Equation 2.4-4 shows this relationship. When SR is 
below 1 the solution is not saturated enough to produce a solid phase whereas 
if it is above 1 spontaneous formation of a solid phase is favourable. 
𝑺𝑹 =
𝑨𝑷
𝑲𝒔𝒑
         Equation 2.4-4 
 
Supersaturation, SR, is a measure of the difference between the system 
concentrations and the equilibrium concentrations and is a measure of how far 
the system is from the equilibrium state and is the thermodynamic driving force 
for crystallisation. Supersaturation can be achieved through a number of different 
methods for example chemical reactions, temperature changes, pH changes and 
solvent evaporation (Mann, 2001a). 
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2.4.1 Nucleation 
The thermodynamic driving force for crystallisation is the supersaturation level in 
a given solution. However, this driving force is often overshadowed by significant 
kinetic effects that prevent crystallisation from occurring (Davey and Garside, 
2000a). The process by which crystallisation is initiated in a supersaturated 
solution to produce a new solid phase is called nucleation. The nucleation 
process can be initiated through homogenous nucleation or heterogeneous 
nucleation. Homogenous nucleation involves the spontaneous formation of a 
new phase within the supersaturated system. This formation of a new phase is 
kinetically unfavourable as the nucleus of the new phase has to become large 
enough to be energetically stable. This nucleus size is known as the “critical 
cluster size”. Any nucleus below this critical cluster size is prone to dissolution 
and often dissolves back into solution before it has had the time to grow to the 
critical cluster size, see Figure 2-4. The origin of the critical cluster size is due to 
the energetically unfavourable formation of a new solid-liquid interface. The 
solid-liquid interface results in the solid phase having 2 classes of atoms, the 
interior atoms and the surface interface atoms. The interior ions have all their 
intermolecular interactions satisfied by other solid phase atoms while the surface 
interface atoms only have a portion of their total interactions satisfied. It is the 
unsatisfied interactions of the surface ions which are energetically strained 
producing a dissolution favouring energy called the interfacial tension γ. 
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Figure 2-4 Schematic describing the nucleation of a crystal phase from a 
saturated solution with respect to the crystal phase. The formation of 
a crystal with a radius below the critical cluster size is energetically 
unfavourable and the equilibrium will be in favour of ions. A small 
number will grow above the critical cluster radius resulting in a stable 
crystal with respect to dissolution. Size of arrow indicative of favoured 
equilibrium position.  
When we consider the energy of the 2 types of atoms in the solid phase Equation 
2.4-5 can be produced with respect to the nucleation free energy ∆Gn, with Gi 
being the internal atoms free energy and Ge being the external ions free energy 
(Davey and Garside, 2000a). 
∆𝑮𝒏 =  𝑮𝒊 +  𝑮𝒆             Equation 2.4-5 
 
The internal molecules stabilise the formation of the new solid phase and so act 
to lower the free energy. The surface molecules destabilise the new phase and 
raise the free energy. We can consider the nucleus as a sphere. The surface 
area is proportional to the number of surface ions and the volume is proportional 
to number of internal ions. The equations for the surface area, Equation 2.4-6, 
and volume, Equation 2.4-7, are shown below with r being the radius of the 
sphere. 
𝑨𝒓𝒆𝒂 𝒐𝒇 𝒔𝒑𝒉𝒆𝒓𝒆 = 𝟒 𝝅 𝒓𝟐             Equation 2.4-6 
𝑽𝒐𝒍𝒖𝒎𝒆 𝒐𝒇 𝒔𝒑𝒉𝒆𝒓𝒆 =
𝟒
𝟑
 𝝅 𝒓𝟑        Equation 2.4-7 
 
It can be seen, from the equations above, that as the sphere grows the number 
of surface atoms decrease with respect to the number internal atoms due to the 
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difference in powers of r. Initially the gain of free energy due to the surface atoms 
outweighs the loss from the internal atoms resulting in the nucleus dissolution. 
As the sphere grows, the positive free energy decreases until it becomes 
negative. At this point the cluster has reached the critical cluster size. Any 
addition growth in the cluster results in the favourable lowering of the free energy 
producing crystal growth. 
The second form of nucleation, heterogeneous nucleation, is a modification of 
the homogeneous process and occurs when the system contains a foreign 
particulate contaminant or an added template seed. If the system contains 
foreign bodies, these can act as catalysts for nucleation as they act to reduce 
the Ge term in equation 2.4-5. This reduction in the dissolution favouring Ge free 
energy lowers the activation energy for nucleation favouring solid phase growth. 
The extent to which a foreign body lowers the Ge term is dependent on how well 
the foreign body mimics the structure of the resulting solid phase. Due to the 
difficulty in producing a system that is completely foreign body free, 
heterogeneous nucleation is the most common way in which a solid phase is 
produced (Davey and Garside, 2000a).  
2.4.2 Crystal Growth 
Once a stable nucleus has formed in a saturated system, the number of atoms 
joining the solid phase is greater than the number of atoms leaving. This results 
in the growth of the solid phase through secondary crystal growth. Secondary 
crystal growth requires the presence of solid crystal material and can occur at 
saturations lower than the values required for heterogeneous and homogenous 
nucleation. Secondary crystal growth can occur through different mechanisms 
but is driven by the clustering of ions in solution near the solid/liquid interface. 
The driving force for crystal growth is the availability of active sites on the crystal 
surface which, having high binding energies, lower the free energy of the system 
when ions are incorporated into these sites, resulting in the growth of the solid 
phase. Certain sites on the surface provide more stabilisation energy than 
others, see Figure 2-5 which shows the potential active sites on a crystal surface. 
The bigger the increase in surface area interaction between incoming ions and 
the solid phase, the higher the binding energy. The step vacancy produces the 
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largest surface area interaction between the solid and incoming ion (in the 
schematic the incoming ion would be a square the size of the step vacancy) while 
the terrace site would produce the lowest surface area interaction (Davey and 
Garside, 2000b). 
 
Figure 2-5 Schematic diagram of the substrate surface showing the 
possible active sites for crystal growth. In order of largest to smallest 
binding energy: terrace vacancy, step vacancy, kink site, step side, 
terrace site (Davey & Garside, 2000a). 
2.4.3 Mineralisation in Biological Systems  
The biological formation of hard tissues can be split into 2 groups depending on 
the level of cellular control over mineralisation. Biologically induced 
biomineralisation has the least amount of control while biologically controlled 
mineralisation has the highest degree of control over the resulting mineral phase 
(Lowenstam and Weiner, 1989). Biologically controlled mineralisation is a cell-
mediated process that produces minerals with specific biological functions. 
Biominerals produced through controlled mineralisation have species-specific 
crystallochemical properties which are a direct result of the cellular control 
exerted during their formation (Mann, 2001b). These properties include, but are 
not limited to, high level of spatial organisation, higher order assembly into 
hierarchical structures and uniform particle size.  
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A distinctive feature of nearly all biologically controlled mineralisation is the 
sealing off of the mineralisation site known as space delineation (Wilbur, 1984). 
The sealing off of the mineralisation front allows the cell-mediated process to 
deliver the required ions to the mineralising matrix, thus preventing the need for 
a system wide supersaturation with respect to the mineral formed. The 
mechanism by which mineral is nucleated in developing enamel is not fully 
understood.  
The amelogenin proteins have been shown to self-assemble to form nanosphere 
structures which have been identified as the principal structural component of 
the forming enamel organic matrix during the secretory stage (Robinson et al., 
1981). The self-assembly of amelogenin is hydrophobically driven and the 
resulting nanospheres have been shown to self-assemble into linear arrays of 
microribbons, which, when immersed in meta-stable calcium phosphate solution, 
produced ordered and aligned crystals along the long axis of the microribbons 
(Du et al., 2005). The presence of mouse amelogenin has been shown to 
promote the nucleation of octacalcium phosphate (OCP) in vitro through a 
suggested lowering of the interfacial energy and increasing supersaturation with 
respect to hydroxyapatite (HA) and OCP (Tarasevich et al., 2007). Previous 
studies carried out by Hunter et al. (1996) using a gel-based in vitro system 
determined that the presence of amelogenin did not increase the quantity or 
affect the morphology of the calcium phosphate mineral produced. The in vitro 
study by Tarasevich et al (2007) did not identify the process that occurs in vivo 
but did determine that amelogenin is capable of calcium phosphate nucleation 
and crystal growth.  
The formation of OCP as an initial precursor to enamel has been hypothesised 
although no consensus has been achieved (Brown et al., 1987; Simmer and 
Fincham, 1995; Tarasevich et al., 2007). The epitaxial growth (deposition of a 
crystalline overlayer) of HA on an OCP surface has been shown to have a “near 
perfect structural fit” producing a very low interfacial energy, see heterogeneous 
nucleation section 2.4.1, which would support the hypothesised OCP to HA 
transition process (Brown et al., 1987). The process by which the mineralised 
tissues of the body are formed are complex which, as described in section 2.2, 
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involve a range of different biological processes which are not fully understood. 
When considering that these mineralised tissues can become damaged, it is a 
challenge to repair or replace them. One condition, caused through the exposure 
of dentine tubules to the oral environment, is dentine sensitivity which continues 
to be a difficult condition to treat.  
2.5  Clinical Challenge of Dentine Sensitivity 
2.5.1 Definition, Causes and Prevalence of Dentine Sensitivity 
Dentine sensitivity is defined as a short sharp pain arising from exposed dentine 
in response to stimuli, typically thermal, evaporative, tactile, osmotic or chemical, 
which cannot be ascribed to any other dental defect or pathology (Holland et al., 
1997). Diagnosis of dentine sensitivity can be difficult as there are many other 
conditions that can result in the same symptoms, examples being caries, failed 
restorations and cracked cusps, which are treated and managed using different 
procedures (Addy and Peace, 1994). Conservative estimates of the prevalence 
of dentine sensitivity in the general population range from 3.8% to 35% 
depending on the population studied (Rees and Addy, 2002) and is most 
common in people aged between 20-40 years with its peak occurring in adults 
aged around 30 years old (Bartold, 2006). To be diagnosed as dentine sensitivity, 
the dentine tubules must be exposed and open. 
In healthy teeth, the dentine is covered in a layer of enamel above the gingiva 
and with a layer of cementum below, with the point at which they meet being 
called the enamel-cementum junction. There are a number of aetiological and 
predisposing factors that can result in the removal of the enamel or cementum, 
rendering the dentine exposed, which can lead to the development of dentine 
sensitivity (Dababneh et al., 1999).  
Enamel can be removed through attrition, abrasion or erosion and it is often a 
combination of these processes that results in the exposure of the underlying 
dentine (Dababneh et al., 1999). In the case of the removal of cementum, 
recession of the gingivae can expose the cementum to the oral environment. The 
cementum can be easily abraded away once exposed (for example through teeth 
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brushing) which in turn exposes the underlying dentine. Gingival recession is a 
condition that itself has a number of causes such as poor dental hygiene, 
improper bushing and general ageing (Marini et al., 2004; Heasman et al., 2017). 
In some people a developmental abnormality results in the enamel and 
cementum not meeting at the enamel-cementum junction which also results in a 
section of dentine being exposed (Bartold, 2006).  
A key part of the definition of dentine sensitivity is not only that the dentinal 
tubules be exposed but that the dentine tubules must be open. Exposed dentine 
naturally acquires a layer of organic and inorganic material which covers the 
dentine surface and produces plugs which penetrate down into the dentine 
tubules, see Figure 2-6. This layer acts as an insulator, protecting the dentine 
from pain-causing stimuli. After dental procedures that involve cutting, through 
the use of chisels, reamers or files, small fragments of mineralised material are 
produced which can become lodged in the dentine tubules producing a “smear 
layer” (Eldarrat et al., 2004). Once lodged in the tubules, the layer can become 
colonised by acid producing bacteria which result in the dissolution of the smear 
layer mineralised component after 7-10 days which can in turn result in the 
development of dentine sensitivity in the patient (Pashley, 2013). 
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Figure 2-6 Smear layer covered human dentine. SL is the smear layer on 
the surface while SP is the penetration of the smear layer into the 
tubule. Image reproduced with permission from Pashley (2013). 
2.5.2 Mechanism of Dentine Sensitivity 
Several theories have been proposed to explain how stimuli acting on the surface 
of exposed dentine can be transmitted through the dentine and result in 
stimulation of the nerves within the pulp (Addy and Dowell, 1983a). The first of 
these theories is the innervation theory, which postulates that the direct 
stimulation of nerves within the dentine is what produces the pain response 
(Fearnhead, 1957). If this theory was the true mechanism of dentine sensitivity, 
the numbing of the nerves within the dentine, and not the nerves of the pulp, 
would result in the prevention of pain. However, this was proven not to be the 
case and so it can be concluded that although the innervated nature of dentine 
could result in the sensing of stimuli and cause pain, it is not solely or at all 
dependent on the nerves present in the inner third of the dentine (Yu and Abbott, 
2007). Another theory is that the odontoblasts act as receptor cells which, with 
their processes extending into the dentine and up to the enamel dentine junction, 
are directly stimulated before transferring this stimulation to the nerves within the 
pulp (Avery and Rapp, 1958) . The issue with this theory is that the odontoblasts 
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are matrix forming cells and are not thought to be able to transmit stimuli as no 
synapses have been observed between the odontoblasts and the nerve endings 
(Yu and Abbott, 2007). The final theory, and the most popular one, is the 
hydrodynamic theory, which postulates that the movement of fluid within the 
dentine tubule in response to stimuli at the dentine surface causes the nerve 
ending in the pulp to excite as they are sensitive to a sudden change in pressure 
and fluid movement (Brannstrom, 1963). The hydrodynamic theory explains why 
the presence of local anaesthetics applied to dentine does not prevent pain as 
the nerves are stimulated within the pulp through a distortion of the pulpal 
pressure. 
2.5.3 Dentine Sensitivity Treatments 
There are a number of treatment options available to sufferers of dentine 
sensitivity for use at home and in the clinic. Treatments can be split into one of 2 
categories depending on the method used to alleviate the painful symptoms, see 
Figure 2-7. The first category uses numbing agents which act through diffusing 
along the dentine tubule and into the pulp. These numbing agents then interact 
with the nerve endings to reduce their sensitivity to changes in pressure (Bartold, 
2006). The second method utilised to provide relief from the symptoms of dentine 
sensitivity is through the occlusion of the dentine tubules, which prevents the 
dentine surface stimuli from interacting with the nerves.  
As previously mentioned there are many different treatments available and the 
following section will provide a summary of the main treatment options currently 
used, along with some of the treatments currently under development. The 
reason for the large range of treatments available is due to a number of criteria 
which are thought to be required for a successful treatment. These requirements 
are: non-irritant to the pulp, easily applied, rapid in action, effective for a long 
time, without staining effects, consistently effective and relatively painless on 
application (Kimura et al., 2000). The lack of any treatment which fulfils all the 
above criteria and the lack of a gold standard treatment to compare new 
treatments against have resulted in a varied array of treatments using different 
methods of action and chemical composition to be produced (Dababneh et al., 
1999).  
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Figure 2-7 The 2 dentine sensitivity treatment strategies, nerve 
stabilisation through the use of numbing agents (Red) which diffuse 
down the tubule and prevent stimulation of the nerves. Tubule 
occlusion blocks the dentine tubule which prevents the change in 
fluid flow within the tubule due to dentine surface stimuli (Blue).  
2.5.4 Nerve Desensitisation Treatments 
Potassium salts are known as “numbing agents” and were used as pain relief 
before the discovery of anaesthetics. Potassium nitrate was first reported to be 
effective in the treatment of dentine sensitivity by Hodosh and fulfilled some of 
the criteria required for a successful treatment, these being its effectiveness, 
non-irritating and non-discolouring effects on teeth (Hodosh, 1974). The 
mechanism by which potassium nitrate alleviates the symptoms of dentine 
sensitivity is unknown but it is postulated that the increase in extracellular 
potassium ions surrounding the nerves could be the mode of action. The 
increased potassium concentration is thought to depolarise the nerve fibres 
preventing them from activating in response to a change in pressure or fluid 
movement (Markowitz et al., 1991). Potassium nitrate, potassium chloride and 
potassium citrate are all used in nerve desensitising toothpastes. Potassium 
nitrate is the most commonly used potassium salt with the 2 largest 
manufacturers, GlaxoSmithKline and Colgate Palmolive, having respectively 9 
and 2 different types of toothpaste  containing potassium nitrate as their active 
ingredient (Beddis et al., 2013). Nerve desensitising treatments do not lend 
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themselves well to clinical use due to the need for repeated applications to 
maintain the potassium concentration surrounding the nerves, hence their 
delivery via toothpaste and mouthwash. Potassium nitrate formulated into a 
mouthwash has recently been shown to be effective in the reduction of dentine 
sensitivity (Gillam et al., 2018) confirming earlier studies (Gillam et al., 1996) 
2.5.5 Occlusion Treatments 
Occlusion of the dentine tubules is the other method used in the treatment of 
dentine sensitivity and there are a variety of different materials and techniques 
which are used to achieve the occlusion of open dentine tubules. Occlusion 
treatments can be split into 2 groups: the first occludes through the introduction 
of compounds which act to block the tubules through the formation of an 
insoluble layer that penetrates into the tubules and covers the dentine surface or 
promotes the formation of natural biological minerals within the tubules 
(Mantzourani and Sharma, 2013);  the second group involves the formation of a 
plugging layer through mechanical means, examples being the brushing of 
dentine to produce fragments of natural hydroxyapatite which then diffuse into 
the tubules producing a smear layer (Knight et al., 1993). The following 2 
sections will describe a number of treatment options split between those applied 
at home, through dentifrices, and those applied in clinic by dental professionals.  
2.5.6 “At Home” Occlusion Treatments 
Strontium in the form of strontium chloride was the active ingredient in the original 
Sensodyne toothpaste and was first introduced commercially over 50 years ago 
although this has now largely been replaced by strontium acetate due to its 
superior clinical efficacy as it is compatible with fluoride (Mantzourani and 
Sharma, 2013). The mechanism by which strontium acts to alleviate the 
symptoms of dentine sensitivity is not fully understood but possible explanations 
of its mode of action include acceleration of the deposition of calcium-containing 
minerals in the dentine tubules reducing fluid movement and stabilisation of the 
nerve cell impulses resulting in nerve de-sensitisation (Addy and Dowell, 1983b). 
Strontium-based dentine sensitivity treatments have been reported to be 
clinically effective in the reduction of the painful symptoms associated with 
dentine sensitivity (Kishore et al., 2002) but the evidence for the effectiveness of 
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strontium (and potassium) based treatments has been questioned and a 
systematic review carried out by Karim and Gillam concluded that, as yet, there 
is no clear evidence to support the effectiveness of these treatments (Karim and 
Gillam, 2013). 
A relatively new treatment for dentine sensitivity utilises the amino acid arginine 
to promote the occlusion of dentine tubules. The treatment is delivered via 
toothpaste and is currently commercially available as Colgate sensitive Pro-
Relief (Olley et al., 2012). The active ingredients consist of arginine, calcium 
carbonate and fluoride which act to plug the open dentine tubules with a calcium 
carbonate layer and accelerate the natural mechanism of tubule occlusion 
through the deposition of dentine-like mineral within the tubules while forming a 
protective layer on the dentine surface (Petrou et al., 2009). Clinical trials have 
reported its effectiveness at reducing the painful symptoms associated with 
dentine sensitivity (Ayad et al., 2009; Schlee et al., 2017). Another clinical trial 
reported that the arginine treatment was less effective when compared to the 
strontium acetate treatment when both underwent a dietary acid challenge which 
suggests that the calcium carbonate layer is more susceptible to acidic diets 
(Olley et al., 2012).   
Another class of compounds used in the treatment of dentine sensitivity are 
bioglasses. Bioglasses have been developed to consist of specific ratios of 
silicon dioxide, disodium oxide, calcium oxide and phosphorus pentoxide, and 
have been reported as effective in the occlusion of dentine tubules (Cochrane et 
al., 2010; Zhong et al., 2015). The mechanism through which tubule occlusion is 
produced proceeds in 5 stages. The first stage begins with the diffusion of the 
bioglass into the dentine and exposure of the glass to an aqueous environment, 
which results in the exchange of sodium ions within the glass with hydrogen ions 
in solution, thereby producing an increase in the local pH. The second stage is 
the loss of soluble silica through the breaking of silicon-oxygen-silicon bonds and 
the formation of silanols at the glass-aqueous interface. The third stage consists 
in the condensation of the silanols at the surface of the glass, producing a silicon 
rich layer. The fourth stage is the migration of calcium and phosphate from within 
the glass to the surface forming a calcium and phosphate rich layer, and the final 
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stage results in the crystallisation of an amorphous hydroxyapatite layer which 
incorporates hydroxyl, carbonate and fluoride anions present in solution (Hench, 
1991). The bioglass ‘45S5’ contains 45% silicon dioxide, 24.5% disodium oxide, 
24.5% calcium oxide and 6% phosphorus pentoxide and for use in dental 
applications is marketed under the name “Novamin” (Cochrane et al., 2010). 
Clinical data suggest that Novamin-based treatment is effective in the occlusion 
of dentine tubules (Pradeep and Sharma, 2010; Majji and Murthy, 2016). 
Research into new bioglasses is ongoing with a number of experimental 
bioglasess being assessed as potential dentine sensitivity treatments (Mitchell 
et al., 2011; Zhong et al., 2015). 
2.5.7 “In Clinic” Occlusion Treatments  
A range of topical treatments require application by a clinical professional due to 
the need for either dentine pre-treatment (drying of the dentine surface or smear 
layer removal) and direct application onto exposed dentine or application of the 
treatment in minimal amounts because of toxicity issues. Oxalate containing 
compounds have been reported to be effective in the occlusion of dentine tubules 
and a number of different oxalate containing compounds are utilised in treatment. 
These include, but are not limited to, potassium oxalate, oxalic acid, ferric oxalate 
and aluminium oxalate (Gillam et al., 2001; Varoni et al., 2017). The mechanism 
by which oxalates promote the occlusion of dentine tubules is through the 
reaction of the oxalate molecule with calcium ions present in the oral environment 
forming calcium oxalate crystals which block the dentine tubules (Mantzourani 
and Sharma, 2013), though oxalate-based treatments have been shown to 
poorly penetrate dentine tubules (Greenhill and Pashley, 1981). Clinical trials of 
oxalate-containing treatments have produced mixed results with some claiming 
their effectiveness while others concluded that they are no more effective than 
placebos (Cunha-Cruz et al., 2011). The use of oxalate containing treatments as 
“at home” treatments are limited because of their toxicity (Guo and McMartin, 
2005).  
Other professionally applied treatments include resins and varnishes which are 
applied to promote the occlusion of dentine tubules. The components of these 
resin and varnish treatments include hydroxyethyl methacrylate, benzalkonium 
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chloride, glutaraldehyde and fluoride. Glutaraldehyde is thought to act through 
causing the precipitation of serum albumin from dentinal fluid, this precipitates 
then inducing the polymerisation of hydroxyethyl methacrylate which blocks the 
dentine tubules (Qin et al., 2006). Fluoride-based varnishes use a highly 
concentrated lacquer that acts by inducing the formation of calcium fluoride 
crystals which block the dentine tubules by producing a layer on the dentine 
surface reducing fluid movement (Mantzourani and Sharma, 2013).  
Laser therapy has also been used in the attempt to find a cure for dentine 
sensitivity. There are a number of different lasers which have been used in the 
treatment of dentine sensitivity with different mechanisms of action depending 
on their power output. Low output lasers, for example He-Ne and GaAlAs, are 
thought to act through producing an analgesic effect related to depressed nerve 
transmission (Kimura et al., 2000). Clinical studies have shown that the use of 
low powered lasers can reduce the painful symptoms associated with dentine 
sensitivity (Hashim et al., 2014). Higher powered lasers, such as Nd:YAG and 
Er,Cr:YSGG, have also been used in the treatment of dentine sensitivity. These 
high power lasers are thought to act through melting and recrystallisation of 
dentine mineral or through obliterating the dentine tubules by stimulating tertiary 
dentine production (Yilmaz and Bayindir, 2014). Studies have been carried out 
on the effectiveness of using high powered laser light and have reported its 
effectiveness in vitro (Kurt et al., 2018) and in the clinic (Yilmaz and Bayindir, 
2014). Surgical procedures can also be used in the treatment of dentine 
sensitivity and involve the grafting of healthy gingiva to the region of gingival 
recession, thereby re-sealing the exposed dentine, through the occlusion of the 
tubules. This type of treatment is invasive and, as it is a graft, will result in some 
form of donor site morbidity. Additionally good periodontal health is also required 
before surgical intervention (Tugnait and Clerehugh, 2001). 
2.6 Measurement of Dentine Permeability  
2.6.1 In Vitro Techniques  
The ability to determine the potential of materials for occlusion of dentine tubules 
in the lab is an important step in the development and assessment of a dentine 
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sensitivity treatment. When we consider the mode of action of a dentine tubule 
occluding treatment, which is decreasing fluid movement within the tubule 
through blocking the tubule at the surface, the need to be able to determine the 
reduction in fluid flow through dentine, once the treatment material of interest has 
been applied, is required. One method used to determine the change in 
permeability of dentine is fluid filtration.  
Fluid filtration is a technique which measures the volume of fluid which can be 
forced through a material of interest under a given hydrostatic pressure per unit 
area of time per unit of pressure (Ertürk and Kirzioğlu, 2007).The first generation 
fluid filtration dentine measurement apparatus required the visual observation of 
a bubble in a micropipette which was part of the fluid line. When the bubble was 
moved by fluid flow, the distance moved was noted which allowed for the 
calculation of the amount of fluid which had passed through the dentine (Reeder 
et al., 1978). This technique was later improved through the use of an electronic 
flow detector which electronically tracked the movement of the bubble removing 
the need for visual recording of the movement. A full review of the fluid filtration 
technique is described in section 6.1. In brief, the fluid filtration technique is able 
to determine the bulk permeability of the dentine under test but other techniques 
are able to provide information on small areas of the dentine surface. One such 
technique is laser scanning confocal microscopy, which, under optimal 
conditions, could provide the fluid flow rate through a single tubule. The 
advantage of using a confocal-based technique is that it may be able to 
determine the treatment effectiveness with respect to differing dentine tubule 
structures (Williams et al., 2008). 
2.6.2 Clinical Trials  
Clinical trials involving patients are essential for the testing of efficacy of dentine 
sensitivity treatments. There are a number of issues with regards to clinical trials 
which have made the comparison of clinical data difficult and are the cause of 
much confusion due to conflicting results (Holland et al., 1997). The basic 
method used to conduct a clinical trial of a dentine sensitivity treatment is to apply 
a stimuli to a patient’s sensitive dentine and record some type of pain response. 
The treatment is then applied before stimuli and pain response are recorded 
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again. The difference in the pain scores is then used to determine the 
effectiveness of the treatment. This seems very straight forward but there are a 
number of issues that need to be addressed before any conclusions on the 
effectiveness can be reported.  
The method of stimulation is important as not all types of stimulation are suitable 
for quantifying dentine sensitivity, which may differ for different types of 
stimulation (Holland et al., 1997). To negate these factors it has become 
generally accepted that thermal stimulation should be accompanied by a tactile 
stimulus (Orchardson and Collins, 1987) although the reproducibility of the tactile 
stimulus can be questionable due to the need for the clinician to manually scratch 
the dentine surface (Ide et al., 2001).  
The most common method for recording the pain scores produced through these 
studies is the visual analogue scale (VAS) which, although used widely in clinical 
research (Ide et al., 2001; Haefeli and Elfering, 2006), has a number of 
disadvantages. The VAS measurement requires the patient to rate their pain 
along a line from “no pain” to “pain as bad as it could be” by placing a cross on 
the line. This method of pain rating can be useful but it is limited by the patient’s 
own interpretation of how painful “pain as bad as it could be” is to them, and 
when we consider a study that happens over a period of weeks the patients 
perception of pain could vary over a given time period (Wewers and Lowe, 1990). 
 A report into the reproducibility of clinical dentine sensitivity assessment 
concluded that the reproducibility was not as good as expected in clinical trials 
and that trials carried out on dentine sensitivity treatments were not as good as 
initially assumed due to the reasons given previously (Ide et al., 2001). 
2.7 Inspiration from Nature 
The difficulty in producing effective dentine sensitivity treatments coupled with 
the challenge of assessing their effectiveness both in vitro and in vivo in reducing 
the pain symptoms associated with the condition has led to increased research 
into the development of materials which take inspiration from nature. As 
previously discussed, section 2.2, biological systems have developed complex 
processes to produce mineralised tissues. Although our current understanding 
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prevents the direct replication of the biological process, materials could be 
developed which mimic known biological mineralising agents to promote the 
occlusion of dentine tubules.  
2.8 Biomimetics 
The term biomimetic was coined by Otto H. Schmitt in 1969 and represents the 
field of study that aims to mimic nature’s methods, designs and processes and 
is increasingly being applied to the fields of science and engineering (Bar-Cohen, 
2006a). The process of evolution has allowed nature to experiment with 
numerous challenges and when successful has archived the information into the 
DNA of living systems. These solutions can range in complexity. Some are 
relatively easy to mimic, for example the use of fins in scuba diving to aid with 
swimming which have been copied from the legs of sea creatures such as seals 
(Bar-Cohen, 2006b). Other are far more complicated and the outcome of these 
solutions can have properties that are novel and surpass the capabilities of man-
made ones. An example of this is the silk (composed of proteins) produced by 
spiders. Silks display remarkable properties such as having high ultimate tensile 
strength and mechanical stability at high temperatures (Bar-Cohen, 2006b). The 
complex biological processes that produce silk have made replicating its 
formation difficult although progress is being made (Carlson et al., 2006).  
The growing field of tissue engineering and regenerative medicine has 
increasingly been trying to use the principles of biomimicry to produce 
biomaterials that can provide a range of properties including, but not limited to, 
the characteristic extracellular matrix environment that is essential for the cellular 
decision process (Patterson et al., 2010), controlled drug delivery (Biondi et al., 
2008) and protein templates in hard tissue repair/replacement (George and 
Ravindran, 2010). 
2.9 Peptide Biomimetics 
Synthetically derived peptides which can mimic the functionality produced by 
biological systems are increasingly seen as providing a route to new biomaterials 
for use in tissue engineering, drug delivery and therapeutics (Bello et al., 2013). 
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The analysis of biological systems and the determination of the mechanism by 
which they achieve their function have allowed new materials with a range of 
applications to be produced. Examples include, but are not limited to, the 
synthesis of cyclic peptide antibiotics (Trauger et al., 2000), the prevention of 
skin ageing (Gazitaeva et al., 2017) and drug delivery (Bhattacharyya et al., 
2016).  
With respect to dental applications, synthetic peptide-based materials have been 
developed with the goal of providing treatment for dentine sensitivity (Wang et 
al., 2014), and for the regeneration of the hard tissues of the tooth (Kirkham et 
al., 2007; Dogan et al., 2018). One such peptide recently developed is a new 
amelogenin-derived 15-amino acid long peptide (ADP5). It has been developed 
through the screening of a cysteine-constrained M13 bacteriophage 
heptapeptide library against hydroxyapatite (HA) powder to identify HA binding 
affinity (Gungormus et al., 2008). This screening resulted in the production of the 
peptide ADP5 which has been shown to produce a 10 µm thick layer of HA 
resembling enamel when applied to artificial white spot lesions of enamel 
followed by incubation for 1 hour in 4.80 mM Ca2+/2.89 mM PO43− (Dogan et al., 
2018). The ADP5 peptide was also tested after 1 hour incubation 4.80 mM 
Ca2+/2.89 mM PO43− with 1100 ppm F to determine if the peptide was compatible 
with fluoride levels found in toothpastes. SEM and EDS analyses of the crystal 
morphologies and compositions formed for both sets of experimental conditions 
confirmed a change in crystal morphology when fluoride was present. When no 
fluoride was present, the crystals formed produced a thick layer (10 µm) of HA 
nanorods while when fluoride was present, 2 crystal morphologies formed: 
clusters of 50-100 nm spherical nanoparticles, and structures composed of 
nanorods that were similar but less dense than the non-fluoride test. It was not 
possible to use the EDS technique to determine if the different mineral 
morphologies had different molar compositions of HA and FA due to the 
overlapping nature of the 2 phases but the overall molar Ca/F ratio was 8.74 ± 
0.78. The authors hypothesised that the small spherical nanoparticles could be 
FA while the nanorods were HA. The analysis of the newly formed HA layer 
showed integration with the underlying enamel supporting the development of 
peptide-based materials to treat damaged enamel.  
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A study produced by Wang et al. (2014) investigated the use of a 
collagen/calcium dual affinitive peptide combined with nanoHA with respect to its 
ability to promote the mineralisation of dentine tubules (Wang et al., 2014). The 
treatment developed by Wang et al. used a synthetic polypeptide designed to 
have affinity for both hydroxyapatite and collagen and combined it with 
commercial nanoHA powder. The dual affinity peptide was designed by 
connecting an 8 amino acid long glutamic acid peptide (EEEEEEEE) sequence 
inspired by bone sialoprotein, known to have a strong binding affinity to HA 
(Goldberg et al., 2001), to a 9 amino acid sequence (DSpESpSpEEDR) inspired 
by DMP1 which has been identified as collagen interacting by peptide sequence 
mapping (He and George, 2004). The 2 peptide sequences were attached to 
produce the peptide E8DS peptide sequence (EEEEEEEEDSpESpSpEEDR). 
The hypothesised treatment mechanism was that the E8DS peptide would bond 
to the acid etched demineralised dentine collagen and to the synthetic nanoHA 
crystals, thus promoting the attachment of the nanoHA to the surface of the 
dentine. It was also hypothesised that the nanoHA particles would penetrate into 
the tubules promoting occlusion deep within them, see Figure 2-8. The treatment 
methodology involved the application of the peptide to the dentine surface at a 
concentration of 1 mg/mL peptide followed by brushing with nanoHA crystals (25 
mg/mL). The peptide treated samples were then washed continuously at a flow 
rate of 1 mL/min for 4 weeks and assessed using SEM to determine 
mineralisation of the dentine surface and dentine tubules. The results showed 
that the D8DS/nanoHA treatment did produce a compact layer of nanoparticles 
on the surface of the dentine but the predicted penetration into the tubules did 
not occur to the depth that was anticipated with no mineralisation visible within 
the dentine tubules (Wang et al., 2014).  
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Figure 2-8 - Schematic of proposed treatment mechanism of D8DS. 
Exposed and open dentine tubules were treated with E8DS peptide. 
NanoHA then brushed onto surface which would interact with the 
peptide not only on the surface but within the dentine tubules. 
Schematic from Wang et al. (2014).  
One issue which may have reduced the Wang et al. (2014) treatment’s ability to 
penetrate the dentine tubules was the nanoHA crystals themselves. The stated 
size of the nanoHA crystals was 20 nm but on inspection of the TEM images 
produced, the crystals look amorphous in shape and were significantly larger 
when compared to the 20 nm scale bar. No particle characterisation techniques 
were published by the authors and on inspection it is difficult to determine if these 
are in fact individual particles aggregated together or very large amorphous 
crystals. The nanoHA suspension was placed under ultrasonic agitation for 30 
minutes prior to addition but due to the lack of characterisation and confirmation 
of the nanoHA suspension, for example using DLS, it cannot be determined 
whether the nanoHA was still in an aggregated state or present as large 
amorphous crystals.  
The second potential issue with respect to achieving the hypothesised nanoHA 
penetration into the dentine tubule was the treatment’s application. The step wise 
addition of E8DS and then nanoHA could be improved through using the 
treatment components simultaneously, which could aid in dentine tubule 
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penetration. It was shown that the E8DS peptide penetrated the dentine tubule 
to a depth of 5 µm using fluorescence microscopy but no HA mineralisation was 
visible within the dentine tubules. Combining the E8DS peptide with the nanoHA, 
similar to the hybrid material assessed in this thesis, may well result in the 
nanoHA penetrating the dentine tubule with the peptide. The E8DS/nanoHA 
interaction would also need to be investigated to ensure the material maintained 
its functionality with respect to dentine adhesion.    
 
Figure 2-9 TEM images of nanoHA crystals used in Wang et al. (2014). 
Crystals are poorly resolved and look larger than the 20nm stated by 
the author. Image modified from Wang et al. (2014). 
2.10 Self-Assembling Peptides 
Self-assembling peptides (SAPs) are inspired by the understanding of protein 
self-assembly and are capable of forming a number of higher order structures 
(Aggeli et al., 1997). SAPs are polypeptide molecules which can interact through 
non-covalent interactions in a hierarchical manner to produce structurally well-
defined aggregates or “assemblies”. The structure and function of the 
aggregates produced are dependent on the isomeric form of the amino acids, 
the sequence of the amino acids in the polypeptide chain, the concentration of 
peptide in solution and the solution conditions, for example pH, temperature and 
ionic strength (Carrick et al., 2007). There are a number of different nano-
41 
 
structures that can be produced through peptide self-assembly. Examples 
include but are not limited to nanotubes (Hartgerink et al., 1996), nanospheres 
and nanotapes (Matsuura et al., 2005).The diversity of the types of structures 
that can be created, their intrinsic biocompatibility and biodegradability, and the 
ability to synthesise them in large quantities have made them the subject of major 
interest (Mandal et al., 2014).  
Particularly relevant to dental hard tissue engineering and this project are anti-
parallel β-sheet forming peptides which can undergo hierarchical self-assembly 
to form 3-dimensional fibrillar networks (Aggeli et al., 2001). The hierarchical self-
assembly of antiparallel β-sheet forming peptides has been extensively studied 
with respect to the aggregates formed and the thermodynamic parameters which 
drive the aggregate formation (Aggeli et al., 1997; Aggeli et al., 2003a; Davies et 
al., 2006; Carrick et al., 2007; Kyle et al., 2010). The principle forces which drive 
peptide self-assembly are the hydrogen bonding between the peptide backbone 
and the non-covalent interactions of the side chains (Kirkham et al., 2007).  
The hierarchical self-assembly process of the SAPs developed at the University 
of Leeds begins when the concentration of peptide monomer (solvated peptide 
molecule) reaches the critical monomer concentration (C*). This is the 
concentration at which the peptides can form stable aggregates (Davies et al., 
2006). At concentrations larger than the C* value, aggregates will form, although 
there is always a background concentration of monomer which is equal to the 
C*. This is a consequence of the reversible nature of peptide self-assembly which 
follows Le Chatelier's principle of equilibrium. The size and structure of the 
peptide aggregates are dependent on the concentration of monomer present and 
follow the hierarchical sequence described in Figure 2-10.  
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Figure 2-10 Schematic of the hierarchical self-assembly of anti-parallel β-
sheet forming peptides as a function of peptide monomer 
concentration. At low concentrations below the critical concentration 
(C*) peptide monomers exist in solution. As the concentration 
increases above C* the monomers interact to form β-sheet tapes 
which can then go on to interact to form ribbons, then fibrils and 
finally fibres with respect to increasing peptide monomer 
concentration. Image modified from Aggeli et al. (2001) Copyright 
(2001) National Academy of Sciences. 
An anti-parallel β-sheet forming self-assembling peptide has been developed at 
the University of Leeds and was reported as safe for use and associated with 
significant enamel regeneration in the treatment of early caries lesions in a 
clinical safety trial (Brunton et al., 2013). The peptide P11-4 has been previously 
shown to produce fibrillar networks that mimic the biological macromolecules 
found in the extracellular matrices of the mammalian skeleton which are known 
to control the mineralisation of hard tissues (Kirkham et al., 2007). The 11 amino 
acid long P11-4 (amino acid sequence AcQQRFEWEFEQQNH2) was designed 
to self-assemble at pH ≤ 2 in deionised H2O (Davies et al., 2006). The design 
principles used to drive self-assembly were principally the complementary 
hydrogen bonding between the glutamic residues at positions 1,2,10,11 
combined with hydrogen bonding of the peptide backbone between peptide 
molecules. The hydrophobic amino acids phenylalanine, at positions 4 and 6, 
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and tryptophan at position 8, can interact through π-π stacking and stabilise the 
ribbon level of the β-sheet self-assembly hierarchy (Kyle et al., 2010). The 3 
glutamic acid residues, at pH ≤2, would be protonated (neutral charge) due to 
the negative charge stabilising effects of the aromatic residues resulting in a pKa 
< 4.25. The arginine residue would be protonated (positive charge) producing an 
overall positive peptide charge of +1. When dissolved in deionised H2O at a 
pH>2, no self-assembly occurs due to the negatively charged glutamic acid 
residues which produce repulsive forces between peptide molecules (Davies et 
al., 2006). Interestingly when the P11-4 peptide was investigated under 
physiological conditions of pH 7.4 and NaCl 130 mM, the repulsive forces of the 
negatively charged amino acid groups were shielded by the salt ions present in 
solution coupled with the ionic interaction between the positively charged 
arginine and the negatively charged glutamic acid, resulting in the self-assembly 
of P11-4 at a pH ≤ 7.5 (Carrick et al., 2007). A schematic of the amino acid 
sequence, with corresponding protonation state at physiological pH is shown in 
Figure 2-11. The surface formed by the self-assembled P11-4 produces sites of 
negative charge (4 deprotonated Glu-residues) which, through molecular 
dynamics simulations, have been shown to be approximately 0.94 nm apart 
which would match the columnar Ca2+ ions in the hydroxyapatite crystal 
(Thomson et al., 2014). The negative charge domains on the self-assembled 
surface are thought to act as a heterogeneous nucleating template, dehydrating 
the calcium ion producing a nucleating centre.      
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Figure 2-11 P11-4 amino acid sequence protonation states at physiological 
pH (7.4). The glutamic acid residues are deprotonated (blue) producing a 
negative charge (-3) and the arginine side chain is protonated (red) 
producing a positive charged (+1) resulting in an overall charge per 
molecule of P11-4 of -2. Hydrophobic side chains tryptophan and 
phenylalanine (lilac) provide sites for π-π interactions for stabilisation of 
the tape-tape interaction present in the ribbon level of β-sheet hierarchy. 
The peptide backbone and glutamine residues (black) form complementary 
hydrogen bonding between peptide molecules.   
2.11 Concluding Remarks 
In conclusion, the lack of a “gold standard” treatment for dentine sensitivity has 
produced a plethora of treatments with no one treatment being able to 
conclusively prove its effectiveness when compared to others. The occlusion of 
dentine tubules seems to be the superior strategy as it could provide a 
permanent alleviation of dentine sensitivity if a suitable material can be 
developed. Nerve stabilisation treatments seem to be the inferior choice due to 
their need for frequent re-application and relatively long time to take effect. The 
biomimetic self-assembling peptide treatment based on P11-4, now CE-labelled 
for clinical use illustrates the strategy of biomimetics in the regeneration of 
enamel (Brunton et al., 2013). If the mineralisation ability of the self-assembling 
peptide P11-4 could be translated into the treatment of dentine sensitivity, it could 
have the potential to provide a superior treatment option. The rationale of using 
nano-hydroxyapatite crystals in tandem with the peptide treatment is supported 
by the energetic considerations of mineral formation.  By providing a crystal seed 
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the energetically unfavourable formation of a nucleus in solution is avoided which 
should increase mineralisation and decrease the time for the treatment to take 
effect. The work carried out by Wang et al. (2014) although promising does 
contain some issues, such as the lack of mineral penetration into the tubules, 
which would need to be improved if the treatment is to provide a permanent 
solution. This issue may be resolved through the use of optimisation of the 
treatment with regards to nano-hydroxyapatite crystal size or type and 
concentration of peptide used.  
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2.12  Project aim 
To investigate a combination of rationally designed self-assembling peptides 
(SAPs) and nano-apatite as novel hybrid biomaterials for the infiltration and 
occlusion of dentinal tubules as a possible future treatment option for dentine 
hypersensitivity. 
Project Objectives: 
1) Synthesise and characterise nanoHA crystals with optimum chemistries and 
sizes to act as seed crystals using hydrothermal and chemical synthesis, 
electron microscopy, X ray diffraction, scanning electron microscopy and 
dynamic light scattering;  
2) Using nanoHA seed crystals produced and characterised in (1) above, 
determine the efficacy of a rationally designed self-assembling peptide/nanoHA 
hybrid material to nucleate and support the growth of hydroxyapatite mineral in 
vitro under steady state conditions;  
3) Develop quantitative and qualitative methodologies to determine the effect(s) 
of the SAP-nanoHA hybrid material on dentine permeability and dentine tubule 
occlusion in extracted human teeth using dentine fluid filtration and scanning 
electron microscopy. 
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Chapter 3 – Synthesis and Characterisation of Nano-sized 
Hydroxyapatite Seed Crystals. 
This chapter will describe the synthesis of hydroxyapatite nanorod powders 
using a hydrothermal synthesis method. The characterisation of the synthesised 
powders by x-ray diffraction, scanning electron microscopy, dynamic light 
scattering, transmission electron microscopy and energy-dispersive x-ray 
spectroscopy will also be described. These characterisation techniques enabled 
crystal structure, morphology, size and atomic composition to be confirmed. The 
powder analysis confirmed the formation of nanohydroxyapatite nanorods with a 
median long axis length of 45 nm. In total, 3 batches of crystals were synthesised 
with batch 2 suspected of being a calcium deficient hydroxyapatite and was not 
used in subsequent experiments. The nanohydroxyapatite powders produced in 
batches 1 and 3 were later combined with a self-assembling peptide material to 
produce the hybrid material investigated in this thesis.  
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3.1 Introduction 
Nano-sized hydroxyapatite (nanoHA) crystals are seen as an attractive method 
to promote the growth of mineral deposits in oral healthcare due to their 
favourable biocompatibility and bioactive properties and have been used in a 
number of dental applications (Huang et al., 2009; Sadat-Shojai et al., 2010; 
Najibfard et al., 2011; Hillet al., 2015a). The advantage of using nanoHA 
compared to micron sized and above HA crystals as seed crystals is primarily 
due to the increased specific surface area to seeding density ratio. In nanoHA, 
the total surface area for a given weight is significantly larger than for micron 
sized particles, providing a larger surface for heterogeneous crystal nucleation. 
There are a number of different techniques that are used to produce nanoHA, 
with a range of sizes, crystallinity and morphologies possible (Sadat-Shojai et 
al., 2013). Chemical precipitation reactions have been shown to produce 
nanoHA powders with the morphology and size controlled by the conditions 
used, for example pH, reaction time, stirring speed and atmospheric conditions 
(Afshar et al., 2003). The methodology commonly involves the addition of an 
ionic calcium solution to an ionic phosphate solution under string while 
maintaining a pH of between 8-10 and constant temperature. The advantage of 
chemical precipitation is that it can produce nanoHA at a low cost and with a 
variety of morphologies. Potential disadvantages are that often the nanoHA is 
not stoichiometric with respect to hydroxyapatite and can contain other calcium 
phosphate mineral phases (Abidi and Murtaza, 2014). 
Hydrothermal synthesis can be considered a chemical precipitation reaction 
followed by a thermal treatment at high temperature and pressure. The 
hydrothermal method provides a highly crystalline sample with excellent control 
of crystal size and distribution through control of pH, temperature, pressure and 
treatment time (Suchanek and Riman, 2006). Hydrothermal synthesis of nanoHA 
often results in a small size distribution, rod/needle morphology, highly crystalline 
and single phase powders. The disadvantages of hydrothermal synthesis of 
nanoHA is that the reactor cost is very high and due to its tendency to produce 
nanoHA with rod like morphology is not useful if other morphologies (for example 
spheres) are required. 
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There were a number of considerations which were taken into account when the 
method of nanoHA synthesis used in this work was chosen. The hydroxyapatite 
crystallites in dentine have been reported as having a rod shaped morphology, 
2-3 nm in diameter and up to 60 nm in length (Goldberg et al., 2011). The 
production of a nanoHA particle that not only enabled the infiltration of the 
dentine tubule but also provided a crystal morphology similar to that of the 
already present biological apatite crystals was desired. A second criterion was 
that the nanoHA particles were single phase and highly crystalline. The use of a 
nanoHA seed crystal that was highly crystalline and single phase hydroxyapatite 
would support the growth of crystalline hydroxyapatite. The improved mechanical 
properties and insolubility of crystalline hydroxyapatite compared to other 
biologically relevant calcium phosphate phases supports the desired growth of 
hydroxyapatite within the dentine tubule (Goldberg et al., 2011).  
The use of a method to produce a small size distribution was desired to ensure 
that the majority of the nanoHA would be of a small enough size to penetrate 
down into the dentine tubule. Previous work by Earl et al. (2006a) and Sayed et 
al. (2013). have shown that hydrothermal synthesis can provide nanoHA which 
is highly crystalline, single phase, stoichiometric HA, with a small size distribution 
that is capable of penetrating dentine tubules and providing crystal nuclei to 
promote crystal growth. For these reasons the hydrothermal method of nanoHA 
synthesis was chosen. 
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3.2 Methods 
3.2.1 Hydrothermal Synthesis of Nanohydroxyapatite 
The hydrothermal method used in this thesis was initially developed by Earl et 
al. (2006b). Stock solutions of 1 M calcium nitrate tetrahydrate (Ca(NO3)2.4H2O, 
Acros Organics ACS grade, Geel, Belgium) and di-ammonium hydrogen 
phosphate ((NH4)2HPO4, VWR Chemicals, Radnor, PA, USA) were prepared in 
distilled water. These were then further diluted to 0.1 M before the drop wise 
addition, via an addition funnel, of di-ammonium phosphate solution to calcium 
nitrate solution to produce a suspension with a Ca/P molar ratio of 1.67. The 
suspension was then pH adjusted to 10 (Hanna Instruments HI2211-02 pH meter 
Woonsocket, RI, USA, fitted with a VWR pH electrode DJ 113, Radnor, PA, USA) 
through the addition of 28-30% ammonium hydroxide solution (Sigma-Aldrich 
ACS Grade St. Louis, MO, USA), then transferred to a 2 L stainless steel 
hydrothermal reactor vessel (Parr instruments model 4524 Moline, IL, USA). The 
suspension was then heated with stirring at approximately 500 rpm, and once 
the target temperature of 200˚C was reached, left for 24 hours. Once the 24-hour 
heating period was complete, the heater was switched off, the heating jacket 
removed and the reactor was left to cool under stirring for a further 24 hours. The 
suspension was poured into 50 mL falcon tubes and underwent a washing cycle 
of centrifugation (Thermo Fisher Scientific Heraeus Megafuge 16R, Waltham, 
MA, USA) at 16500 g, supernatant removal and resuspension in distilled H2O 
aided by ultrasonic agitation (Ultrawave Ltd, 120W, 4L, UK) and vortexing 
(Vortex Genie 2 Scientific Industries, Bohemia, NY, USA). This process was 
repeated 6 times with ethanol replacing H2O in the last 2 washes and a 
centrifugal speed of 30000 g. The particles were suspended a final time in 
ethanol before being poured into a foil lined tray and placed in a fume hood 
overnight. To ensure all the ethanol had evaporated, the tray was then 
transferred to a heated cabinet at 50˚C overnight. Once dry, the powder was 
collected and stored in 50 mL falcon tubes under vacuum. The synthesis was 
completed 3 times producing 3 batches of nanoHA powders. 
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3.2.2 Powder Characterisation  
The 3 synthesised powder batches were characterised using the methods 
outlined below. A commercially available nanoHA sample was also characterised 
to provide a control sample (Sigma-Aldrich, nanopowder, <200 nm particle size 
(BET), ≥97%, synthetic St. Louis, MO, USA). 
3.2.2.1 X-Ray Diffraction  
Powders were loaded into the spinner type sample holder using the back fill 
method to ensure a flat homogenous test surface. The sample was then loaded 
into the x-ray diffraction instrument (XRD Phillips X’pert, Amsterdam, 
Netherlands) and scanned over a 2θ range of 10-60˚ using a scan speed of 
0.027˚ s-1. The resulting spectrum was processed using the Highscore software 
(Phillips, Amsterdam, Netherlands) by performing a baseline correction followed 
by automatic peak fitting. These selected peaks where then compared to the 
ICDD reference database to confirm the crystal structures present.  
3.2.2.2 Dynamic Light Scattering  
Powder suspensions were produced in ethanol at a concentration of 0.2 mg/mL. 
All samples were thoroughly vortexed and sonicated (Ultrawave Ltd, 120W, 4L, 
UK) to ensure dispersion and limit aggregation during measurement. A small 
volume (approx. 1 mL) of sample was placed into a disposable cuvette and 
placed into the Malvern Zetasizer ZS device (Malvern Instruments Ltd, UK) and 
analysed with the average of 3 runs per sample being produced.  
3.2.2.3 Scanning Electron Microscopy  
Carbon adhesive disks were attached to 15 mm SEM stubs (Agar Scientific Ltd, 
UK) and then coated with a small amount of each batch of nanoHA powder. The 
samples where then sprayed with compressed air to remove any loose particles 
and coated in carbon (Agar Automatic Carbon Coater, Stansted, UK). Samples 
were then loaded and imaged in turn with a Hitachi SU8230 scanning electron 
microscope (Hitachi, Tokyo, Japan) 20 kV accelerating voltage, 21.1 µA 
emission current with secondary electron emission detection. EDS spectra of 
each batch were obtained (Oxford Instruments Aztec Energy EDX system with 
80mm X-Max SDD detector, Abingdon, UK) to allow for the atomic composition 
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and therefore the Ca/P molar ratio to be calculated and compared to the 
theoretical HA ratio of 1.67 (He et al., 2003).  
3.2.2.4 TEM 
A small amount of each powder was suspended in ethanol at a concentration of 
50 µg/mL. All suspensions were vortexed and sonicated to ensure dispersion. A 
small amount of each suspension was dropped onto copper TEM grids and left 
to dry. Each sample was then imaged by TEM (Thermo Fisher Scientific FEI 
Tecnai TF20: FEGTEM, Waltham, MA, USA) using 200 kV accelerating voltage 
and emission current 1 µA. Size distributions were then produced through the 
measurement of the longest axes of 200 particles from each batch using ImageJ. 
The data was then statistically analysed using SPSS 21 (IBM, NY, USA) using 
the non-parametric tests independent samples median test, Mann-Whitney U 
test and Kolmogorov Smirnov test. 
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3.3 Results 
3.3.1 Hydrothermal Synthesis of NanoHA Batches 
To synthesise the nanoHA which would later be used to infiltrate human dentine 
tubules as part of the hybrid material, the hydrothermal method was chosen due 
to its ability to produce hydroxyapatite crystals with nanorod morphology which 
are capable of penetrating dentine tubules (Earl et al., 2006b). Synthesis of 
nanoHA was completed as described in section 3.2.1. The powders produced in 
the 3 hydrothermal experiments were white in colour with no visible differences 
between the 3 batches. The powder produced was visibly finer than the Sigma 
powder, which was more granular. All samples were stored in a vacuum 
desiccator when not in use. Yields for batches 1, 2 and 3 were 7.64 g, 6.89 g and 
7.25 g respectively.  
3.3.2 X-Ray Diffraction of NanoHA Batches 
To determine the crystal structure and confirm the formation of hydroxyapatite 
samples in the synthesised powders obtained in batch 1, 2, 3 and in the powder 
purchased from Sigma, samples were loaded into the XRD powder sample 
holder, scanned and processed as described in section 3.2.2.1. The resulting 
spectra, see Figure 3-1, were stack plotted together and the selected peaks 
labelled with a dotted line. The list of peaks for each sample was then submitted 
to the ICDD database and compared. When compared to the reference 
database, all powders used here had the same hexagonal crystal system with 
P63/M point group (LeGeros, 1994). Batch 2 was the only batch which did not 
confirm the presence of hydroxyapatite, see Table 3-1. Instead it matched to a 
hydrated form of hydroxyapatite called calcium phosphate hydroxide hydrate 
with the formula Ca4.65(PO4)3(OH)0.3(H2O).  
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Powder 
sample 
Matched reference Ref Code ICDD 
Batch 1 Hydroxyapatite 04-016-2958 
Batch 2 Calcium Phosphate Hydroxide 
Hydrate 
04-012-1119 
Batch 3 Hydroxyapatite 01-074-0565 
Sigma  
sample 
Hydroxyapatite 01-080-6199 
Table 3-1 Table showing which reference samples matched the 
synthesised and Sigma powder samples. Batches 1, 3 and Sigma 
matched hydroxyapatite references while batch 2 matched a calcium 
deficient hydroxyapatite
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Figure 3-1 Graph showing XRD patterns produced from batch 1, 2, 3 and Sigma nanoparticles. Dashed line represent 
common peaks between samples (average standard deviation between peaks 0.02 2θ). Batch 1, 3 and Sigma all confirmed 
a hydroxyapatite crystal structure while batch 2 confirmed a hydrated form of hydroxyapatite. 
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3.3.3 Scanning Electron Microscopy of NanoHA Batches 
To confirm the morphology of the crystals within the powders produced as 
described in section 3.2.1, samples were prepared as described in section 
3.2.2.3 and analysed using SEM. SEM analysis confirmed the presence of rod 
shaped particles in all of the synthesised batches and spherical shaped particles 
in the Sigma sample, see Figure 3-1. It was not possible to provide a size 
distribution as the density of particles prevented accurate measurement.  
 
Figure 3-2 SEM images of powders from A) batch 1, B) batch 2 and C) batch 
3 all showing densely packed rod shaped particles. In contrast, D) 
Sigma powder showed spherical particles. Density of particles 
prevented measurement although morphology was clearly visible. 
EDS measurements of the powder material were also taken, with the molar Ca/P 
ratios for each sample presented in Table 3-2. The Ca/P ratios present in Table 
3-2 show that the batches 1 and 3 confirmed a close value compared to the 
theoretical ratio of 1.67 when the ± 3% error in EDS measurements was taken 
into account (MyScopeTM, 2014). Batch 2, with the EDS measurement error 
taken into account, produced a calcium deficient Ca/P ratio of 1.60 ± 0.05. The 
Sigma nanoHA produced a Ca/P of 1.73   
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Powder Sample Ca/P molar ratio 
Theoretical molar ratio 1.67 
Batch 1 1.63 
Batch 2 1.60 
Batch 3 1.70 
Sigma 1.72 
Table 3-2 Calculated Ca/P molar ratios obtained from EDS data. Powders 
from synthesised batches 1, 3 and Sigma produced Ca/P molar ratios 
characteristic of stoichiometric hydroxyapatite (1.67) when the ± 3%) 
error in EDS measurements was taken into account (Ca/P error = ± 
0.05). The synthesised batch 2 produced a calcium deficient Ca/P 
ratio.  
3.3.4 Dynamic Light Scattering Analysis of NanoHA Batches 
To provide a bulk measurement of the particle size distribution, each of the 
powder batches was analysed using DLS, as described in section 3.2.2.2. The 
resulting size distributions confirmed the presence of nanoHA particles in each 
of the powders although the size distributions were different across the 4 
batches. The plot shown in Figure 3-3 confirms that as a function of the number 
of particles, the majority of the particles in all the samples were between 25-130 
nm. Figure 3-3 B provides a more detailed view of the distributions, with batches 
2, 3 and Sigma powders all showing a large peak around 68 nm, while batch 1 
had a large peak at 38 nm. Both batches 1 and 2 had a bimodal peak distribution 
with batch 1 also producing a small peak at 91 nm while batch 2 had a smaller 
peak at 38 nm.   
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Figure 3-3 Dynamic light scattering (DLS) data showing size distribution of 
particles as a function of the % of total particle number for batches 1, 2, 3 
and Sigma powders. DLS measurements confirmed the bulk of the 
particles were in the 30-130 nm size range. 
3.3.5 Transmission Electron Microscopy of NanoHA Batches 
TEM analysis was undertaken to provide a direct measurement of the particle 
sizes and allow for comparisons with the DLS distribution measurements. The 
TEM images of particles in each of the powders were produced as described in 
section 3.2.2.4. The TEM images confirmed the presence of nano-sized rod 
shaped particles in batches 1, 2 and 3, see figures Figure 3-4, Figure 3-5, and 
Figure 3-6 respectively. The Sigma particles were confirmed as spheres, see 
Figure 3-7. 
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Figure 3-4 TEM image showing rod shaped particles present in batch 1 
powder. Images confirmed a range of particle sizes present within the 
sample, with the majority below 100 nm in length with respect to the 
longest axis. Scale bar 100 nm. 
 
Figure 3-5 TEM image showing rod shaped particles present in batch 2 
powder. Images confirmed a range of particle sizes present within the 
sample with the majority below 100 nm in length with respect to the 
longest axis. Scale bar 100 nm. 
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Figure 3-6 TEM image showing rod shaped particles present in batch 3 
powder. Images confirmed a range of particle sizes present within the 
sample with the majority below 100 nm in length with respect to the 
longest axis. Scale bar 100 nm. 
 
Figure 3-7 TEM image showing spherical shaped particles present in the 
Sigma powder. Images confirmed a range of particle sizes present 
within the sample with the majority below 100 nm in length with 
respect to the spherical particle diameter. Scale bar 100 nm. 
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Particles were then analysed using ImageJ by measuring the longest axis of the 
rods, or the diameter of the spheres. This data was then used to produce size 
distributions, see Figure 3-8. A Kolmogorov-Smirnov test of normality was 
carried out on the measurements which determined that particles from all 
batches and the Sigma particles were not normally distributed. Due to the non-
normal distribution, non-parametric tests were undertaken to determine any 
statistical differences. The Kruskal-Wallis statistical test was performed on 
particles from all synthesised batches and confirmed that the distributions were 
the same across the 3 data sets (significance level p< 0.05) and a median test 
confirmed that the median values, see Table 3-3, of batches 1, 2 and 3 were not 
statistically different (significance level p<0.05). The interquartile range for all 
batches was relatively large compared to the median value which suggests that 
the spread of particle size was large. 
 
Figure 3-8 Size distributions produced from TEM measurement data for 
batches 1, 2, 3 and Sigma particles. Measured length was of the 
longest axis for rods, or diameter for spheres. All synthesised batches 
and Sigma particles produced a similar particle size distribution.  
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Sample Median (nm) Interquartile range 
(nm) 
Batch 1 45 54 
Batch 2 51 47 
Batch 3 45 36 
Sigma 42 29 
Table 3-3 Table summarising median and interquartile range calculated 
from TEM measurement data for particles from batches 1, 2, 3 and 
Sigma samples.  
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3.4 Discussion 
The hydrothermal synthesis method described in section 3.2.1 produced 
nanoHA particles of similar crystal structure, size and morphology as those 
previously reported by Earl et al. (2006b) and Sayed (2013). The XRD data 
confirmed the presence of a hexagonal crystal system with P63/M point group, 
which is characteristic of apatite (LeGeros, 1994) for batches 1, 2, 3 and Sigma 
samples through comparison with the ICDD reference database. Batch 2 was 
matched to a calcium deficient HA reference sample, see Table 3-1.The 
formation of the calcium deficient HA phase calcium phosphate hydroxide 
hydrate Ca4.65(PO4)3(OH)0.3(H2O)) in batch 2 was not confirmed but could have 
been due to an error in the precipitation reaction step that resulted in the initial 
Ca/P ratio being below the predicted value of 1.67. The Ca/P ratio determined 
by the EDS analysis for batch 2 was the lowest of all the Ca/P ratios for the 
powders synthesised, see Table 3-2, and it was also outside the EDS error 
boundaries (± 3%) but not as low as the Ca/P ratio of 1.55 generated by the 
Wilson et al (2005) which produced the calcium deficient XRD data used in the 
reference file. The XRD spectra can be used to distinguish between 
stoichiometric HA and calcium deficient HA through analysis of the peaks around 
approximately 32° 2θ, with the peaks resolution becoming less defined in calcium 
deficient HA (Liou et al., 2004). The XRD spectra determined for batches 1, 2 
and 3, Figure 3-1, did not appear to be different with regards to the resolution of 
the large peak around 32° 2θ and would seem to be less resolved in batch 1 
although this was confirmed as stoichiometric HA.  
Another factor which could explain the assignment of batch 2 as calcium deficient 
HA is the peak broadening effects associated with nano-sized particles. As 
particles decrease in size, the effect of the surface atoms, which have a slightly 
different coordination, cause peak broadening to occur (Scardi et al., 2011). 
When comparing the sizes of particles produced in batches 1,2 and 3 it was 
found that there was not a significant difference in particle size suggesting that 
the particle size effect was not the cause of the batch 2 being identified as 
calcium deficient. The combination of the peak broadening effects associated 
with nanoparticles and calcium deficient HA made confirmation of the batch 2 
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composition difficult. To determine if the HA sample batch 2 was calcium 
deficient further experiments would need to be carried out which are more 
sensitive to calcium deficiency, for example x-ray absorption which can be used 
to determine the fine structural changes that occur with calcium deficient HA 
(Liou et al., 2004). With regards to this work, it was deemed unnecessary to 
further explore the reason for the failure of batch 2 to match to stoichiometric HA 
and this batch was simply excluded from future use with batches 1 and 3 taken 
forward.  
The images produced using the SEM clearly confirmed the presence of rod 
shaped particles in batches 1, 2 and 3, with no obvious differences between the 
samples, while the Sigma particles had a profoundly different, spherical 
morphology, Figure 3-2. The measurement of the particles as imaged in the SEM 
was not possible due to the quantity of particles and aggregated nature of the 
samples, which was caused by the method of sample preparation. The SEM 
images did, however, provide a bulk sample view of the powders and confirmed 
a seemingly homogenous sample morphology of rod shaped particles across all 
batches with spherical particles for the Sigma particles. 
The confirmation of nanoparticle size was determined using a combination of 
DLS and TEM (Earl, 2007; Murdock et al., 2008; Cengiz et al., 2008; Sayed, 
2013). These 2 techniques were combined to ensure that the known 
disadvantages of each individual method were eliminated by the other. The main 
weakness with regards to the DLS technique is that it does not directly measure 
particle size and relies on the assumption of a spherical morphology for the 
particles, which, for the rod-like particles of batches 1, 2 and 3 could generate 
inaccurate values (Cengiz et al., 2008). DLS is also obviously affected by sample 
aggregation which is an issue when measuring HA nanoparticles. The DLS 
technique is never the less useful for its bulk measurement approach which 
allows for the measurement of the entire sample. TEM enables the direct 
measurement of particles along with information on particle morphology. The 
disadvantage of using TEM is that the particle distributions produced only rely on 
a small proportion of the whole sample, which may not be representative of the 
bulk. When these 2 techniques are combined, a more complete analysis of the 
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size distributions of the particles can be obtained. The DLS data confirmed the 
presence of particles below 100 nm in all samples, see Figure 3-3. The TEM 
measurements broadly agreed with the DLS data but with some exceptions. In 
the DLS analysis, all samples appeared to contain a small percentage of particles 
with sizes above 200 nm. When compared to the TEM measurements, some 
particles of 200 nm or over were seen but not to the extent seen in the DLS. This 
apparent discrepancy is most likely due to aggregation effects in the DLS 
samples caused by incomplete sonication or aggregation of particles during the 
testing period. A bimodal distribution was seen in batches 1 and 2 with the peak 
intensities seeming to mirror each other. The cause of this bimodal distribution 
in the DLS data is unclear and it was not present in batch 3 or the Sigma sample. 
It was also unconfirmed by the TEM data. The intensity of the DLS readings 
around 100 nm (approximately 10% for batches 2, 3 and Sigma) was not 
confirmed by the TEM measurements, see Figure 3-8. This discrepancy could 
have been caused by aggregation as it seems to have affected all particles 
equally, independent of particle shape. Another cause for this discrepancy could 
be due to the DLS measurement itself, which measures the hydrated particle 
radius, resulting in a larger particle reading than the actual particle size 
(Kaasalainen et al., 2017), this may be the cause of the disagreement between 
the 2 measurement techniques. For a summary of the information provided and 
limitations of the characterisation techniques used in this work see Table 3-4.  
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Characterisation 
Method 
Information Provided  Limitations 
Dynamic light 
scattering (DLS) 
Size distribution of HA 
particles  
Resulting distribution affected 
by aggregation. Assumes 
spherical particles. 
X-ray diffraction 
(XRD) 
Crystal structure of HA 
crystals, can be matched 
to sample database. 
Degree of crystallinity 
measurements based on 
peak broadening.  
Crystallinity determination 
affected by nano-sized HA 
particles which results in 
broadening of peaks. No size 
or morphology information 
Scanning 
electron 
microcopy 
(SEM) 
Morphology and size 
measurements  
Values obtained are limited by 
sample size measured. Does 
not provide bulk sample 
size/morphology values. 
Transmission 
electron 
microscopy 
(TEM) 
Morphology and size 
measurements  
Values obtained are limited by 
sample size measured. Does 
not provide bulk sample 
values. Provides better 
resolution at nm scale than 
SEM 
Energy-
dispersive X-ray 
spectroscopy 
(EDS) 
Atomic composition of HA 
particles  
No size or morphology 
information 
Table 3-4 Table summarising information provided by HA characterisation 
techniques used in this work with the limitations of each method. 
When comparing the results produced by Earl (2007) and Sayed (2013), see 
Table 3-5, there were some pronounced differences between the resulting 
particle sizes and distributions with those found in this work, despite using the 
same methodology. Earl produced a nanoHA powder with mean particle size of 
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112 nm, almost double the particle size produced in this work, with a well-defined 
single peak in the TEM data. It is not possible to compare the size distributions 
per se as Earl (2007) did not provide any further information other than the mean 
size for the hydrothermal synthesis at pH 10. In contrast Sayed (2013) did not 
provide a mean particle size and only provided a particle size range of 50 – 
475nm. The reason for this was most likely due to the complexity of the TEM 
derived particle distribution which would not be sufficiently described through a 
mean or median particle size. When comparing the DLS data of batches 1, 2 and 
3 generated in this thesis to Sayed’s DLS distribution, the particle range was 
slightly smaller, with the larger particles reported by Sayed possibly attributable 
to aggregation effects.  
Sample TEM (nm) DLS range (nm) 
Batch 1 45 (median) 62 (mean) 28 - 400 
Batch 2 51 (median) 60 (mean) 24 - 400 
Batch 3 45 (median) 58 (mean) 38 - 460 
Sigma  42 (median) 46 (mean) 44 - 712 
Sayed 
(Sayed, 2013) 
50 – 475 (range) 56-550  
Earl 
(Earl, 2007) 
112 (mean) No data 
Table 3-5 Table showing TEM and DLS nanoparticle size distribution 
compared with previously reported nanoparticle size following 
synthesis using the Earl et al. (2007) hydrothermal method. 
The cause of the differing particle size distributions reported using the same 
method by 3 different operators is most likely due to the different types of 
hydrothermal reactor and stirring used. Earl (2007) used a small 125 mL Teflon 
lined reactor with no stirring capability while Sayed (2013) used a larger 1.6 L 
capacity vessel (Model 4570, Parr Instrument) and a stirring rate of 
approximately 500 rpm. The reactor used in this work was a 2 L reactor vessel 
(Parr instruments model 4524) with approximately 500 rpm stirring speed. 
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Although the stirring speeds in this work and that of Sayed (2013) are 
approximately the same, the forces experienced by the growing crystals due to 
stirring in the 2 different models are likely to be different from each other due to 
the different shaped reactor vessels and the resulting agitation flows within the 
reactor during the hydrothermal process. Once the first stage of crystal 
nucleation has occurred in the reactor, resulting in the formation of many small 
crystals, secondary crystal growth will depend on the mixing process which can 
affect crystal size and morphology through Oswald ripening and aggregation 
effects (Cushing et al., 2004). A study by Riman et al. (2002) was able to control 
the size of hydrothermally synthesised HA from 44 nm with no stirring to 38 nm 
with stirring at 1500 rpm at 200°C for 15 hours. The measurements were carried 
out using DLS although no statistical comparisons between the distributions 
were provided (Riman et al., 2002). The difference in agitation may be the cause 
of the difference in particle size distributions between batches 1, 2, 3 reported 
here and those described by Earl (2007) and Sayed (2013), although further work 
would be required to confirm this hypothesis.  
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3.5  Conclusion  
The hydrothermal synthesis of 3 batches of hydroxyapatite nanoparticles were 
completed and characterised using XRD, SEM, EDS, DLS and TEM. SEM and 
TEM of synthesised powder batches confirmed nanoHA rods present in all 
batches with a median size of 45, 51, 45 nm in batches 1, 2, and 3 respectively. 
XRD analysis confirmed that batches 1 and 3 powder had hydroxyapatite crystal 
structure through comparisons with reference files. EDS analysis confirmed a 
stoichiometric Ca/P molar ratio for both batches 1 and 3. XRD analysis of batch 
2 produced a calcium deficient hydroxyapatite match to the reference files which 
was supported by EDS analysis. Further analysis would be required to confirm 
the composition of batch 2, for example FTIR or X-ray absorption. Batches 1 and 
3 were therefore taken forward and used to optimise the concentration of 
nanoparticles in the IVNCG and for use as part of the hybrid self-assembling 
peptide/nanoHA material. 
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Chapter 4 - In Vitro Nucleation and Crystal Growth Assay 
Validation with Assessment of the Effect of 
Nanohydroxyapatite Seeding.  
The following chapter describes the validation of an in vitro nucleation and crystal 
growth assay (IVNCG). The validated assay was then used to determine the 
minimum concentration of nanohydroxyapatite required to produce increased 
mineralisation compared to the poly-L-glutamic acid positive control to inform 
subsequent formulations in combination with self-assembling peptides. Crystals 
produced in the IVNCG were isolated and imaged using SEM. It was found that 
at low nanohydroxyapatite seeding densities the seeds dissolved due to 
undersaturation with respect to hydroxyapatite prior to the diffusion of the buffer 
solutions into the sample wells. Nanohydroxyapatite crystals produced by Sayed 
were then compared with the nanohydroxyapatite crystals produced in this 
thesis. The minimal nanohydroxyapatite seeding density required to produce a 
significant difference compared to the glutamic acid positive control was found 
to be 3 times greater than the value obtained by Sayed using the same system 
(Sayed, 2013) .  
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4.1 Introduction  
To enable the optimisation of a nanohydroxyapatite/self-assembling peptide 
hybrid material with regards to its ability to support the growth of hydroxyapatite 
seed crystals, a validated, reliable and quantitative in vitro assay was needed. 
The assay used throughout this thesis to optimise the hybrid material prior to its 
application to dentine was the so-called in vitro nucleation (IVN) assay developed 
and described by Sayed (2013) in his thesis. Although named the in vitro 
nucleation assay, the assay was not capable of differentiating between 
nucleation and subsequent crystal growth, with the resulting mineral recovered 
being the product of both crystal nucleation and growth. The IVN assay was 
developed from diffusion assay work by De Jong and co-workers ( 1978; 1980), 
Boskey (1989) and Hunter and Goldberg ( 1993; 1994). 
All of the previous methods described in the papers cited above can be divided 
into either static or dynamic diffusion, depending on the experimental design 
(Dorvee et al., 2012). Static systems assume that a steady state is quickly 
achieved with regards to the ions of interest within the sample well when 
compared to the length of the experiment. Dynamic systems are based on the 
assumption that the concentration of the ions of interest is always changing 
within the sample well and that a steady state is not achieved within the time 
frame of the experiment. In a stirred flow reactor, a steady state system is a 
system in which the concentration of constituent ions present within the solution 
are independent of time (Muller, 1994). In a precipitate-forming system this 
means that the concentrations of constituent ions present within the solution are 
constant and independent of any mineral formation. The use of a steady state 
system provides a method which better reflects the biological processes involved 
in biomineralisation and allows for the study of biological nucleation and crystal 
growth.  
The origins of the IVN assay developed by Sayed can be traced back to work 
carried out by Cornelisse and van Duijn ( 1973) which aimed to study the kinetics 
of the capture reaction in phosphatase enzyme cytochemistry. The method used 
a polyacrylamide film containing inorganic phosphate ions which were then 
placed into an incubation medium containing lead ions. Precipitation of lead 
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phosphate in polyacrylamide films dosed with phosphate was measured to 
determine the trapping efficiency of lead ions by phosphate ions. Later, De Jong 
et al. identified issues with the method and developed an improved system (De 
Jong et al., 1978). The Cornelisse and van Duijn (1973) system only allowed a 
short time, 5 – 60 seconds, for precipitation to occur and during this short time 
the concentration of phosphate was falling due to the formation of the lead 
phosphate precipitates. The system was not representative of the cytochemical 
reaction in tissues where enzymes produce phosphate continuously, resulting in 
a steady state of phosphate at the enzymes’ catalytic sites. De Jong et al. (1978) 
developed a system whereby a solution containing lead was pumped along one 
side of the polyacrylamide film and a phosphate-containing solution was pumped 
along the opposite side, Figure 4-1. This arrangement allowed for the diffusion 
of lead and phosphate ions into the film, resulting in lead phosphate precipitation 
once the solubility limit of lead phosphate had been exceeded. The constant flow 
of fresh solutions containing lead and phosphate allowed the lead phosphate 
precipitation to occur under steady state conditions as the continued pumping of 
fresh solutions ensured that the concentration of ions was constant and 
independent of the amount of precipitation. The films were then either processed 
for quantitative measurements of phosphate, light microscopy or electron 
microscopy studies.  
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Figure 4-1 – Schematic of sample chamber described by De Jong et al. 
(1978), comprising of a polyacrylamide film with lead-containing 
solution on one side and phosphate-containing solution on the 
opposite side. The lead and phosphate ions would diffuse into the 
polyacrylamide film sample. Precipitation formed within the 
polyacrylamide film once the saturation limit with respect to lead 
phosphate was reached. Image modified from De Jong et al.  (1978). 
De Jong et al. (1980) then used the system to study calcium phosphate mineral 
precipitation and how the addition of collagen and chondroitin sulphate to the 
polyacrylamide matrix affected resulting nucleation and crystal growth in the 
system. The effect of the addition of 25 μM pyrophosphate (a known inhibitor of 
crystal growth) to the pumped solutions was also studied (De Jong et al., 1980). 
The calcium and phosphate solutions were buffered using 0.15 M Tris-HCl buffer 
(pH 7.4) which produced a more physiologically relevant system compared to 
the previous lead phosphate system. The method was able to determine 
differences in nucleation abilities between the chondroitin sulphate-doped 
polyacrylamide films and the polyacrylamide control. It was shown that the 
addition of chondroitin sulphate lowered the calcium phosphate solubility product 
required to initiate the nucleation of calcium phosphate mineral. The addition of 
25 μM pyrophosphate to the calcium-containing buffer and phosphate-containing 
buffer resulted in a decrease in calcium phosphate solubility product for the onset 
of calcium phosphate mineralisation compared to the polyacrylamide control. It 
74 
 
also had an inhibitory effect on the growth of the mineralised phase during the 
crystal growth phase compared to the polyacrylamide control. However, it was 
unable to determine any differences in the nucleation abilities between the 
collagen sample and polyacrylamide film control, permitting conclusions to be 
drawn in respect of the relative nucleating abilities of chondroitin sulphate and 
collagen. The ability to quantitatively determine differences between 
macromolecules of interest with respect to their nucleation and crystal growth 
abilities at physiological pH provided a means to test biologically relevant 
macromolecules for their ability to nucleate and support calcium phosphate 
crystal growth. It was also shown to be capable of assessing a material’s ability 
to inhibit crystal growth. However, the system still relied on a polyacrylamide 
sheet, which did not provide a biologically relevant matrix, such as collagen, 
which would be analogous to that in calcifying tissues. The method also used 
multiple sample holders in series which could result in each sample being 
exposed to progressively lower concentrations of the ions of interest due to their 
removal through precipitation in the previous sample holder.  
Crystal growth within gels has been frequently used to study the growth of 
biological minerals in matrices such as gelatine and silicates. These systems 
involved the formation of a gel containing the material under investigation with 
the constituent ions of the mineral phase being supplied by either adding to the 
surface or including into the gels. Alternatively, the ions were trapped in a 
separate gel and placed either side of the gel containing the material under 
investigation (Hunter et al., 1987). These systems shared similar issues with the 
Cornelisse and van Duijn (1973) system discussed previously, as the 
concentrations of ions were not in steady state. In addition, the respective ions 
of the mineral being studied were often of supra physiological concentration to 
allow mineralisation to occur within a reasonable time frame.  
Boskey  (1989) identified these issues and produced a hybrid system based on 
these gel-based systems and De Jong’s steady state system. Her method 
required the production of gelatine slabs which were then mounted into sample 
holders. The gels were dosed with macromolecules of interest and separate 
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buffers containing calcium and phosphate were pumped around the system 
diffusing into the gels from opposite sides. 
This system did not provide a steady state within the time frame of the 
experiment due to the use of 6 cm long samples which precluded the reaching 
steady state across the full length of the gel. The long sample length allowed the 
analysis of sample across the hydroxyapatite supersaturation threshold from 
sub-threshold to super-threshold (Dorvee et al., 2012) within a single sample. To 
ensure mineralisation occurred within an acceptable time frame, the 
concentration of calcium and phosphate-containing buffers was optimised at 100 
mM (Boskey, 1989). The system also allowed the measurement of multiple 
samples within one experiment which increased the throughput. One issue that 
was not resolved however was the non-physiological (20-25˚C) temperature 
used in the method, due to the fact that the gelatine would melt if incubated at 
37˚C. Nevertheless, this system was used to investigate a variety of proteins to 
determine their mineralisation promotion/inhibition properties. For example, it 
was shown that complexed acidic phospholipids were promoters of 
mineralisation, decreasing the time required for mineralisation to occur and that 
proteoglycans inhibited the formation of mineral within the system (Boskey, 
1989). 
The De Jong et al. (1978) system was also adapted by Hunter and Goldberg 
(1993), who opted to change the original polyacrylamide matrix to agarose, 
which was stable at physiological temperature and allowed for the study of 
nucleation and crystal growth under more physiologically relevant conditions. 
The Hunter and Goldberg method used separate chambers, similar to the De 
Jong et al. method, to contain the agarose gel. Agarose gels (2% agarose, 150 
mM NaCl, 10 mM Tris-HCl at pH 7.4) were poured into each chamber and a 
piece of dialysis membrane placed over each side, Figure 4-2 (Hunter and 
Goldberg, 1993). The chambers were added in series with a total number of 12 
being used per experiment. Calcium-containing buffer was pumped in one 
direction and phosphate-containing buffer was pumped in the opposite direction. 
Once the buffers had travelled the 12 holders, the buffer was collected as waste 
while fresh buffer continued to circulate.  
76 
 
 
Figure 4-2 – Schematic of sample holder used by Hunter and Goldberg 
(1993). Calcium-containing buffer would flow past one side of the 
agarose sample and phosphate-containing buffer would flow past the 
opposite side. The calcium and phosphate ions would diffuse into the 
agarose sample with the mass of mineral formed dependent on the 
macromolecules seeded within the agarose samples. Image modified 
from Hunter & Goldberg (1993) Copyright (1993) National Academy of 
Sciences. 
The system was used to study the roles of different phosphoproteins in the 
nucleation of hydroxyapatite and demonstrated that bone sialoprotein was 
capable of nucleating hydroxyapatite under steady state conditions at sub 
threshold supersaturation (Hunter and Goldberg, 1993).  
The Hunter and Goldberg (1993) system was later adapted by Sayed (2013) who 
developed an in vitro nucleation assay (IVN) with high throughput that was 
capable of consistent results. The IVN system replaced the flow of fresh buffers 
used in both the Hunter and Goldberg (1993) system and the Boskey (1989) 
experimental set-up with a large buffer reservoir which approximated constant 
buffer composition over the course of the experiment. The IVN assay comprised 
of a large container, 10 L capacity, with a 36 well sample holder separating 2 5 
L compartments, see Figure 4-3. The sample wells were filled with agarose gel 
(controls) each containing one of the materials of interest and each compartment 
was filled with either calcium-containing buffer (6.5 mM Ca(NO3)2.4H2O, 20 mM 
HEPES,150 mM NaCl) or phosphate-containing buffer (3.9 mM Na2HPO4.2H2O, 
20 mM HEPES,150 mM NaCl).The buffers were then incubated at 37 ºC for 4 
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days with stirring. The samples were then removed from the sample wells and 
analysed for their phosphate content (Sayed, 2013). The advantage of this 
method compared to the Hunter and Goldberg (1993) method was that the ionic 
concentrations of calcium and phosphate experienced by all the samples were 
the same, where as in the latter method, the concentration of buffer ions in 
successive sample cells could be affected by mineralisation in the preceding 
cells.  
The use of agarose in Sayed’s (2013) IVN system allowed the system to test 
materials under physiological temperature. The large 5 L compartments which 
housed the buffers ensured that an approximate steady state was maintained in 
the sample wells within the time frame of the experiment and the ion 
concentrations were maintained throughout the 5-day run time. The system was 
used to determine the minimum nanohydroxyapatite (nanoHA) seeding density 
required to produce an increased phosphate reading compared to the positive 
control of 10 µg/mL poly-L-glutamic acid in agarose. This was found to be 10 
µg/mL. The assay was later used to determine the effectiveness of a number of 
self-assembling peptides combined with nanoHA with respect to their potential 
use as a hybrid material for bone and enamel repair. The self-assembling 
peptides P11-4, P11-8 and the complementary peptides P11-13 and P11-14 were 
analysed using the IVN to determine their nucleating and crystal growth 
supporting properties with and without the addition of 10 µg/mL nanoHA (Sayed, 
2013). It was shown that P11-4 and P11-8 were excellent nucleators of the calcium 
and phosphate containing mineral, hydroxyapatite, (HA) although both were 
unaffected by the addition of nanoHA. The complementary peptide P11-13/14 
showed poor nucleating properties with respect to hydroxyapatite when tested 
alone but provided good crystal growth capability with the addition of nanoHA 
(Sayed, 2013). 
This system, referred to by Sayed (2013) as the in vitro nucleation (IVN) assay, 
not only allowed the study of the nucleating potential of a material but also its 
ability to sustain the growth of the crystal nuclei over a 4-day testing period. The 
system allowed for the use of calcium-containing buffer and phosphate-
containing buffer at sub threshold concentrations with respect to hydroxyapatite. 
78 
 
The majority of the experiments carried out in this thesis using the IVN assay 
had seed crystals present within the samples themselves and so were primarily 
focussing on crystal growth. The IVN assay is not able to distinguish between 
the calcium-phosphate containing mineral precipitate formed through nucleation 
or crystal growth and will most likely reflect a combination of both. For this 
reason, from this point on, the in vitro nucleation assay will be referred to as the 
in vitro nucleation and crystal growth (IVNCG) assay as this better reflects the 
capability of the assay.  
The following chapter will describe the validation of the experimental IVNCG 
assay through statistical analysis of positive (10 μg/mL poly-L-glutamic acid in 
agarose) and negative (agarose) controls. The validation results will be 
compared to previous work carried out by Sayed (2013) and Hunter and 
Goldberg (1993). The nanoHA synthesised as part of this thesis, see Chapter 3, 
will then be optimised with regards to the minimal seeding density of nanoHA in 
agarose required to provide a statistically significant difference compared to the 
positive control. The crystals grown within the IVNCG will then be isolated and 
studied using SEM and EDS.  
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4.2 Methods 
4.2.1 In Vitro Nucleation and Crystal Growth Assay (IVNCG) 
Validation  
The IVNCG apparatus was first described by Sayed in his thesis (Sayed, 2013). 
To validate the assay in this study, the apparatus, see Figure 4-3, was first 
soaked overnight in 0.1M HCl (Sigma-Aldrich St. Louis, MO, USA) to remove any 
mineral present within the sample wells from previous experiments. Calcium-
containing buffer at pH 7.4 was prepared with calcium nitrate tetrahydrate 
(Ca(NO3)2.4H2O, Acros Organics ACS grade, Waltham, MA, USA) 6.5 mM, in 20 
mM HEPES (Sigma-Aldrich St. Louis, MO, USA) and 150 mM NaCl (Sigma-
Aldrich St. Louis, MO, USA) in distilled H2O. Phosphate-containing buffer at pH 
7.4 was prepared using 3.9 mM sodium phosphate dibasic dihydrate 
(Na2HPO4.2H2O 99%+ for analysis Acros Organics) with HEPES 20 mM (Sigma-
Aldrich St. Louis, MO, USA) and 150 mM NaCl (Sigma-Aldrich St. Louis, MO, 
USA) in distilled H2O. All buffers were pH adjusted using 5 M NaOH (Sigma-
Aldrich St. Louis, MO, USA) to pH 7.4 and filtered using a 22 μm bottle top 
vacuum filtration system (Corning 1L filtration system Corning, NY, USA, 
431098). Two agarose (BIO-RAD low melt agarose, Hercules, CA, USA, 
1613111) samples were produced from 2% agarose in distilled H2O and kept at 
50˚C. All samples tested using the IVNCG were prepared in steady state buffer 
at pH 7.4 (20 mM HEPES and 150 mM NaCl) to maintain physiological pH and 
salt concentration throughout the experiment. The positive control was made by 
adding an equal volume of 2x concentrated steady state buffer at pH 7.4 (40 mM 
HEPES and 300 mM NaCl) to agarose producing 1% agarose in steady state 
buffer at pH 7.4 (20 mM HEPES 150 mM NaCl) with 10 μg/mL poly-L-glutamic 
acid (Sigma-Aldrich St. Louis, MO, USA, P4886) added. The negative control 
was made by adding an equal volume of 2x steady state buffer to agarose 
producing a 1% agarose sample in steady state buffer. Both positive and 
negative controls were pipetted into the sample wells (0.85 mL, 10 mm long, 
diameter 5.2 mm), see Figure 4-3 C, with dialysis membrane (SpectraPor-3 
MWCO 3.5kD, Hoeksteen Netherlands, 132724) covering both sides (n=16 
positive, n=20 negative). Once cooled, the sample holder was screwed into place 
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within the system and 5 L of calcium-containing buffer was added to one 
compartment and 5 L of phosphate-containing buffer to the other compartment. 
The IVNGC apparatus with samples in situ was then incubated at 37°C, with 
stirring, for 5 days. The agarose gels were then removed from the sample holder 
and stored in 14 mL glass vials. 
 
Figure 4-3 – Schematic representation of the IVNCG assay showing the 
position of the buffer compartments, A and D, Sample holder, B, and 
sample wells, C. Image modified from Sayed (2013). 
4.2.2 Determination of Phosphate Content in Agarose Controls 
Recovered from IVNCG After 5 Days. 
Agarose samples were recovered from the sample wells of the IVNCG after the 
5-day test period and were ashed in 10 mL sealable glass vials following the 
method of Chen et al. ( 1956). Concentrated nitric acid, 2 mL (Sigma-Aldrich St. 
Louis, MO, USA) was added to each gel and to each of 4 additional empty 10 
mL glass vials (to act as blanks). The solution was then boiled until the volume 
had reduced to 1 mL. The solutions were then made up to 10 mL using de-
ionised H2O. The solutions were then further diluted 10 times through the 
addition of de-ionised H2O prior to analysis. Phosphate standards were produced 
(10.5 mM phosphate standard, Fisher Chemicals, Loughborough, UK) across a 
range of concentrations from 0-100 μM phosphate in 10 μM intervals. Each 
sample and standard (300 μL) was added to individual 1 mL Eppendorf tubes. 
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To each sample or standard, 700 µL of a mixture of 10% ascorbic acid (Sigma-
Aldrich St. Louis, MO, USA; solution A) and 0.42% ammonium molybdate.4H2O 
(VWR chemicals Lutterworth UK) in 0.5M H2SO4 (Sigma-Aldrich St. Louis, MO, 
USA; solution B) was added in a ratio of 1 part A to 6 parts B. Each sample (300 
μL) was then pipetted into wells of a 96 well plate. The phosphate calibration 
standards (also 300 µL) were added to the 96 well plate in triplicate. The plate 
was incubated at 37° for 1 hour 30 minutes. The absorbance was then read using 
a plate reader (Thermo Fisher Scientific, VarioSkan Flash, software SkanIt RE, 
Waltham, MA, USA) at 820 nm. The absorbance readings from the 4 blanks were 
averaged and subtracted from each calibration reading. Once the blank reading 
was subtracted, average absorbance against standard concentration was plotted 
and a line of best fit generated. R2 analysis of the fit was calculated to determine 
linearity with 0.999 being used as the minimal acceptable level. The gradient of 
the line of best fit was used to calculate the mass of phosphate in each sample 
chamber assuming a IVNCG sample volume of 0.85 mL, resulting in a total 
sample dilution factor of 117.65 (0.85 mL sample diluted to 10 mL followed by 
an additional 10 times dilution prior to analysis). The resulting phosphate 
concentration was then used to calculate hydroxyapatite (HA) present in each 
sample, presuming that the mineral deposited in the samples was wholly HA and 
that all of the phosphate derived from the HA. The experiment was repeated 4 
times to allow analysis of inter run variability.  
4.2.3 IVNCG Statistical Analysis  
The phosphate mass data produced from the IVNCG experiments were imported 
into SPSS and the Kolmogorov-Smirnov statistical test of normality and the 
independent t-test were used to confirm a normal distribution and determine 
statistical differences between sample groups. When IVNCG experiments were 
undertaken with more than 2 sample groups, a one-way ANOVA post hoc 
Bonferroni test was run to determine differences between runs. A power test was 
also undertaken using the validation data to determine the number of controls 
which would be required for future testing (Rosner, 2011). A significance level of 
p<0.05 was used for all statistical analysis.   
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4.2.4 Effect of IVNCG Run Time on Buffer Calcium and Phosphate 
Content 
The buffer compartments of the IVNCG were designed to be large enough to 
ensure that the concentration of calcium in the calcium-containing buffer and the 
concentration of phosphate in the phosphate-containing buffer approximated 
steady state conditions throughout the 5-day testing period, such that the 
concentrations of the ions did not change as a function of time or as a function 
of calcium phosphate mineral formation within the sample wells. To test this 
assumption, the IVNCG experiment was run as previously described in section 
4.2.7 using samples with nanoHA at seeding densities of 10, 20 and 30 µg/mL 
in agarose (n=10), and including positive and negative controls (n=3). For each 
day of the 5-day run period, a 10 mL sample of the calcium-containing buffer and 
the phosphate-containing buffer was taken from the IVNCG assay buffer 
compartments and stored in sealed vials under refrigeration prior to analysis.  
4.2.5 Determination of Buffer Phosphate Concentration  
A phosphate assay was then carried out on both the phosphate-containing buffer 
and calcium-containing buffer. The samples taken from the calcium-containing 
buffer on days 0-5 were diluted 10 times while the samples taken from the 
phosphate-containing buffer on days 0-5 were diluted 100 times. A solution of 
10% ascorbic acid (Sigma-Aldrich St. Louis, MO, USA) (solution A) and 0.42% 
ammonium molybdate.4H2O (VWR chemicals Lutterworth UK) in 0.5M H2SO4 
(Sigma-Aldrich St. Louis, MO, USA) (solution B) in a ratio of 1 part A to 6 parts 
B was prepared and 210 µL aliquoted into the wells of a 96 well plate. The diluted 
calcium-containing buffer samples, the diluted phosphate-containing buffer 
samples and phosphate standards as described previously were then added, 90 
µL to each well, in triplicate to the solutions of AB. The plate was left to incubate 
at 37 °C for 1 hour and 30 minutes before absorbance was read at 820 nm as 
described in section 4.2.2. 
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4.2.6 Determination of Buffer Calcium Concentration  
The calcium concentration within each of the buffer reservoirs was determined 
using a Arsenazo III method previously described by Smith and Bauer (Smith Jr. 
and Bauer, 1979). A solution of 0.932 g Arsenazo III (Sigma-Aldrich St. Louis, 
MO, USA) and 6.808 g of Imadazol buffer (Sigma-Aldrich St. Louis, MO, USA) 
diluted to 500 mL with DI H2O and the pH adjusted to 6.5) was prepared and 50 
µL added to all the wells of a 96 well plate. The samples taken from the calcium-
containing buffer on days 0-5 were diluted 50 times; samples taken from the 
phosphate-containing buffer on days 0-5 were used undiluted. Samples (50 µL) 
were then added in triplicate to the 96 well plate wells containing 50 µL of 
Arsenazo III solution described above. Calcium standards (1 M calcium chloride, 
BDH laboratory supplies Poole, UK) were produced by dilution with DI H2O to 
produce a 1 mM calcium chloride stock solution. The 1 mM calcium chloride 
stock solution was then further diluted using DI H2O to produce concentrations 
between 0 and 0.6 mM in 0.1 mM increments in 1.5 mL Eppendorf tubes. Each 
calibration standard (50 µL) was then pipetted, in triplicate into the 96 well plate 
wells already containing 50 µL of previously added Arsenazo III solution 
described above. After 10 minutes the absorbance was read using a plate reader 
(Thermo Fisher Scientific, VarioSkan Flash, software SkanIt RE, Waltham, MA, 
USA) at 640 nm.  
4.2.7 Determination of Minimum NanoHA Seeding Density 
Required to Produce Increased HA Formation Compared to 
Controls Using IVNCG 
To minimise the possibility of any potential cytotoxic effect arising from using 
nanoHA in the treatment of dentine sensitivity, the minimum amount of nanoHA 
required to produce a statistically significant difference in mineral precipitation 
compared to the positive control was determined using the IVNCG. The 
preparation method for the IVNCG was carried out as described in section 4.2.1 
except that the number of control samples was reduced to n=3 for both positive 
and negative controls, following the power test analysis carried out during the 
validation. A 1 mg/mL suspension of nanoHA batch 1, see Chapter 3, was 
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produced by weighing out 25 mg of nanoHA into a 50 mL falcon tube and adding 
25 mL of 2x steady state buffer. A second 1 mg/mL suspension of the nanoHA 
batch 3, see Chapter 3, was produced by weighing out 25 mg of batch 3 nanoHA 
into a 50 mL falcon tube and adding 25 mL of 2x steady state buffer. Both 
suspensions were vortexed for 30 seconds followed by 2 x 20 second periods of 
sonic probe agitation (MISONIX model XL2010 model XL2010 Farmingdale, NY, 
USA , with micro probe output 20 KHz). The 2 suspensions of nanoHA were then 
combined together in equal volumes to produce a 1 mg/mL nanoHA stock 
suspension combined from batches 1 and 3. The combined suspension was then 
further diluted and added to an equal volume of 2% agarose in DI H2O to produce 
1% agarose samples with nanoHA seeding concentrations of between 10 and 
100 µg/mL with an interval of 10 µg/mL in 1% agarose steady state buffer. 
Samples were then placed in a sonic bath at 37 °C until required (no longer than 
20 minutes) to ensure the nanoHA remained suspended and the agarose 
remained molten. Each agarose sample was then pipetted in triplicate into the 
IVNCG sample holder and the calcium-containing buffer added to one buffer 
compartment and the phosphate-containing buffer added to the other. The 
IVNCG system was then placed in the incubator at 37°C with stirring for 5 days.  
After 5 days the samples were removed from the sample wells and their 
phosphate concentration determined as previously described in section 4.2.2. 
Due to the high phosphate values obtained in the agarose samples containing 
nanoHA, see section 4.3.3, a calibration curve with a greater range was 
produced, using standards of between 0 and 160 µM phosphate. The experiment 
to determine minimal nanoHA seeding density was carried out in triplicate, using 
nanoHA seeding densities of 10, 20 and 30 µg/mL in agarose, n=10. This 
experiment was then repeated 3 times to confirm the minimum concentration of 
nanoHA which could produce a statistically significant increase in phosphate 
concentration compared with the positive control.  
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4.2.8 Isolation and Analysis of Mineral Formed in NanoHA Seeded 
Agarose After 5 Days in IVNCG  
To enable the elemental composition and morphological analysis of the mineral 
formed during the IVNCG experiment to be investigated, the agarose control 
samples and nanoHA seeded agarose samples used in the IVNCG buffer 
experiment described in section 4.2.4 were processed to enable the isolation of 
any crystals present. After the 5-day IVNCG test period was completed, the 
agarose gel samples were removed from the IVNCG sample wells and placed 
into a 24 well plate. Images of the gels were taken using a Bio-Rad ChemiDoc™ 
MP Imaging System from both above, and perpendicular to, the buffer contact 
surface with respect to their positions when in the IVNCG assay. Images were 
taken using the Coomassie Blue Bio-Rad ChemiDoc™ standard protocol 
selected from the ChemiDoc™ software, using a white light screen, standard 
filter, automatic exposure time and white light transillumination. Once imaged, 
the agarose gels were combined into sample groups of positive control, negative 
control, 10 µg/mL nanoHA seeding density, 20 µg/mL nanoHA seeding density, 
30 µg/mL nanoHA seeding density in separate 50 mL falcon tubes. Milton 
Sterilising Fluid (2 % w/v sodium hypochlorite) was then added, 40 mL, to each 
sample falcon tube and left overnight. The resulting suspensions were then 
centrifuged (Thermo Sci Heraeus Megafuge 16R) at 16,500 g for 10 minutes, 
then washed with DI H2O pH adjusted to 10 using ammonium hydroxide (Sigma) 
3 times to ensure the Milton Sterilising Fluid was removed. A pH of 10 was used 
as hydroxyapatite is sparingly soluble at high pH limiting any change in crystal 
size or morphology. Suspensions were finally washed 3 times in ethanol and 
stored in ethanol. Samples were then pipetted onto SEM stubs and left to dry. 
Once dry the samples were sputter coated in gold (Agar Auto Sputter Coater 
B3743, Stansted, UK) and analysed using SEM (Hitachi S-3400N VP, Tokyo, 
Japan) with accelerating voltage 10 kV and current 84 µA to determine particle 
size and morphology. EDS analysis was also undertaken (Bruker XFlash 129 ev, 
Billerica, MA, US) to determine atomic composition.  
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4.2.9 Effect of Shortening the IVNCG Run Duration with Respect to 
Crystal Growth  
To enable direct comparisons to the work of Sayed, a repeat of the experiment 
described in section 4.2.7 was carried out but with the experimental duration 
decreased from 5 days to 4 days (Sayed, 2013). The IVNCG experiment was 
repeated using a sample size of n=3 for the positive and negative controls and a 
sample size of n=10 for the 10, 20 and 30 µg/mL nanoHA combined batches 1 
and 3 seeded in agarose samples.  
4.2.10 Comparison of NanoHA Synthesised in this Work to Other 
Synthetic NanoHA with Respect to Crystal Growth in IVNCG 
The IVNCG assay was run over a 4-day period using nanoHA synthesised by 
Sayed (2013) (“small-HA”), nanoHA obtained from Sigma-Aldrich (Sigma-
Aldrich, nanopowder, < 200 nm particle size (BET), ≥ 97 %, synthetic St. Louis, 
MO, USA) and the nanoHA synthesised in this work to determine if the nanoHA 
produced in this work differed with respect to its ability to seed crystal growth. 
The experiment was run in the same manner as described previously in section 
4.2.7 using samples of 5, 10 and 30 µg/mL of each nanoHA sample, along with 
the usual positive and negative controls (10 μg/mL poly-L-glutamic acid in 1% 
agarose and 1% agarose only respectively). All samples were tested in triplicate. 
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4.3 Results 
4.3.1 Validation of In Vitro Nucleation and Crystal Growth Assay 
(IVNCG)  
To enable the comparison of materials with respect to their ability to 
nucleate/support the growth of hydroxyapatite, the IVNCG was validated using a 
positive control of 10 μg/mL poly-L-glutamic acid in 1 % agarose and a negative 
control of 1% agarose. For the experiment to be considered valid, the positive 
control had to have produced a statistically significant increase in phosphate 
mass compared to the negative control. The IVNCG validation experiment was 
run on 4 separate occasions as described in section 4.2.1, using multiple 
samples of poly-L-glutamate in agarose (positive controls) or agarose alone 
(negative controls) in each run. Following a 5-day incubation, the samples were 
retrieved and phosphate analysis completed as described in section 4.2.2. A 
typical calibration curve for the phosphate standards used for these experiments 
is shown in Figure 4-4. This produced a linear line of best fit with an R2 value of 
0.999 that was used to calculate the concentration of phosphate in the positive 
and negative controls. A calibration curve for phosphate was produced for each 
of the IVNCG validation runs.  
 
Figure 4-4 Typical calibration curve showing absorbance at 820 nm against 
phosphate concentration. The line of best fit showed a linear response 
with a R2 value of 0.999. Error bars show 2x standard deviation, n=3. 
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Statistical analysis of the distributions of the phosphate mass produced in both 
positive and negative controls using the Kolmogorov-Smirnov statistical test 
confirmed a normal distribution which enabled the use of the independent t-test 
to test for significance between the positive and negative controls. This showed 
a statistically significant difference between the positive and negative controls in 
each individual experimental run, with a significance level of at least p<0.05.  
 
Figure 4-5 Bar histograms showing amounts of phosphate determined in 
positive (poly-L-glutamate in agarose, n=16) and negative (agarose, 
n=20) controls after 4 separate 5-day runs in the IVNCG. Greater 
amounts of phosphate were present in the positive controls compared 
with the negative controls on each occasion. Error bars show 2x 
standard deviation. * confirms statistically significant difference using 
independent t-test significance level of at least p<0.05. 
To determine the reproducibility of the assay with regards to the quantity of 
phosphate produced in the positive and negative controls between IVNCG 
experimental runs, a post hoc Bonferroni test was undertaken, with the results 
shown in Table 4-1. To directly compare the phosphate quantities produced 
between individual experimental runs, the quantity of phosphate produced in the 
positive controls and negative controls must not be statistically different with 
respect to its corresponding control over the 4 individual runs. The post hoc 
analysis confirmed that this was not the case. The positive controls produced 
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similar mean phosphate masses over the 4 individual IVNCG runs but the run 3 
positive control had a statistically significant lower mean phosphate mass 
compared to the phosphate masses of run 1, run 2 and run 4 (p<0.05). Similarly, 
the run 1 negative control produced a statistically significant larger mean 
phosphate mass compared to phosphate masses produced in run 2, run 3 and 
run 4. 
  
Run 1 
Positive 
Control 
Run 1 
Negative 
Control 
Run 2 
Positive 
Control 
Run 2 
Negative 
Control 
Run 3 
Positive 
Control 
Run 3 
Negative 
Control 
Run 4 
Positive 
Control 
Run 4 
Negative 
Control 
Run 1 
Positive 
Control 
  SD SD SD SD SD N/A SD 
Run 1 
Negative 
Control 
SD   SD SD SD SD SD SD 
Run 2 
Positive 
Control 
SD SD   SD SD SD N/A SD 
Run 2 
Negative 
Control 
SD SD SD   SD N/A SD N/A 
Run 3 
Positive 
Control 
SD SD SD SD   SD SD SD 
Run 3 
Negative 
Control 
SD SD SD N/A SD   SD N/A 
Run 4 
Positive 
Control 
N/A SD N/A SD SD SD   SD 
Run 4 
Negative 
Control 
SD SD SD N/A SD N/A SD   
Table 4-1 Output from Bonferroni statistical test carried out on the 4 
separate IVNCG validation runs comparing the positive and negative 
controls. Statistically significant differences were found between the 
amounts of phosphate measured in the positive controls across the 4 
runs. Statistically significant differences were also found between the 
amounts of phosphate measured across the negative control runs. SD 
shows significant difference while N/A shows no significant 
difference, significance level = 0.05.  
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4.3.2 Effect of IVNCG Run Time on the Calcium and Phosphate 
Concentrations of the Reservoir Buffers 
To determine if the IVNCG reservoir buffers (calcium-containing buffer on one 
side of the sample holder and phosphate-containing buffer on the other) maintain 
a steady state with respect to ionic calcium and ionic phosphate concentrations 
throughout the 5-day testing period, 10 mL of each of the reservoir buffers were 
removed each day from the respective buffer compartments and analysed for 
calcium and phosphate concentrations. The analyses were carried out as 
described in section 4.2.4 and the results are shown in Figure 4-3. The 
theoretical concentration of ions in each buffer is shown by the solid black line 
present on each graph. There was very little change with respect to the 
concentration of ionic calcium and phosphate in the buffers over time.  
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Figure 4-6 A) Scatter graph showing the phosphate concentration in 
phosphate-containing reservoir buffer (red) and calcium-containing 
reservoir buffer (black) during the IVNCG 5-day run period. B) Scatter 
graph showing the calcium concentration in the phosphate-
containing reservoir buffer (red) and calcium-containing reservoir 
buffer (black) during the 5-day run period. Error bars show standard 
deviation. The concentration of phosphate in the phosphate-
containing buffer and the concentration of calcium in the calcium-
containing buffer remained reasonably constant over time, confirming 
the IVNCG system was in steady state over 5 days (n=3).  
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4.3.3 Determination of Minimum NanoHA Seeding Density in 
Agarose Required to Produce Increased HA Formation 
Compared to Controls Using IVNCG. 
To minimise any potential cytotoxic effect caused by the use of nanoHA within a 
dentine occlusion material, the minimum nanoHA seeding density required to 
outperform the positive control with respect to increased total phosphate mass 
was determined. The IVNCG was run as described in section 4.2.7 with 
phosphate analysis determined as described in section 4.2.2. In order to 
accommodate the higher amounts of phosphate present in the sample gels 
following seeding with nanoHA, the calibration curve for phosphate was re-run 
to check for linearity at higher phosphate values. The resulting line of best fit was 
linear with an R2 value of 0.999, confirming the linearity of the response at 
concentrations higher than the 100 µM phosphate standard previously used. All 
absorbance readings from the samples containing nanoHA seed crystals in the 
IVNCG experiments were within the absorbance value limits of the new 
calibration curve.  
 
Figure 4-7 Calibration curve showing absorbance at 820 nm against 
phosphate concentration up to 160 µM. The line of best fit shows a 
linear response with a R2 value of 0.999 confirming linearity. Error bars 
show 2x standard deviation, n=3.  
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The experiment to determine the minimum nanoHA seeding density required to 
significantly increase the phosphate mass showed a significant difference 
between the positive and negative controls (p<0.05), Figure 4-8, which confirmed 
that the run was valid. The results suggested a linear increase in phosphate 
mass within the samples seeded with 10 to 50 µg/mL nanoHA with any seeding 
density above 50 µg/mL producing a similar phosphate mass up to the maximum 
seeding density tested at 100 µg/mL nanoHA. The minimum nanoHA seeding 
density required to produce a statistically significant increase in phosphate mass 
compared to the positive control was found to be 30 µg/mL (p<0.05). 
 
Figure 4-8 Bar chart showing phosphate mass in samples of increasing 
nanoHA seeding density (n=3) after 5 days in IVNCG compared with 
positive and negative controls. Positive control was agarose with 10 
µg/mL poly-L-glutamic acid, negative control was agarose alone. Error 
bars show 2x standard deviation, N/S= no significant difference, *= 
significant difference (p<0.05). The minimum seeding density of 
nanoHA required to produce a statistically significant increase in 
phosphate mass compared to the positive control was 30 µg/mL. 
Added phosphate in form of nanoHA 5.66 µg of phosphate per 10 µg 
of nanoHA added. 
To confirm the results from the IVNCG assay using a range of different seeding 
densities (10-100 µg/mL nanoHA seeded 1% agarose, see Figure 4-8), the 
experiment was repeated using the lower concentrations of 10, 20 and 30 µg/mL 
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of nanoHA seeded in 1% agarose with n=10 per concentration. This experiment 
was repeated 3 times to determine reliability. The results of the IVNCG 
experiments using samples containing 10, 20 and 30 µg/mL nanoHA seeded in 
1% agarose confirmed that a minimum nanoHA seeding density of 30 µg/mL was 
required to produce a significant increase in phosphate mass over the 5-day 
IVNCG experiment when compared to the positive control (p<0.05), Figure 4-9. 
Each of these repeats showed statistically significant differences between the 
positive and negative controls (p<0.05). Runs 1 and 2 produced similar results 
for samples containing 10 and 20 µg/mL nanoHA which were both significantly 
below the phosphate values for the positive control. However, in contrast, the 10 
and 20 µg/mL nanoHA samples in run 3 produced larger phosphate masses, 
with both the mean phosphate mass for the 10 and 20 µg/mL nanoHA seeding 
density samples not statistically different to the positive control.  
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Figure 4-9 Bar chart showing quantity of phosphate produced as a function 
of nanoHA seeding density after 5 days in the IVNCG. All 3 runs 
showed that a 30 µg/mL nanoHA seeding density was the minimal 
seeding density required to produce statistically significant increase 
in phosphate mass compared to the 10 µg/mL poly-L-glutamic in 1% 
agarose positive control (*=p<0.05). Added Phosphate in form of 
nanoHA 5.66 µg of phosphate per 10 µg/mL of nanoHA added. Error 
bars show 2x standard deviation. Samples n=10, controls n=3. 
4.3.4 Isolation and Analysis of Mineral Formed in NanoHA Seeded 
Agarose after 5 Days in IVNCG  
To investigate the mineral formed during the IVNCG 5-day run, the deposits were 
isolated and then analysed using SEM and EDS to determine morphology and 
elemental composition. Following the 5-day IVNCG experiment described above 
using increasing amounts of seed crystals in each of the sample wells, the Bio-
Rad ChemiDoc™ MP Imaging system was used to image the precipitated 
mineral in each recovered sample gel at the end of the run. Figure 4-10 shows 
clearly the band-like precipitation of mineral present in the positive (poly-L-
glutamate) control and in the sample seeded with 30 µg/mL nanoHA. The 
samples seeded with 10 µg/mL and 20 µg/mL nanoHA showed not only an 
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apparently less dense mineral precipitation but also a wider spread of 
mineralisation foci throughout the gel. The negative control showed only very 
sparse formation of mineral.  
The precipitated material was then recovered from the agarose gels using the 
method described in 4.2.8. Both the positive controls and the samples containing 
30 µg/mL of nanoHA formed a cloudy suspension after the agarose had been 
dissolved by the sodium citrate, with no large aggregates visible. In contrast the 
negative control and samples seeded with 10 µg/mL and 20 µg/mL nanoHA all 
maintained the large “particle-like” morphology visible in the Bio-Rad 
ChemDoc™ images, see Figure 4-10. In order to determine crystal morphology 
and composition in the samples, SEM and EDS analyses were completed as 
described in section 4.2.8.  
 
Figure 4-10 Images of mineral precipitate formed within agarose gels and 
retrieved after 5 days in the IVNCG assay. A) Positive control (1% 
agarose with poly-L-glutamate at 10 µg/mL); B) Negative control (1% 
agarose only); C) 10 µg/mL nanoHA in 1% agarose; D) 20 µg/mL 
nanoHA in 1% agarose; E) 30 µg/mL nanoHA in 1% agarose. Images 
taken on the Bio-Rad ChemDoc™ MP imaging system using the 
Coomassie Blue standard protocol available on the ChemDoc™ 
software. Top row images show side-on view of the samples, bottom 
row shows gel from the perspective of the buffer interface with respect 
to position in the IVNCG assay. A change in precipitate appearance is 
visible when nanoHA seeding density increased from 20 µg/mL 
nanoHA (sparse regions of precipitate) to 30 µg/mL nanoHA (dense 
band of precipitate was visible). 
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The negative control and samples seeded with 10 µg/mL and 20 µg/mL nanoHA 
revealed the presence of large micron sized spherical particles which increased 
in number from the negative control to the 20 µg/mL nanoHA seeded sample, 
see Figure 4-11 C, E and G. The particles were, however, all of similar size with 
diameters between 300 – 600 µm and had a similar surface morphology, see 
Figure 4-11 D, F and H. Material obtained from the poly-L-glutamate positive 
control sample had a sparse covering of what appeared to be small rod and 
needle shaped crystals with the longest axis having a size of 3 – 5 µm, see Figure 
4-11 A and B.  
Finally, crystals recovered from the 30 µg/mL nanoHA seeded sample produced 
material more similar in morphology to the positive control than the lower 
concentrations of nanoHA seeded gels, with a dense coverage of needle and 
plate-like crystals, although these appeared larger than those crystals present in 
the positive control with the longest axis having a size of 7 – 20 µm, see Figure 
4-11 I and J.  
EDS analysis of the particles produced, shown in Table 4-2, indicated that the 
crystals produced in the negative control, 10 and 20 µg/mL nanoHA samples had 
Ca/P molar ratios of 1.36, 1.38 and 1.42 respectively, suggesting the presence 
of octacalcium phosphate. The Ca/P ratios for the positive control at 1.51 and 
the 30 µg/mL nanoHA seeded sample at 1.65 suggest a calcium deficient HA 
and stoichiometric HA respectively.  
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EDS Sample Ca/P ratio Standard deviation 
Negative 1.36 0.04 
10 µg/mL 1.38 0.20 
20 µg/mL 1.42 0.12 
Positive 1.51 0.01 
30 µg/mL 1.65 0.05 
Stoichiometric HA 1.67 
 
OCP 1.33 
 
Table 4-2 Table showing Ca/P molar ratio of isolated crystals produced in 
different samples in the IVNCG after 5 days, determined through EDS 
analysis. The analyses suggest that crystals produced in the negative 
control, 10 and 20 µg/mL nanoHA seeded samples were of similar Ca 
and P composition to OCP. The 30 µg/mL nanoHA sample produced a 
Ca/P ratio similar to hydroxyapatite while the positive control Ca/P 
ratio suggested a calcium deficient hydroxyapatite.  
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Figure 4-11 SEM images of mineral recovered from samples retrieved from 
the IVNCG assay after a 5-day run. A) and B) Positive control 10 µg/mL 
poly-L-glutamic acid in 1% agarose C) and D) negative control 1% 
agarose, E) and F) 10 µg/mL nanoHA G) and H) 20 µg/mL nanoHA, I) 
and J) 30 µg/mL nanoHA seeded agarose. Changes in crystal 
morphology were seen when nanoHA seeding density was increased 
from 20 µg/mL to 30 µg/mL, from large (300-600 µm), single spherical 
aggregates to smaller (7-20 µm) plate-shaped individual crystals 
(arrowed) respectively. The crystals retrieved from samples 
containing 30 µg/mL nanoHA had a similar appearance to the positive 
control while the crystals retrieved from samples containing 10 and 
20 µg/mL nanoHA looked similar to those seen in the negative control.  
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4.3.5 Effect of Shortening the Duration of the IVNCG Run with 
Respect to Crystal Growth  
To determine the effect of decreasing the length of the IVNCG experiment on the 
amount of phosphate produced after 4 days, the IVNCG experiment was 
repeated using agarose seeded with nanoHA at 10, 20 and 30 µg/mL using 
nanoHA from a combination of batches 1 and 3, as described in section 4.2.7. 
This was undertaken to determine the effect of decreased run duration on the 
quantity of phosphate produced as well as enabling comparisons with the data 
described by Sayed (2013), who used a 4-day incubation.  
After 4 days, the samples were removed from the IVNCG assay sample wells, 
ashed and analysed before determining phosphate mass as previously 
described in section 4.2.2. The phosphate masses produced in samples during 
the 4-day IVNCG assay run confirmed statistically significant differences 
between the positive (poly-L-glutamate in 1% agarose at 10 µg/mL) and negative 
(1% agarose) controls for all 3 individual runs (p<0.05), see Figure 4-12 Bar chart 
showing phosphate mass produced in samples with different nanoHA seeding 
density after 4 days in the IVNCG assay, error bars show 2x standard deviation. 
All phosphate amounts detected in nanoHA seeded agarose samples were 
significantly lower compared to the positive control (p<0.05) except for the 
sample seeded at 30 µg/mL nanoHA in run 2 which contained a significantly 
increased level of phosphate (p<0.05). Samples seeded with 30 µg/mL nanoHA 
(produced by combining nanoHA batches 1 and 3) was the only sample to 
produce a statistically significant increase in recovered phosphate mass 
compared to the positive control (p<0.05) and this was only apparent in run 2. 
The phosphate masses produced for samples seeded with nanoHA at 10 and 20 
µg/mL were significantly lower compared to the positive control in all 3 
experimental runs (p<0.05). 
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Figure 4-12 Bar chart showing phosphate mass produced in samples with 
different nanoHA seeding density after 4 days in the IVNCG assay, 
error bars show 2x standard deviation. All phosphate amounts 
detected in nanoHA seeded agarose samples were significantly lower 
compared to the positive control (p<0.05) except for the sample 
seeded at 30 µg/mL nanoHA in run 2 which contained a significantly 
increased level of phosphate (p<0.05). Added phosphate in form of 
nanoHA 5.66 µg of phosphate per 10 µg of nanoHA added. 
4.3.6 Comparison of Synthesised NanoHA Produced in this Work 
to Other Synthetic NanoHA Using the IVNCG over a 4-Day 
Test Period.  
To investigate if the source of nanoHA had any effect on the amount of 
phosphate produced during a 4-day IVNCG run, an experiment was designed 
using 3 different nanoHA samples (nanoHA produced in this thesis, combining 
batches 1 and 3), nanoHA of <200nm purchased from Sigma and “small-HA” 
produced by Sayed). The experiment would therefore enable comparisons to be 
made to the work of Sayed (2013) using the same IVNCG assay run length and 
the actual nanoHA sample that he used to produce his results. The IVNCG was 
run as described in sections 4.2.1 and 4.2.10.  
After 4 days, there was a statistical difference in the amount of phosphate 
recovered from the positive and negative controls (p<0.05). Only samples 
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seeded with 30 µg/mL nanoHA produced in this thesis produced a phosphate 
mass that was insignificantly different to the positive control (p>0.05). All other 
samples produced phosphate levels similar to the negative control, see Figure 
4-13.  
 
Figure 4-13 Bar chart showing effect of nanoparticle source (“small HA” 
from Sayed’s work, combined batches 1 and 3 nanoHA produced in 
this thesis and nanoHA purchased from Sigma) at varying seeding 
densities against phosphate mass in the samples after 4-day IVNCG 
assay runs (n=3). Red shows Poly-glutamic acid in agarose seeded 
with 30 µg/mL batch 1 3 nanoHA seeding density. Green bars show 
phosphate in samples with a 5 µg/mL nanoHA seeding density, orange 
bars show 10 µg/mL seeding density and blue bars how 30 µg/mL 
seeding density. Almost all samples contained significantly lower 
amounts of phosphate compared with the positive control. The 
exceptions were samples containing 30 µg/mL nanoHA produced in 
this thesis by combining batches 1 and 3. No significant differences 
were seen between these and the positive control (significance value 
p<0.05). Added phosphate in form of nanoHA 5.66 µg of phosphate per 
10 µg of nanoHA added. Error bars show 2x standard deviation. 
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4.4 Discussion  
The ultimate aim of this thesis was to generate a hybrid material containing 
nanoHA and self-assembling peptides for use in the treatment of dentine 
sensitivity. To enable the optimisation and assessment of the hybrid material with 
respect to its ability to support nanoHA crystal growth, a validated, quantitative 
assay was needed. The assay used in this work was developed from previous 
steady state assays as described in section 4.1.  
Poly-L-glutamic acid was selected as the positive control for the IVNCG assay 
developed here as it has been used as a positive control in hydroxyapatite crystal 
nucleation and growth studies previously (Hunter et al., 1996; Sayed, 2013) and 
has also been investigated as a potential material to promote the nucleation and 
growth of hydroxyapatite in demineralised dentine collagen (Sun et al., 2014) . 
Poly-L-glutamic acid is a peptide polymer composed of L-glutamic acid residues. 
Glutamic acid residues have been reported to be associated with the nucleating 
domains of a number of non-collagenous proteins implicated in biological HA 
nucleation (Deshpande et al., 2011).The mechanism by which poly-L-glutamic 
acid promotes the nucleation of HA under biological conditions is presumed to 
be a function of the negative charge that the amino acid carries at pH 7.4 due to 
deprotonation of the carboxylic acid R group. The negative charge on the 
carboxyl group is thought to attract calcium ions, increasing the local saturation 
of ions with respect to HA, favouring the formation of stable crystal nuclei which 
can then undergo crystal growth (Jahromi et al., 2013). Poly-L-glutamic acid has 
not only been shown to promote HA nucleation, it has also been shown to interact 
with growing HA crystals through bonding preferentially to specific crystal planes 
during crystal growth. The interaction of poly-L-glutamic acid at concentrations 
of 20 – 80 mg/mL with HA surfaces in an environment saturated with respect to 
HA has also been investigated (Wang et al., 2015). The results confirmed a 
change in the morphology of the crystals formed through limiting growth along 
the crystal axis to which the poly-L-glutamate was bound, resulting in plate like 
crystals, in contrast to the chemical precipitation method which resulted in 
needle-like crystal morphology.  
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A number of macromolecules thought to be potential nucleators of HA in the 
formation of bone have been shown to contain domains of negative charge due 
to glutamic acid rich sequences. Bone sialoprotein, which contains a significant 
amount of glutamic acid residues, was shown by Hunter and Goldberg (1994) to 
promote the nucleation of HA in vitro. A follow up paper also confirmed the 
effectiveness of bone sialoprotein and phosphophoryn as nucleators of HA when 
compared to the negative control of 1% agarose. Both bone sialoprotein and 
phosphophoryn produced an increase in calcium and phosphate mass as a 
function of the concentration of protein added, with bone sialoprotein producing 
a larger calcium phosphate mass than phosphophoryn when equal masses of 
the protein were used. Interestingly, when osteopontin was used in the same 
experiments, it was found to have no calcium phosphate nucleating properties. 
The structure of osteopontin is very similar to that of bone sialoprotein except for 
the glutamic acid rich motif, which is absent from the osteopontin protein (Hunter 
et al., 1996). This suggested that the presence of the glutamic acid rich region of 
bone sialoprotein is important to the calcium phosphate nucleation properties of 
the bone sialoprotein protein. 
The effectiveness of poly-L-glutamate as nucleator of HA makes it an ideal 
choice as a positive control within the IVNCG due to its proven ability as a 
nucleator of HA. This not only enables the validation of the system through 
comparisons with other established in vitro nucleation methods but also provides 
a means to assess how effective other materials are with regards to their 
nucleation and support of crystal growth.  
To validate the IVNCG assay with respect to its ability to determine the nucleation 
and crystal growth supporting properties of a given sample, a statistical 
comparison between the positive control, 10 µg/mL poly-L-glutamic acid in 1% 
agarose and the negative control, 1% agarose, was used. The results from the 
4 individual experiments carried out in order to validate the IVNCG system 
produced significant differences between the positive and negative controls on 
each occasion (p<0.05; Figure 4-5). These data confirmed the work initially 
carried out by Sayed (2013) and showed that the IVNCG assay is a reliable 
assay capable of providing reproducible differences between the positive and 
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negative controls. However, each individual run resulted in different amounts of 
mineral being deposited in both the positive and negative control samples, 
underlining the individuality of each run and the necessity to run controls for each 
experiment when testing unknown samples. The optimisation and assessment 
of material with respect to their nucleation and crystal growth supporting 
properties would require the materials of interest to be tested within one 
experimental run if their properties are to be compared and statistically analysed. 
Measurement of the concentrations of phosphate and calcium in the calcium-
containing buffer and the phosphate-containing buffer in the respective reservoir 
tanks of the IVNCG assay confirmed the approximate steady state nature of the 
system, see Figure 4-6.  
When comparing the quantity of phosphate measured in each of the controls in 
the experiments carried out in this thesis to the work of Sayed (2013), there was 
a significantly increased level of phosphate in both the negative and positive 
controls in the current work. Amounts of phosphate were also significantly 
different from those reported by Hunter and Goldberg (1994), using a different 
system but the same controls. Table 4-3 summarises these differences. Sayed 
(2013) used the same system as that described in the current work so it is 
perhaps surprising to see significant differences between his previous work and 
that carried out in the course of this thesis. The most simple and straightforward 
explanation for the significant difference between the values of phosphate 
precipitated in the Sayed (2013) experiments and those obtained here, is a 
possible error made in the mathematical calculation of phosphate mass. Sayed 
(2013) present’s images showing significant precipitation within the retrieved 
agarose gels after his IVNCG assay runs which would be expected to correspond 
to a significantly larger phosphate mass than the levels quoted. The negative 
controls obtained in this thesis after the IVNG runs contained very little or no 
visible mineral deposits, yet apparently yielded phosphate masses that were 
larger than those quoted for the positive controls in the work by Sayed (2013). 
The method by which the data was processed by Sayed (2013) states that the 
amount of phosphate measured in a background sample that had not been in 
contact with the reservoirs buffers was subtracted from each sample’s phosphate 
mass at the end of the IVNCG assay experiment. The contribution of phosphate 
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to the final sample arising from the reservoir buffer itself was not accounted for. 
Given that the phosphate-containing reservoir buffer has a concentration of 
approximately 315 µg/mL, the quoted value of 15 -25 µg/mL quoted by Sayed 
(2013) as the amount of phosphate present in the agarose negative control at 
the end of the IVNCG run is very low.  
 Negative control (µg 
of phosphate/mL) 
Positive control (µg 
of phosphate/mL) 
IVNCG assay: This 
work  
120 - 300 470 – 770 
IVNCG assay Sayed 
2013  
15-25 120-170 
Hunter and Goldberg 
1994 
440 
(70 % = 310) 
1000 
(70 % = 700) 
Table 4-3 Table showing comparison of approximate phosphate masses 
produced during in vitro mineralisation studies normalised to µg/mL. 
The 70% values in brackets show expected phosphate concentrations 
when the decrease in surface area of sample in contact with calcium-
containing and phosphate-containing buffer is taken into account due 
to the smaller sample wells used in the IVNCG assay. 
Comparison of the phosphate values obtained in IVNCG assay control samples 
in this work and those presented by Hunter and Goldberg suggests that the 
phosphate mass values obtained using the IVNCG assay were slightly lower, 
see Table 4-3. The ion concentrations of the buffer solutions used by Hunter and 
Goldberg (1994), (6 mM CaCl2 and 6 mM NaPO4 compared with 6.5 mM 
Ca(NO3)2.4H2O and 3.9 mM Na2HPO4.2H2O used here) may be one reason for 
the elevated phosphate masses produced in their agarose controls. A further 
experimental parameter which is different between the IVNCG assay used here 
and the Hunter and Goldberg (1994) system is the surface area of each sample 
that is in contact with the calcium-containing and phosphate-containing buffers. 
The surface area of the sample in contact with the buffer in the IVNCG used here 
is approximately 70% of the area in contact with the buffers in the Hunter and 
Goldberg (1994) method (0.785 cm2 and 1.12cm2 respectively). On inspection of 
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the positive controls after the 5-day IVNCG testing period, it can be seen that a 
band of mineral had formed in the middle of the gel with no mineral formed at 
either end. The presence of this mineralising band has been reported previously 
using other in vitro mineralisation assay techniques (De Jong et al., 1980; 
Boskey, 1989; Hunter and Goldberg, 1993). If we consider that the band volume 
near the centre of the gel has the potential to mineralise because the 
concentrations of calcium and phosphate have reached the required 
concentration to support the nucleation and growth of crystals, see Figure 4-14, 
a decrease in the area of the surface area of sample in contact with the calcium-
containing and the phosphate-containing reservoir buffers would be expected to 
have a significant effect on the amount of mineralisation that can occur. The 
smaller diameter of the sample wells (thus the surface area in contact with the 
calcium containing and phosphate-containing buffers) in the IVNCG system used 
here is thus likely to result in a smaller phosphate reading, 30% lower, than the 
values obtained using the Hunter and Goldberg system (1994), assuming the 
thickness of the mineralised band is the same in both methods. When this is 
taken into account, the values displayed in Table 4-3 seem reasonably close 
when using the higher end of the range produced in this work.  
The formation of a small amount of precipitate in the negative controls is most 
likely caused by heterogeneous nucleation of mineral on the surface of impurities 
within the agarose samples, which in effect act as crystal seeds. The presence 
of solid particles (e.g. dust) provides a liquid/solid interface which acts to lower 
the free energy of crystal formation, as part of the energy barrier to crystal 
nucleation is the creation of a new phase which would no longer have to occur 
due to the solid phase present in the form of dust. The concentrations of calcium 
and phosphate ions present in the IVNCG system are below that expected to 
result in spontaneous homogenous nucleation but are high enough to promote 
crystal growth once stable nuclei are present. The effect of the solid phase with 
respect to its ability to support the growth of a mineral precipitate will depend on 
how well the surface of the solid particle mimics the crystal structure of the 
calcium phosphate phase growing on its surface. The minimal amount of 
phosphate mass present in the negative controls confirms that the steps taken 
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to limit the solid impurities through thorough cleaning of the IVNCG assay 
equipment and filtration of the buffer solutions, is effective.  
 
Figure 4-14 – Graph showing the model diffusion properties of the IVNCG 
system assuming a static system. The model holds only prior to the 
formation of mineral. Dashed lines indicate region where 
mineralisation is possible. 
The phosphate masses recovered from control samples reported in this work are 
considerably closer to those obtained by Hunter and Goldberg (1994) than those 
previously reported by Sayed (2013) despite the fact that Sayed used the same 
experimental set-up as that used here and are even closer when the smaller 
sample surface area in contact with the calcium-containing and phosphate-
containing buffers is considered. The reliability of the IVNCG assay data 
produced during this study coupled with the similar phosphate masses produced 
when compared to the work of Hunter and Goldberg (1994) confirms the 
validation of the IVNCG assay with regards to the outcomes produced using 
positive and negative agarose controls.  
Having validated the IVNCG with respect to its ability to demonstrate statistically 
significant differences between the abilities of materials to nucleate and support 
the growth of HA under physiological conditions, the assay was then used to 
determine the minimum seeding density of nanoHA required to increase the 
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quantity of phosphate mass produced during the 5-day test period compared to 
the positive control.  
The use of nanoHA as a material for bone tissue engineering and as a material 
for use in dental applications is seen as an effective means to provide the 
materials required to form new bone and enamel tissues (Zhou and Lee, 2011). 
NanoHA is seen as a potentially useful source of HA as the small size of the 
crystals are similar to those of the native tissues themselves and they are able 
to penetrate into small spaces, for example into dentine tubules. However, one 
important issue regarding the clinical use of nanoHA in medical applications is 
potential toxicity and changing of cellular function. This currently is a matter of 
debate due to the variable effects of the particle size (Shi et al., 2009), seeding 
density (Motskin et al., 2009) and morphology (Xu et al., 2009) of the nanoHA 
used. There are a number of authors who have investigated the effect of nanoHA 
on a range of cells but with the results seemingly inconclusive (Xu et al., 2009; 
Remya et al., 2014; Shi et al., 2017).  
One factor which was explored by Xu et al. (2009) was how different nanoHA 
crystal morphologies (spherical versus needle), at a seeding density of 10 mg/mL 
affected protein expression in osteoblasts (Xu et al., 2009). They showed that 
nanoHA needle morphology resulted in significantly reduced osteoblast cell 
numbers compared to the nanoHA spherical morphology over a 4-day period in 
culture. Both spherical and needle nanoHA crystal morphologies produced 
significantly lower osteoblast cell density compared to the controls, suggesting 
that nanoHA was toxic to osteoblast cells. The concentration of nanoHA used in 
the Xu et al. (2009) study was 10 mg/mL which was considerably greater than 
the concentrations used in this work (<100 µg/mL) but the mechanism of the 
toxicity was hypothesised to be a function of local calcium concentration due to 
the dissolution of nanoHA crystals (Liu et al., 2009). This then could be an issue 
even at lower concentrations, depending on how the nanoHA and the cells 
interact (Shi et al., 2017). However, a study by Remya et al. (2014) concluded 
that the use of nanoHA crystals with a needle morphology at a seeding 
concentration of up to 800 µg/mL had no significant effect on bone marrow 
mesenchymal stem cells isolated from mouse bone marrow.  
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The literature is inconclusive with respect to the toxicity of nanoHA and its effects 
on cellular function and so to limit the effect of any potential toxicity or interaction 
with cellular processes when using the proposed hybrid material, which contains 
nanoHA with needle morphology, the minimum concentration of nanoHA 
required to provide a statistically significant increase compared to the positive 
control was undertaken using the IVNCG assay. The IVNCG experiment would 
also provide an overview of the effect of the addition of increasing the sample 
nanoHA seeding density.  
The testing of agarose samples seeded with nanoHA at concentrations above 
40 µg/mL was carried out to determine what levels of phosphate mass could be 
achieved using concentrations that were higher than the previous work carried 
out by Sayed (2013), which analysed samples with a maximum nanoHA seeding 
density of 40 µg/mL. The results from the current study showed that there was a 
direct relationship between phosphate mass in precipitates recovered from 
samples containing 10 to 50 µg/mL nanoHA seeds after incubation in the IVNCG 
system. This was in agreement with the work of Sayed (2013). Above 50 µg/mL, 
it appeared that the addition of more seed crystals had no effect on the resulting 
phosphate mass of the precipitated mineral after 5 days in the IVNCG system. 
The reason for this plateau in recovered phosphate mass in precipitates as 
seeding density increased over and above 50 µg/mL is unclear but one possible 
cause is disruption to the diffusion pathway within the gels caused by significant 
mineral accumulation within the sample gel, which would act to impede further 
mineralisation on either side of the central mineralised band. Further work to 
confirm this hypothesis would be required, via measurement of phosphate and 
calcium ion concentrations in areas of the sample gel either side of the 
mineralisation band, in a similar manner to the work of Boskey (1989). However, 
this would be difficult to achieve in the IVNCG system which uses sample gels 
that are only 1 cm long compared to the 6 cm gels used in the Boskey method.  
Further repeats of the seeding density experiments described previously 
confirmed that a minimal seeding density of 30 µg/mL nanoHA was required to 
provide a positive statistically significant difference compared to the positive 
control (p<0.05,Figure 4-9). The minimal seeding density of 30 µg/mL nanoHA 
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was different to that identified by Sayed (2013), who reported a minimal seeding 
density value of 10 µg/mL nanoHA using the same IVNCG system. Further work 
was therefore carried out to explore the reasons behind this difference.  
There are no works in the literature that explore the effect of nanoHA seeding 
density on the rate or quantity of phosphate/mineral produced in gel-based 
systems. Seeding density studies have, however, been undertaken in dilute 
aqueous systems. For example Moreno et al. (1977) studied the crystal growth 
kinetics of hydroxyapatite seeds added to a stirred 250 mL vessel through pH 
and calcium and phosphate analysis. Using starting seeding densities equating 
to 80 µg/mL- 200 µg/mL HA (particle size of 44 -53 µm), Moreno et al. (1977) 
determined an initial linear relationship between precipitation rate and seeding 
density up to 160 µg/mL HA, at which point the rate decreased away from linear. 
The system employed by Moreno et al. (1977) provided a quantitative means for 
measuring the effect of seed crystals on initial precipitation rates but due to the 
non-steady state of the method, determination of the quantity of phosphate as a 
function of seeding density mass was not possible.  
The use of nanoHA should have the effect of decreasing the seeding density 
required to increase the total mass of phosphate mineral produced compared to 
micron sized particles due to the large increase in surface area of nanoHA 
compared to micron sized HA when using equal seeding masses. The increased 
surface area would be expected to increase the potential for crystal growth as 
there would be a larger surface for calcium and phosphate ions to interact with. 
To determine the possible cause of the discrepancy between the results of this 
work and that of Sayed (2013), the variables of experimental run time, see 
section 4.3.5, and source of synthesised nanoHA used, see section 4.3.6, 
including a sample of small-HA produced by Sayed (2013), were investigated.  
The use of a shorter, 4-day IVNCG experimental run did not affect the resulting 
minimum nanoHA seeding density of 30 µg/mL nanoHA required to significantly 
increase recovered phosphate mass in samples compared to the positive 
control. However, the decrease in run time did result in 2 of the 3 experimental 
runs returning a non-significant difference between the positive control and the 
30 µg/mL nanoHA seeding density, see Figure 4-12. The decrease in IVNCG 
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assay run time had the effect of making the IVNCG assay less reliable. The use 
of different nanoHA samples (nanoHA produced in this thesis combined from 
batches 1 and 3, nanoHA purchased from Sigma and Sayed’s “small-HA”) over 
a 4-day time period did not produce any significant increases in phosphate mass 
compared to any sample. The combined batches 1 and 3 was the only sample 
to produce a phosphate mass that was similar when compared to the positive 
control with all other samples producing a significantly lower phosphate mass 
compared to the positive control (p<0.05), see Figure 4-13. The variables of 
IVNCG assay run time and nanoHA sample source were investigated although 
neither variable could be proven to have caused the differences in the minimum 
nanoHA seeding densities required to significantly increase phosphate 
compared to the control between this work and the work of Sayed (2013). 
To investigate the morphology and composition of the mineral produced in the 
nanoHA seeded agarose samples, the IVNCG was repeated using nanoHA 
seeding densities of 10, 20 and 30 µg/mL in 1% agarose, along with the positive 
and negative controls. The resulting precipitate was isolated from the agarose 
gels and analysed using SEM and EDS using the method described in section 
4.2.8. SEM images of the crystals isolated from each sample at the end of the 
IVNCG assay run suggested that increasing the crystal seeding density from 20 
µg/mL to 30 µg/mL nanoHA resulted in a profound change in the resulting 
morphology of the mineral deposited within the gels, see Figure 4-11. The 
mineral formed below a 30 µg/mL nanoHA seeding density appeared in the form 
of large spherical crystal aggregates of approximately 400 µm in diameter after 
5 days in the IVNCG assay. These large crystals were also seen in the negative 
controls but increased in number from between 1 and 3 in the negative control 
up to 30-40 in the 20 µg/mL nanoHA seeded samples. No smaller crystals were 
seen which suggested that either the smaller crystals were lost during the 
isolation process or the initial seed crystals dissolved during the initial diffusion 
period when the sample gels were undersaturated with respect to HA. In 
contrast, the mineral recovered from the samples seeded initially with 30 µg/mL 
nanoHA was comprised of many small plate and rod-like crystals, see Figure 
4-10 I and J. These were more similar, although larger, to those obtained from 
the positive controls, see Figure 4-10 A and B.  
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The reason for this change in crystal morphology above the 30 µg/mL nanoHA 
seed crystal concentration could be that lower concentrations of seeds are 
dissolving due to initial conditions of undersaturation with respect to HA at the 
beginning of the IVNCG experiment. This in turn would be expected to increase 
the local calcium and phosphate ion concentrations in the sample gels and would 
eventually result in re-precipitation of mineral with chemistry and morphology 
different to that of the initial crystal seeds. When seeding density is at 30 µg/mL 
nanoHA, the initial dissolution of seed crystals would still be expected to occur 
but crucially a significant number would endure, which could then undergo 
secondary crystal growth once the buffer calcium and phosphate ions had 
diffused into the samples. The resulting crystals would then be expected to be 
more similar in morphology to hydroxyapatite, such as was seen in the SEM.  
This theory is also partly supported through the comparison of the crystals 
recovered from the 30 µg/mL nanoHA with the crystals recovered from the 
positive control. In both cases, a mineral precipitant was produced which 
comprised of many small crystals, with crystals in the positive control samples 
being smaller than those recovered from the seeded samples. The positive 
control, poly-L-glutamic acid, contained no crystal seeds and formed mineral 
purely through the nucleation and subsequent crystal growth of HA (Hunter et 
al., 1996; Tye et al., 2003).The formation of crystal nuclei by the positive control 
is a consequence of the saturation level with respect to HA. Once the saturation 
threshold is reached, HA nucleation initiates and is then overtaken by seeded 
crystal growth resulting in the large number of small crystals seen in the SEM 
images, see Figure 4-11. In the case of the samples seeded with 30 µg/mL 
nanoHA, the local saturation levels ultimately reached would prevent the further 
dissolution of seed crystals and would also be expected to favour the growth of 
crystals through Ostwald ripening (Iggland and Mazzotti, 2012).  
The EDS analysis also supported the theory of seed crystal dissolution at lower 
seeding densities as indicated by a change in the Ca/P ratio that accompanied 
the change in crystal morphology when the nanoHA seeding density was 
increased from 20 µg/mL to 30 µg/mL. The Ca/P ratio of crystals formed within 
the negative controls, 10 µg/mL and 20 µg/mL nanoHA samples suggested that 
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the calcium phosphate phase present was OCP-like and this was supported by 
the comparisons of the SEM image presented in Figure 4-1 D,F and G which 
look nearly identical to published SEM images of OCP coatings, see Figure 4-15 
produced in the literature (Lin et al., 2015). The complete initial loss of nanoHA 
seed crystals in the 10 µg/mL and 20 µg/mL nanoHA seeded samples would 
result in the formation of OCP which is kinetically favoured over HA at pH<9 due 
to its lower activation energy (Hill and Gillam, 2015). The formation of HA mineral 
at 30 µg/mL nanoHA seeding density would occur only if the nanoHA seeds were 
still present due to the template effect of having HA mineral already present 
within the solution. The increased number of seed crystals still available prior to 
the diffusion of ions into the gels from the buffers compared to the lower seeding 
density samples results in significant crystal growth once steady state is 
achieved. The remaining seeds crystals then grow under the steady state 
saturated system present in the agarose gels producing the increased mineral 
density and increased number of crystals compared to the lower nanoHA seeded 
samples.  
 
Figure 4-15 SEM micrographs of OCP coating reproduced from Lin et al 
(2015) 
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4.5 Conclusion  
The work undertaken in this chapter has validated the IVNCG assay with respect 
to its ability to provide reproducible, statistically significant differences between 
phosphate levels recovered from positive and negative gel controls over a 5-day 
period. Analysis of the calcium and phosphate concentrations in the reservoir 
buffer solutions demonstrated the steady state principle of the assay. The IVNCG 
assay was also able to identify a minimal nanoHA seeding concentration of 30 
µg/mL, defined as providing a statistically significant increase in phosphate mass 
compared to the poly-L-glutamate positive control, indicating that this amount of 
crystal seed would be useful in further experiments to minimise any potential 
toxic effects associated with the use of nanoHA. Differences between the work 
here and that presented previously by Sayed (2013) were investigated by 
changing the IVNCG run length and nanoHA source with no sample other than 
30 µg/mL (or above) nanoHA seeds produced in this study being able to provide 
a statistically significant positive difference or statistically similar result when 
compared to the positive control. Analysis of crystals formed in the agarose gels 
provided an insight into the mineralisation mechanisms operating within the 
samples, suggesting that initial conditions of undersaturation influence the 
resulting mineral formed. This should be taken in to account when using samples 
which can be affected by the initial undersaturated conditions. 
  
116 
 
Chapter 5 – IVNCG Assay Assessment and Optimisation of 
Self-Assembling Peptide/Nano-Apatite Hybrid Material With 
Respect to its Mineral Forming Potential. 
The following chapter will introduce the self-assembling peptide/nanoHA hybrid 
material (“hybrid material”) and describe the combination and assessment of the 
material with regards to its mineral forming ability using the IVNCG assay. Issues 
arose with respect to the solubility of the hybrid material when used in the IVNCG 
assay which resulted in hybrid material precipitation. Novel precipitation studies 
were undertaken to determine the cause of the precipitation in high ionic strength 
media i.e. the conditions found in the IVNCG assay and in artificial saliva. It was 
determined that the hybrid material was unstable with respect to its solubility 
when testing with the calcium and phosphate-containing buffers used in the 
IVNCG assay. Conversely it was found to be soluble when using calcium and 
phosphate concentrations associated with artificial saliva solutions.  
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5.1 Introduction 
The use of self-assembled peptides is a vast research area with a wide variety 
of potential applications including tissue engineering (Kyle et al., 2009), drug 
delivery (Fan et al., 2017), active therapeutics (Tsomaia, 2015) and cell culture 
scaffolds (Worthington et al., 2015). The ease of peptide synthesis and limitless 
sequences that can be synthesised make them attractive alternatives to natural 
products for use in medical applications (Vlieghe et al., 2010). Peptide self-
assembly is a strategy used to make functional materials and relies on the 
reversible association of molecules through a multiplicity of weak (compared to 
thermal energy) non-covalent interactions (typically Van der Waals, electrostatic, 
hydrophobic, hydrogen bonds, π- π stacking) to produce large (nanoscale to 
macroscopic) highly ordered structures (Whitesides and Boncheva, 2002). The 
reversible nature of the interactions between the individual peptide molecules is 
key to the self-assembly process and results in the thermodynamic minimum 
energy configuration being produced negating the effect of any kinetic 
intermediates which may form (Marini et al., 2002). There are many different 
structures which can be formed using peptide self-assembly including but not 
limited to nanotubes (Hatip Koc et al., 2017), spherical micelles (Hatip Koc et al., 
2017), cylindrical micelles (Hartgerink et al., 2001) monolayers (Leo et al., 2017) 
and 3D fibrillar networks (Davies et al., 2006) . The driving force for self-assembly 
of molecules is a combination of the formation of non-covalent molecular 
interactions between molecules (listed above) which lower the Gibbs free 
energy, and the release of the structured array of solvent molecules which 
increases the entropy of the system. When considering H2O as a solvent this 
effect is called the hydrophobic effect and is a significant driving force in self-
assembling systems containing hydrophobic domains in an aqueous 
environment. The energy of interaction between the H2O and self-assembling 
molecules is smaller than for the interaction between self-assembling molecules, 
therefore providing an enthalpic force to the self-assembly process in addition to 
the entropic driving force (Beer et al., 2003).  
The self-assembling peptide (SAP) component of the hybrid material under 
investigation in the following chapter has been developed from the active 
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ingredient in the commercially available “Curodont” dental product range. The 
active ingredient present in the Curodont products is based upon the P11-4 self-
assembling peptide developed at the University of Leeds (Aggeli et al., 2003b; 
Davies et al., 2006; Kirkham et al., 2007; Carrick et al., 2007). P11-4 with the 
amino acid sequence AcQQRFOWOFOQQNH2 structure, shown in Figure 5-1, 
belongs to a class of SAPs that is designed to undergo a well characterised and 
understood 1 dimensional self-assembly into nano-tapes through the formation 
of the β-sheet conformation (Davies et al., 2006). The β-sheet tapes then 
undergo further self-assembly in a hierarchical manner to produce ribbons, fibrils 
and finally fibres, see section 2.10. P11-4 was assessed alongside the hybrid 
material to determine its potential effectiveness when added to the dentine 
surface. 
 
Figure 5-1 Amino acid sequence of peptide P11-4 with one letter amino acid 
code labels. At pH 7.4 the 3 glutamic acid residues (E) of P11-4 are 
deprotonated (pKa<4.25, see section 2.10) and the Arginine (R) is 
protonated (pKa= 12.5) producing an overall negative charge of 2-. 
Stereochemistry shown through dashed line representing behind the 
peptide backbone while thick black line represents in front of the 
peptide backbone. 
Through appropriate design and consideration of the chemistry behind the 
monomer interactions, it is possible to control or trigger self-assembly; examples 
include but are not limited to temperature, pH, solvent polarity and presence of 
metal ions (Zou et al., 2015). The peptides that were used as the primary target 
for development of the hybrid material described in this work are triggered to 
assemble through the addition of 2 different monomer units which, when 
dissolved individually at pH 6-8 and in physiological salt concentrations, remain 
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in an unassembled monomer state, but when added together in equal molar 
concentrations, the monomers self-assemble producing a self-supporting gel 
system. This class of SAPs are termed peptide electrolyte complexes or 
commonly referred to as ‘complementary’ peptides due to the need for both to 
be added for self-assembly to be triggered (Kyle et al., 2012). The 
complementary peptides P11-13 and P11-14 are 2 11 amino acid long peptides 
with the amino acid sequence AcEQEFEWEFEQENH2 and 
AcQQOFOWOFOQQNH2 respectively, see Figure 5-2.  
 
Figure 5-2 – Amino acid sequence of complementary peptides P11-13 and 
P11-14 with one letter amino acid code labels. At pH 7.4 the glutamic 
acid residues (E) of P11-13 are deprotonated (pKa<4.25 see section 
2.10) producing an overall negative charge of 6-. At pH 7.4 the 
ornithine residues (O) are protonated (pKa=10.76) producing an 
overall positive charge of 4+. Stereochemistry shown through dashed 
line representing behind the peptide backbone while thick black line 
represents in front of the peptide backbone.  
Both P11-13 and P11-14 were designed so that when dissolved individually at 
physiological pH and salt concentration (pH 7.4, 120 mM NaCl), no self-
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assembly would occur due to the 4+ charge on P11-14 (protonation of the 
ornithine residues pKa = 10.76) and 6- charge on P11-13 (deprotonation of the 
glutamic acid residues pKa < 4.25 see section 2.10). When the peptide powders 
are dissolved, they are in monomeric form which is in an un-assembled and 
unordered conformation and exist as a non-Newtonian liquid. When the 
monomers are added together in equal molar ratios, with respect to peptide 
concentration, the peptide monomers self-assemble into an anti-parallel β-sheet 
conformation resulting in β-sheet tapes. The β-sheet tapes then interact in a 
hierarchical manner to form a 3-dimentional fibrillar network. There are a number 
of interactions which occur between the P11-13 and P11-14 -strands which, when 
combined, result in the formation of anti-parallel β-sheets. The hydrophobic 
residues on both P11-13 and P11-14 can interact through the hydrophobic effect, 
and these interactions are further stabilised through π-π stacking due to the 
respective positions of the tryptophan and phenylalanine residues on both the 
P11-13 and P11-14 monomer units. The peptide backbone of the peptide 
monomers interact with one another through hydrogen bonding of the double 
bonded oxygen to the hydrogen of the nitrogen on the peptide backbone either 
side with respect to the β-sheet. The hydrogen bonds act like a “zip” and the 
monomer units will position themselves to maximise the number of 
corresponding hydrogen bonds between each monomer unit to minimise the free 
energy. Finally, the negatively charged glutamic acid residues (6 in total) form 
ionic interactions with the positively charged ornithine residues (4 in total), see 
Figure 5-3. The cumulative result of these non-covalent interactions is the 
formation of the anti-parallel β-sheet configuration as this produces the minimal 
energy state.  
 
121 
 
 
Figure 5-3 - Schematic of the non-covalent interactions between one 
molecule of P11-13 and one molecule of P11-14 when in anti-parallel β-
sheet formation under physiological conditions (pH 7.4, 150 mM 
NaCl). Lilac residues show position of charged groups present at pH 
7.4. Blue residues show positions of hydrophobic residues at pH 7.4. 
Red atoms show position where hydrogen bonding occurs between 
peptide backbones. For simplicity only 2 units are shown although in 
reality a continuous repeating dimeric unit of P11-13 and P11-14 is 
present when critical concentration is reached.  
The combination of one unit of P11-13 and one unit of P11-14 results in an overall 
charge of -2 per repeating unit. This overall charge aids the self-assembled 
peptide with respect to its solubility (Pace et al., 2004). The odd number of 
peptide residues ensures that the anti-parallel configuration occurs as this 
ensures that the hydrogen bonding between partnering peptides is maximised in 
contrast to the parallel configuration, which would result in 1 set of unsatisfied 
hydrogen bonds on each individual monomer unit. The reversible nature of self-
assembly ensures that the lowest energy conformation is produced. The self-
assembled tapes can then interact due to the attraction of the hydrophobic sides 
of the tapes resulting in the formation of fibrils. The fibrils formed by P11-13/14 
have been investigated by Kyle et al. (2012).using TEM. The maximum length 
was found to be 2 µm long with a fibrillar diameter of 10-20 nm  
The hybrid material used through this work was produced through combining the 
P11-13/14 complementary peptide pair with nanoHA seed crystals. The resulting 
peptide hydrogel is highly charged due to the -2 charge per repeating dimeric 
unit which results in dense overall negative charge domains across the fibril 
surface. The peptides were designed as such in the hope that the negative 
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charge domains would replicate the negatively charged domains present in 
extracellular matrix proteins responsible for the nucleation and crystal growth of 
biological hydroxyapatite during biological mineral growth (Boskey, 2003).  
Previous studies carried out by Sayed have shown that the complementary 
peptides P11-13 and P11-14 were poor nucleators of hydroxyapatite but when 
combined with nanoHA were excellent at supporting the growth of hydroxyapatite 
seed crystals when tested using the IVNCG assay described here in Chapter 4 
(Sayed, 2013). The following chapter will investigate the mineral supporting 
properties of the hybrid material with respect to its ability to support the growth 
of the previously synthesised nanohydroxyapatite crystals, (Chapter 3), through 
using the previously validated IVNCG assay (Chapter 4). 
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5.2 Methods 
5.2.1 Assessment of Mineralisation Potential of P11-13/14 SAP 
Seeded with 30 µg/mL NanoHA Using the IVNCG Assay 
To assess and optimise the hybrid material with respect to its ability to promote 
and support the growth of hydroxyapatite, the hybrid material was tested in the 
previously validated IVNCG assay (Chapter 4). The IVNCG assay was cleaned 
and prepared as described in section 4.2.1. A 1 mg/mL suspension of the 
synthesised nanoHA batch 1 was produced by weighing out 25 mg of batch 1 
nanoHA, (Chapter 3), into a 50 mL falcon tube and adding 25 mL of steady state 
solution (20 mM HEPES, 150 mM NaCl in DI H2O). A second 1 mg/mL 
suspension of the synthesised nanoHA batch 3, (Chapter 3), was produced by 
weighing out 25 mg of batch 3 nanoHA into a 50 mL falcon tube and adding 25 
mL of steady state solution. Both suspensions were vortexed (Vortex Genie 2 
Scientific Industries, Bohemia, NY, USA) for 30 seconds followed by 2 times 20 
second periods of sonic probe agitation (MISONIX model XL2010 Farmingdale, 
NY, USA with micro probe output 20 KHz). The 2 suspensions were then 
combined together in equal volumes to produce a 1 mg/mL nanoHA stock 
suspension of combined batches 1 and 3 nanoHA which was further diluted 
through the addition of steady state solution to produce a final concentration of 
30 µg/mL nanoHA in steady state buffer. Peptide powders of P11-13 and P11-14 
were weighed out into 2 mL glass vials (1 sample per concentration) and diluted 
using the combined nanoHA at 30 µg/mL in steady state solution, creating P11-
13 and P11-14 peptide solutions at concentrations of 10 mM, 13 mM, 16 mM and 
20 mM seeded with 30 µg/mL nanoHA (1.8 mL of each concentration). A small 
amount of base (5 M NaOH) was added dropwise to P11-13 suspensions to fully 
dissolve the peptide and reach a pH of 8.0. A small amount of acid (1 M HCl) 
was added dropwise to P11-14 samples to lower the pH to 7.0. Peptide solutions 
were then sonicated before 425 µL of P11-13 solution of each concentration was 
added in triplicate into separate IVNCG assay sample wells. The corresponding 
P11-14 peptide solution was then added in to each well, which resulted in the 
formation of a self-supporting gel of P11-13/14 in steady state buffer seeded with 
30 µg/mL nanoHA. Controls containing 10 µg/mL poly-L-glutamic acid in 1 % 
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agarose and 1 % agarose in triplicate were included as positive and negative 
controls respectively as described in Chapter 3. A P11-13/14 sample at a peptide 
concentration of 20 mM was also included without any addition of nanoHA 
seeding. A P11-4, known to nucleate HA, was also included as a control at a 
concentration of 20 mM. This was prepared by dissolving a small amount of P11-
4 in steady state solution producing a final concentration of 20 mM. The P11-4 
solution was then pH adjusted to pH 7.4 and heated (50 °C) to prevent gelation 
before pipetting into sample holder and cooling to form a gel. Calcium-containing 
buffer and phosphate-containing buffer were added to the IVNCG assay buffer 
compartments and the whole equipment, including the samples, was incubated 
at 37°C, with stirring, for 5 days. After the 5-day test period the samples were 
removed from the sample wells and analysed for phosphate content as 
previously described in Chapter 3.  
5.2.2 Effect of Decreasing the NanoHA Seeding Density and IVNCG 
Assay Run Length on Quantity of Mineral Formed by the 
Hybrid Material  
The effect of decreasing the nanoHA seeding density added to the peptide gels 
from 30 µg/mL to 10 µg/mL and of decreasing the length of the IVNCG testing 
period from 5 to 4 days, with respect to the phosphate mass produced in the 
hybrid material using the IVNCG assay, was investigated. This experiment was 
undertaken to determine the effect of decreased nanoHA seeding density and 
IVNCG run length on the hybrid material’s ability to promote mineral growth and 
to allow for comparisons to the work of Sayed (2013). The IVNCG assay 
experiment described in section 5.2.1 was repeated using a lower concentration 
of nanoHA seeds of 10 µg/mL and an IVNCG test duration of 4 days.  
5.2.3 Effect of Using a Benzoylated Dialysis Membrane on Quantity 
of Mineral Formed In The Presence of the Hybrid Material 
Using the IVNCG Assay 
To determine if the self-assembling P11-13/14 aggregates were disassembling 
due to monomer diffusion through the dialysis membrane, the membrane was 
changed to a 2000 kD benzoylated membrane which decreased the molecular 
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weight cut off (MWCO) to 57% of the original. The precipitation of the hybrid 
material after 5 days in the IVNCG could have been caused by the disassembly 
of the hybrid material due to diffusion of peptide through the dialysis membrane. 
To determine if a decrease in pore size of the dialysis membrane used to cover 
the hybrid material samples in the IVNCG assay sample wells had any effect on 
the resulting mass of phosphate formed, the IVNCG experiment was repeated 
as described in section 5.2.1, with the replacement of the membrane 
(SpectraPor-3 MWCO 3.5kD, Hoeksteen Netherlands, 132724) with a 
benzoylated membrane (Dialysis tubing, benzoylated 2000 kD, Sigma-Aldrich, 
St. Louis, MO, USA).  
5.2.4 Investigation of Peptide Precipitation  
During IVNCG experiments using the hybrid material, precipitation was seen to 
occur in the sample wells. A novel experiment was therefore designed to 
investigate the cause of the peptide precipitation. Peptide samples (200 µL total 
volume) were placed into the well of a 96 well plate and buffer solutions pipetted 
onto the surface (100 µL). The plate was then incubated at 37 °C for 5 days with 
any precipitation being monitored visually and recorded photographically daily. 
When recording the daily observations of the sample appearance, each sample 
was assessed and assigned to one of 3 categories depending on the severity of 
the precipitation present. If the sample was clear with no precipitation evident, it 
was assigned as “clear”. If a small amount of precipitation was present but it was 
still possible to see through the sample, then it was assigned as “slightly opaque”. 
If it was not possible to see through the sample, it was assigned as “opaque”.  
5.2.4.1 Effect of Addition of IVNCG Calcium and Phosphate-Containing 
Buffers on Solubility of the Hybrid Material at Varying P11-13/14 
Concentrations 
The novel precipitation assay was first used to investigate the effect of P11-13/14 
concentration (10, 13, 16, 20 mM) with a seeding density of 30 µg/mL nanoHA 
when calcium-containing buffer, phosphate-containing buffer or 
calcium/phosphate-containing buffer was added. Control samples of 20 mM P11-
13/14 (no nanoHA), 20 mM P11-4 (no nanoHA), 20 mM P11-4 (30 µg/mL nanoHA) 
were also analysed. The peptide solutions were produced as previously 
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described, see section 5.2.1., and each sample and control (200 µL) was 
pipetted into a 96 well plate sample well in triplicate. To each of the sample 
triplicates, 100 µL of either IVNCG assay calcium-containing buffer (6.5 mM 
CaNO3, 20 mM HEPES 150 mM NaCl), phosphate-containing buffer (3.9 mM 
NaHPO4.2H2O 20 mM HEPES 150 mM NaCl) or a combination of IVNCG assay 
calcium and phosphate-containing buffer (6.5 mM CaNO3, NaHPO4.2H2O 20 
mM, HEPES 150 mM NaCl) was added. The plate was then incubated at 37 °C 
for 5 days with any precipitation being monitored visually and recorded 
photographically daily. 
5.2.4.2 Effect of Decreasing Calcium and Phosphate Concentrations on 
Hybrid Material Stability at 37°C  
To investigate the effect of changing the calcium and phosphate concentrations 
on the precipitation of 20 mM peptide hybrid material samples, a second 
precipitation assay was carried out. Samples of hybrid material (20 mM P11-
13/14 seeded with 30 µg/mL nanoHA) were added (200 µL) to 9 of the 96 well 
plate as described in section 5.2.4.1. IVNCG assay buffers were prepared at 
varying concentrations to produce 9 different buffers, all containing 20 mM 
HEPES and 150 mM NaCl but with varying levels of calcium and phosphate 
corresponding to 100 %, 75 % or 50 % of the concentrations present in the 
original IVNCG assay buffers ; [Ca] 6.5 mM (100 %), [Ca] 4.875 mM (75 %), [Ca] 
3.75 mM (50 %)[PO4] 3.9 mM (100 %), [PO4] 2.925 mM (75 %), [PO4] 1.95 mM 
(50 %) [Ca+PO4] 6.5 mM + 3.9 mM (100 %), [Ca] 4.875 mM + 2.925 mM (75 %), 
[Ca] 3.75 mM + [PO4] 1.95 mM (50 %). Each buffer was added to one sample of 
P11-13/14 at 20mM concentration seeded with 30 µg/mL of nanoHA. Control 
samples of 20 mM P11-13/14 (no nanoHA), 20 mM P11-4 (no nanoHA), 20 mM 
P11-4 (30 µg/mL nanoHA) were exposed to IVNCG assay buffer at 100 % 
concentration only. The plate was then treated and monitored using the same 
method as described previously. 
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5.2.5 Quantitative Precipitation Study Comparing IVNCG to 
Artificial Saliva Calcium and Phosphate-Containing Buffers 
with Respect to Hybrid Material Precipitation. 
The novel precipitation assay developed in section 5.2.4 was further adapted to 
provide better quality images and a quantitative measurement of the degree of 
hybrid material precipitation. The improvement in image quality was achieved 
through the use of the Bio-Rad ChemiDoc™ MP Imaging system using the 
Coomassie Blue standard protocol available on the Bio-Rad Chemidoc™ 
software, using a white light screen, standard filter, automatic exposure time and 
white transillumination. The quantitative improvement was achieved through the 
measurement of turbidity using the plate reader at wavelength 860 nm. Turbidity 
standards were produced using concentrations of 0-2000 NTU in 1000 NTU 
intervals (VWR Chemicals, standard turbidity formazin 4000 NTU, Lutterworth, 
UK). To determine if the hybrid material precipitated when in the presence of 
artificial saliva (AS) solution, a precipitation assay plate was prepared. The AS 
used throughout this work was first developed by Eisenburger et al. (2001) and 
is composed of CaCl2 0.7 mM (Sigma), MgCl2 0.2 mM (Sigma-Aldrich St. Louis, 
MO, USA) KH2PO4 4 mM (BDH AnalaR, Poole, UK), KCl 30 mM (Sigma-Aldrich 
St. Louis, MO, USA) and HEPES 20 mM (Sigma-Aldrich St. Louis, MO, USA) 
with the pH adjusted to 7 using KOH (Eisenburger et al., 2001). For the 
precipitation assay, 3 solutions of AS were prepared using the above method, 
one containing all of the listed constituents, the second containing all except the 
CaCl2 and MgCl2 and the final solution containing all with the exception of 
KH2PO4. The 3 IVNCG assay buffers being calcium-containing buffer (6.5 mM 
CaNO3, 20 mM HEPES 150 mM NaCl), phosphate-containing buffer (3.9 mM 
NaHPO4.2H2O 20 mM HEPES 150 mM NaCl) and a combination of IVNCG 
assay calcium and phosphate-containing buffer (6.5 mM CaNO3, NaHPO4.2H2O 
20 mM, HEPES 150 mM NaCl), were also produced creating a total number of 6 
buffers (3 AS solution buffers and 3 IVNCG buffers). Peptide solutions of 20mM 
P11-13/14 seed with 30 µg/mL nanoHA, 20 mM P11-13/14 (no nanoHA), 20 mM 
P11-4 and 20 mM P11-4 seeded with 30 µg/mL nanoHA were prepared as 
described in section 5.2.1. Each peptide sample (200 µL) was pipetted into 6 
wells of a 96 well plate and had one of the 6 buffers (100 µL) described previously 
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(3 AS solution buffers and 3 IVNCG buffers) added. The plate was then 
incubated at 37 °C for 7 days with daily observations, turbidity measurement and 
imaging as described above.  
5.2.6 The Use of 1H NMR Analysis to Probe Peptide Aggregation 
with Respect to IVNCG NanoHA, Ionic Calcium and Ionic 
Phosphate Concentrations.  
1H NMR was used to investigate the potential interaction of P11-13 and P11-14 
monomers with the added nanoHA particles in an environment containing ionic 
calcium at concentrations equal to those found in the calcium-containing buffer 
used in the IVNCG experiment (6.5 mM). A solution of D2O steady state solution 
(20 mM HEPES, 150 mM NaCl in D2O) was prepared and doped with 0.125 mM 
3-(trimethylsilyl) propionic acid sodium salt (TMSP, Sigma-Aldrich St. Louis, MO, 
USA). The TMSP was added as an internal standard during the 1H NMR 
experiments for the integration of the peaks, allowing comparisons between 
samples to be made. For both P11-13 and P11-14, 4 samples were prepared as 
described in the table below. D2O steady state solution was used to dilute the 
peptide powders at a concentration of 20 mM producing a 0.8mL total sample 
volume. Samples were pD adjusted using DCl (Alfa Aesar, 20% w/w in D2O, 
99.96+%, Haverhill, MA, USA), and NaOD (Sigma Aldric, 40 wt. % in D2O, 99.5 
atom % D, St. Louis, MI, USA) to pD 6 for the P11-4 samples, and pD 8 for the 
P11-13 samples.  
Samples were placed into a Bruker av500lc 500MHz NMR device using a H2O 
pre-saturation programme with 1024 scans per spectrum. Once the spectrums 
were produced, they were analysed using the ACD/Spectrus Processor 
Academic addition (Advanced Chemistry Development, Inc., Toronto, On, 
Canada, www.acdlabs.com, 2015) software and the integral of the peaks in the 
6.9-7.8 ppm region was measured and normalized to the TMSP peak. When the 
peptide is in a monomeric state, the free induction decay of the aromatic region 
hydrogen atoms proceeds at the same rate, producing sharp peaks in the signal. 
When the peptide is in an assembled state, the free induction decay is limited 
due to the close proximity of other hydrogen atoms resulting in a broadening of 
the signal. By comparing the integrals of the aromatic region, it was possible to 
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determine if the peptide was in a monomeric form, which would produce sharp 
peaks, or in an assembled state, which would produce broad peaks (Miles, 
2012).  
Sample 
number 
Starting solution: 20 mM P11-
13 D2O, 150 mM HEPES, 
150 mM NaCl 
Starting solution 20 mM P11-
14 D2O, 150 mM HEPES, 150 
mM NaCl 
1 Control (as above) Control (as above) 
2 30 µg/mL nanoHA added 30 µg/mL nanoHA added 
3 6.5 mM Ca(NO3)2 added 6.5 mM Ca(NO3)2 added 
4 30 µg/mL nanoHA,  
6.5 mM Ca(NO3)2 both 
added  
30 µg/mL nanoHA, 
6.5 mM Ca(NO3)2 both added 
Table 5-1 Composition of samples investigated using 1H NMR analysis to 
determine if peptide material was assembling on the nanoHA crystals.  
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5.3 Results 
5.3.1 Assessment of Mineralisation Potential of P11-13/14 SAP 
Seeded with 30 µg/mL NanoHA (the “Hybrid Material”) Using 
the IVNCG Assay 
To confirm the work of Sayed (2013) with respect to the hybrid material’s ability 
to support the growth of nanoHA crystals, the hybrid material was tested in the 
IVNCG assay. The concentration of P11-13/14 within the hybrid material was 
varied, while maintaining a constant nanoHA seeding density of 30 µg/mL, to 
investigate the effect of peptide concentration on the mass of phosphate 
produced. The experiment was completed as described in section 5.2.1.  
After the 5-day testing period, the gels were removed from the sample holder 
onto the bench. The agarose samples (controls) had all retained their gel-like 
appearance as seen during the validation experiments previously. The P11-4 gels 
retained a gel-like structure and were easily transferred to the glass vials. None 
of the P11-13/14 samples had maintained a gel-like appearance and were mainly 
liquid when removed from the sample wells. The samples had an opaque 
appearance indicative of mineral formation, though no band was visible prior to 
removal from the holder. The samples were grainy in appearance with small 
amounts of gel-like material surrounded by liquid. It was extremely difficult to 
transfer the samples to the glass vials due to the complete loss of gel structure. 
The samples were collected from the IVNCG sample wells using a Pasteur 
pipette and transferred to individual 10 mL glass vials. Phosphate analysis was 
determined as described in Chapter 3 and statistical analysis completed using 
one-way ANOVA with a post hoc Bonferroni test at the significance level 0.05.  
The control sample of 1 % agarose seeded with 30 µg/mL nanoHA produced a 
significant increase in phosphate mass compared to the positive control (poly-L-
glutamate, no nanoHA seeds, p<0.05) which supported previous results, see 
Chapter 3. Statistical analysis confirmed a statistically significant increase in the 
phosphate mass produced in the positive control (poly-L-glutamate in agarose) 
compared to the negative control (agarose only), confirming that the run was 
valid, see Chapter 4. The 20 mM P11-13/14 control containing no nanoHA and 
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the 20 mM P11-13/14 sample with 30 µg/mL nanoHA were statistically 
insignificant compared to the positive (p>0.05). There was no statistical 
difference in recovered phosphate mass between the 20 mM P11-13/14 with or 
without the additional 30 µg/mL nanoHA seeds (p>0.05). The P11-13/14 nanoHA 
seeded samples and the P11-4 sample all produced a phosphate reading 
statistically similar to the negative control (p>0.05).  
 
Figure 5-4 Bar chart showing the effect of changing SAP concentration on 
the amount of phosphate produced in the IVNCG assay. P11-13/14 
samples were seeded with 30 µg/mL nanoHA. One sample at 20 mM 
was not seeded with 30 µg/mL nanoHA to act as a control. Control 
samples were 1 % agarose with 10 µg/mL poly-L-glutamic acid 
(positive), 1% agarose (negative), 1 % agarose seeded with 30 µg/mL 
nanoHA (nanoHA positive control) and 20 mM P11-4 (peptide positive 
control). * = p < 0.05 . Error bars show 2x standard deviation. 
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5.3.2 Effect of Decreasing the NanoHA Seeding Density of P11-
13/14 and Experiment Duration on Quantity of Mineral 
Formed Using the IVNCG Assay 
To investigate the effect of decreasing the nanoHA seeding density from 30 
µg/mL to 10 µg/mL in the hybrid material on the resulting phosphate mass formed 
in the IVNCG experiment, experiments were completed as described in section 
5.2.2. The objective of this experiment was to not only study the effect of 
decreasing nanoHA seeding density but to also allow comparisons to the work 
of Sayed (2013).  
At the end of the experiment, the P11-13/14 samples retrieved from the IVNCG 
assay had the same partially liquid/ broken gel structure as seen in the previous 
experiment, with the decreased nanoHA seeding density having had no 
discernible effect on the appearance of the samples. Again, the agarose controls 
and the P11-4 samples all retained their self-supporting gel appearance. The 
masses of phosphate recovered from the samples after the IVNCG run were 
statistically analysed using one-way ANOVA with post hoc Bonferroni test at the 
significance level of 0.05, see Figure 5-5. The analysis confirmed a statistically 
significant difference between the positive and negative controls, validating the 
run. The negative control (1% agarose) seeded with 10 µg/mL nanoHA resulted 
in a low phosphate content which was not statistically different compared to the 
negative control itself, confirming the previous experiments undertaken in 
nanoHA seeding density determination. The P11-4 sample (no nanoHA seeds) 
resulted in a phosphate recovery that was statistically similar to the positive 
control. The P11-13/14 samples however, had all produced low phosphate mass 
with all being statistically different to the positive control, except for the 10 mM 
P11-13/14 seeded with 10 µg/mL nanoHA sample which was statistically similar 
to the positive control (p<0.05).  
133 
 
 
Figure 5-5 Bar chart showing effect of varying peptide concentration in 
hybrid material on phosphate mass produced in IVNCG assay when 
seeded with 10 µg/mL nanoHA over 4 days. The phosphate masses 
produced confirmed a statistically significant lack of phosphate mass 
accumulation for all the P11-13/14 samples compared with the positive 
control (poly-L-glutamic acid). Error bars show 2x standard deviation. 
5.3.3 Effect of Using a Benzoylated Membrane on P11-13/14 on 
Quantity of Mineral Formed Using the IVNCG Assay 
To determine if the use of a dialysis membrane with a smaller pore size would 
affect the quantity of mineral formed and prevent the breakdown of the gels when 
using the SAP/nanoHA hybrid material, the IVNCG experimental run was 
completed as described in section 5.2.3 using a benzoylated membrane to 
replace the standard membrane used previously. The benzoylated membrane 
reduced the molecular weight cut off by 57%. Unfortunately, at the end of the 
IVNCG run, there was no statistical difference in recovered phosphate mass 
between the negative and positive controls, which invalidated the run although 
the gels did maintain a gel structure. 
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Figure 5-6 Bar chart showing varying hybrid material concentration IVNCG 
assay using benzoylated dialysis membrane. Hybrid material was 
seeded with 10 µg/mL nanoHA. Error bars show 2x standard deviation. 
5.3.4 Precipitation Studies  
5.3.4.1 Effect of Peptide Concentration, IVNCG Calcium and IVNCG 
Phosphate Buffers on Hybrid Material Precipitation. 
To investigate if the addition of calcium-containing buffer, phosphate-containing 
buffer and a calcium/phosphate containing combination buffer (at calcium and 
phosphate concentrations used in the IVNCG assay) had any effect on the 
precipitation behaviour of the hybrid material, the precipitation assay was used 
over a 5-day testing period and observations were taken as previously described. 
Samples were loaded into the precipitation assay 96 well plate and the IVNCG 
assay calcium-containing buffer, phosphate-containing buffer and 
calcium/phosphate containing combination buffer added as described in section 
5.2.4.1.  
Initially, all P11-13/14 seeded with 30 µg/mL nanoHA samples, including the P11-
13/14 control (no nanoHA), were clear. P11-4 samples were slightly opaque 
which is consistent with the appearance of P11-4 gels at a concentration of 20 
mM, see Figure 5-7 day 0. On day 2, the samples of 10 mM P11-13/14 seeded 
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with 30 µg/mL nanoHA in calcium-containing buffer were slightly opaque, with all 
other peptide gels remaining unchanged. On day 3, precipitation was apparent 
in the samples containing 10 mM, 13 mM and 16 mM P11-13/14 with 30 µg/mL 
nanoHA that were exposed to calcium-containing buffer. The severity of the 
precipitation decreased with increasing peptide concentration. The sample 
containing 10 mM P11-13/14 seeded with 30 µg/mL nanoHA in calcium and 
phosphate combination buffer also turned slightly opaque. All other samples 
remained clear, see Figure 5-7 day 3.  
On day 4, all the nanoHA seeded P11-13/14 samples with no calcium-containing 
buffer had precipitation present, increasing in severity with decreasing peptide 
concentration. In addition, precipitation was visible in the samples containing 10 
mM P11-13/14 seeded with 30 µg/mL nanoHA in phosphate-containing buffer, 
which appeared slightly opaque. The P11-13/14 control sample (no added 
nanoHA) with calcium-containing buffer had a slightly opaque appearance. 
Precipitation in the nanoHA seeded P11-13/14 samples with calcium and 
phosphate combination buffer was visible in the 10 mM P11-13/14 sample and, 
to a lesser extent, in the 13 mM P11-13/14 sample. All the other samples 
remained unchanged.  
On day 5, see Figure 5-7, the severity of the precipitation in the nanoHA seeded 
P11-13/14 samples with calcium-containing buffer had increased so that there 
was no observable difference between the samples, all containing a significant 
amount of precipitation and assigned as opaque. The sample containing 20 mM 
P11-13/14 (no nanoHA) with calcium-containing buffer control looked slightly 
opaque with a small amount of precipitation present. The sample containing 10 
mM P11-13/14 seeded with nanoHA in phosphate-containing buffer was opaque 
with precipitation visible and the sample containing 13 mM P11-13/14 seeded 
with nanoHA was slightly opaque in appearance indicating a small amount of 
precipitation. All other samples incubated in the phosphate-containing buffer 
solutions remained unchanged from initial observations.  
To summarise, the addition of calcium-containing buffer resulted in the most 
severe precipitation of P11-13/14 peptide gels with the effect increasing with 
decreasing peptide concentration. The addition of phosphate-containing buffer 
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had only a small effect on peptide precipitation which was again most noticeable 
in the samples with lower peptide concentrations. The results, obtained when 
using the calcium/phosphate containing combination buffer, were similar to those 
obtained using the calcium-containing buffer alone, although the rate and 
severity of precipitation formed in the samples were lower.  
 
Figure 5-7 – Daily photographs taken during precipitation assay showing 
effect of peptide concentration on rate and severity of precipitation 
under different buffer conditions. The white opaque appearance was 
indicative of peptide precipitation. Addition of calcium-containing 
buffer caused precipitation to occur at the fastest rate with samples 
containing the lower concentrations of peptide precipitating first. 
Addition of phosphate-containing buffer also resulted in precipitation 
but this was slower and less severe compared to the effects of the 
calcium-containing buffer. The addition of nanoHA also increased the 
severity and rate of precipitation compared to the unseeded P11-13/14 
20 mM control samples. 
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5.3.4.2 Effect of Calcium and Phosphate-Containing Buffer 
Concentration on Hybrid Material Precipitation  
To investigate any relationship between the observed precipitation in the hybrid 
material and calcium and phosphate concentration in the incubation buffer, a 
repeat of the precipitation assay was undertaken using a fixed peptide 
concentration of 20 mM. The concentration of calcium and phosphate in the 
calcium-containing, phosphate-containing and calcium/phosphate-containing 
buffers was decreased to 75 % and 50 % of the initial concentrations used during 
the IVNCG experiment. The precipitation assay was prepared as described in 
section 5.2.4.2. When initially loaded into the wells, all of the P11-13/14 samples 
were clear and the P11-4 samples were slightly opaque, as expected from 
previous experiments, see Figure 5-8 day 0. After 24 hours, there was no change 
in appearance for any of the samples, with no opaque precipitation present with 
no opaque precipitation present until day 4.  
On day 4, the samples containing P11-13/14 with 30 µg/mL nanoHA and 100% 
concentration IVNCG calcium-containing buffer developed a slightly opaque 
appearance, as did the samples being incubated with the same buffer at 75 % 
concentration. A small amount of precipitation was also visible in the P11-13/14 
control (no added nanoHA) that was exposed to calcium-containing buffer, 
although not to the same extent as the samples containing nanoHA seeds. All 
other samples were unchanged.  
On day 5, the samples that had been incubated with calcium-containing buffer 
had an opaque appearance that was severe in the case of the sample containing 
P11-13/14 with 30 µg/mL nanoHA seeds at 100% IVNCG calcium concentration. 
Decreasing severity of precipitation was seen as the calcium concentration of 
the added buffer decreased. P11-13/14 (no nanoHA) that was exposed to 
calcium-containing buffer also contained a small amount of precipitation and was 
considered slightly opaque. All other samples remained unchanged over the test 
period. 
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Figure 5-8 Daily photographs taken during precipitation assay showing 
effect of IVNCG buffer concentration on rate and severity of 
precipitation in the hybrid material. White opaque appearance due to 
precipitation of peptide was visible in the calcium-containing buffer 
samples on day 5. Decrease in buffer calcium concentration resulted 
in a decrease in the rate and severity of precipitation over the 5-day 
test period. 
5.3.5 Quantitative Precipitation Study Comparing IVNCG to 
Artificial Saliva (AS) Calcium and Phosphate Concentrations 
with Respect to Hybrid Material Precipitation.  
To determine if the hybrid material displayed similar precipitation properties 
when exposed to AS solution (lower ionic calcium and phosphate 
concentrations) compared to the IVNCG buffer conditions, the enhanced 
quantitative precipitation assay was used. The previous novel precipitation assay 
was enhanced through the use of turbidity standards to enable measurement of 
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the precipitation while imaging was improved through the use of a Bio-Rad 
ChemiDoc™ MP Imaging system. The precipitation assay samples were loaded 
and measured as described in section 5.2.5. Initial observations agreed with the 
previous work with regards to clear P11-13/14 samples and the slightly opaque 
P11-4 samples prior to the incubation period. Between days 1 to 4, all samples 
remained unchanged apart from the formation of bubbles, which occurred in a 
number of samples on day 1, see Figure 5-9. On day 5, the IVNCG calcium-
containing buffered samples P11-13/14 seeded with 30 µg/mL nanoHA produced 
an opaque precipitate while the P11-13/14 control had a small amount of 
precipitate present. On day 6, the precipitate present in the IVNCG calcium-
containing buffered samples had increased, with the P11-13/14 30 µg/mL 
nanoHA sample having a severe amount of precipitation present. Both the 
IVNCG phosphate-containing buffered samples produced a small amount of 
white precipitate with the nanoHA seeded sample having slightly more white 
precipitate. The IVNCG calcium/phosphate combination buffer P11-13/14 30 
µg/mL nanoHA samples also had a small amount of precipitation present. On 
day 7, the precipitation in the IVNCG calcium buffered P11-13/14 samples had 
increased with the nanoHA seeded sample having a large amount of white 
precipitate present and the unseeded sample having a slightly opaque 
appearance. The precipitate present in the IVNCG phosphate-containing buffer 
had maintained a similar small amount of precipitate as visible on day 6. The 
IVNCG calcium/phosphate combination buffer also maintained the slightly 
opaque precipitate seen on day 6, with the nanoHA seeded sample being the 
most affected. The P11-13/14 sample under artificial saliva conditions maintained 
a clear appearance through the 7-day experiment with no precipitation visible. 
The P11-14 samples under both IVNCG and AS buffer conditions maintained their 
appearance over the course of the 7-day experiment with the cloudiness 
attributed to the P11-4 sample at 20 mM concentration seeming to spread evenly 
over the entire sample as a function of time.  
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Figure 5-9 Daily photographs showing severity of peptide precipitation 
under IVNCG and AS buffer conditions. Dark grey areas indicate 
peptide precipitation. All the P11-4 samples maintain a slightly opaque 
grey throughout the 7-day experiment. The P11-13/14 samples under 
AS buffer conditions remained unchanged over the 7-day test period. 
The P11-13/14 under IVNCG calcium-containing buffer conditions 
increase in grey value as the experiment progresses with the nanoHA 
seeded sample producing the darkest grey due to the significant 
precipitation produced. Full 7-day results see appendix 1.3. 
Each day the turbidity of each sample well was measured using the plate reader 
to determine whether precipitation had occurred over the preceding 24-hour 
period. The turbidity analysis results provided a complex picture of the change 
in turbidity over time, see Figure 5-10, Figure 5-11 and Figure 5-12. The readings 
for the P11-4 samples are generally higher than for the P11-13/14 samples, 
irrespective of the conditions used, which is as expected due to the opaque 
appearance of the P11-4 gels when used at 20 mM concentrations.  
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The turbidity analysis of the peptide samples incubated in the presence of 
calcium-containing buffer confirmed the visual observations with regards to the 
precipitating effect of adding the calcium-containing buffer at calcium 
concentrations used in the IVNCG assay. The addition of the IVNCG calcium-
containing buffer to the 20 mM P11-13/14 (no nanoHA) control was associated 
with an increase in turbidity from below 200 NTU on day 4 to over 1600 NTU on 
day 7, see Figure 5-10. A similar effect was seen in the samples containing P11-
13/14 seeded with 30 µg/mL nanoHA, although to a lesser extent, with an 
increase from 110 NTU on day 4 to 1000 NTU on day 7. The P11-13/14 samples 
and controls exposed to the AS calcium-containing buffer showed no visible 
change in turbidity over the 7-day testing period.  
 
Figure 5-10 Bar chart showing turbidity measurements of precipitation 
assay using 860 nm absorbance over the 7-day test period with buffer 
containing IVNCG and AS calcium ion concentrations. AS calcium-
containing buffer samples remain nearly constant over time. The P11-
13/14 samples with IVNCG calcium-containing buffer show a large 
increase in turbidity around day 6/7 corresponding to the 
development of opaque samples observed.  
The turbidity analysis of the peptide samples under phosphate-containing buffer 
conditions produced less well-defined results with respect to visual observations. 
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The addition of the IVNCG phosphate-containing buffer to the 20 mM P11-13/14 
control caused an increase from below 200 NTU on day 4 to 500 NTU on day 7, 
see Figure 5-11. A similar effect was seen in the P11-13/14 seeded with 30 µg/mL 
nanoHA which increased from below 200 NTU on day 4 to 500 NTU on day 7. 
The P11-13/14 samples and controls exposed to the AS calcium-containing buffer 
showed a large turbidity reading (over 1000 NTU) throughout the testing period. 
When considering the P11-13/14 nanoHA seeded sample, the cause of the large 
turbidity measurements is most likely down to an uneven surface or small 
bubbles as the measured values did not confirm the visual observations. The 
results of the phosphate-containing buffer experiments with regards to the AS 
buffer samples are inconclusive. The analysis of IVNCG buffered samples 
suggests that the addition of phosphate has a limited effect with regards to the 
solubility of the hybrid material with and without the addition of nanoHA due to 
the small variation in turbidity over the course of the experiment. 
 
Figure 5-11 Bar Chart showing the turbidity measurements of precipitation 
assay using 860 nm absorbance over the 7-day test period with buffer 
containing IVNCG and AS phosphate ion concentrations.  
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The AS calcium and phosphate-containing combination buffer samples, see 
Figure 5-12, showed that once the initial turbidity subsided on day 1, the readings 
for all the P11-4 samples are reasonably constant across the 7-day test period. 
The comparison of the readings and the observations would suggest that any 
large changes in turbidity shown in the absorbance readings, for example P11-4 
IVNCG nanoHA day 4, are most likely due to bubbles present within the sample 
or an uneven surface. The P11-13/14 samples (no nanoHA and 30µg/mL 
nanoHA) in IVNCG buffer showed that, after day 1, the turbidity was comparable, 
and that, on day 6, both samples experienced an increase in turbidity, with the 
nanoHA seeded sample increasing significantly from 125 NTU up to 450 NTU 
which corresponds to the increase in precipitation seen in the images taken. The 
P11-13/14 sample in AS showed an extremely large increase on day 2 and day 3 
which does not correspond with the observations taken. These large values 
could be due to the formation of bubbles or an uneven gel surface which could 
diffract the light away from the sensor and result in the recording of a larger 
absorbance. As the experiment progressed the turbidity slowly increased from 
day 4 to day 7 although the increases are small from 190 NTU to 225 NTU 
respectively. The P11-13/14 nanoHA sample in AS buffer had a large increase in 
turbidity on day 1 and day 2 of 700 NTU and 800 NTU respectively, compared to 
an initial day 0 value of 165 NTU. The reason for this initial large turbidity value, 
followed by a decrease to below 200 NTU on day 3, is not clear as no bubbles 
are visible in the sample photos but could be caused by an uneven gel surface.
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Figure 5-12 Bar chart showing turbidity measurements of precipitation 
assay using 860 nm absorbance over the 7-day test period buffer 
containing IVNCG and AS phosphate/calcium ion concentrations. 
5.3.6 1H NMR Analysis of Peptide Monomers Interaction with 
NanoHA Particles in Ionic Calcium Environment.  
To investigate any co-operative precipitation between the hybrid material, ionic 
calcium and the nanoHA particles, indicated in the previous studies, a series of 
1H NMR experiments was undertaken. Peptide monomer samples were 
produced and 1H NMR analysis completed as described in section 5.2.6. The 
results of this experiment are summarised in Table 5-2. The line width 
broadening present in the P11-13 nanoHA sample in the presence of ionic 
calcium produced a larger peak integral in the 7-8 ppm region which indicated 
the loss of the free induction decay of the aromatic region due to the assembled 
state of the P11-13 peptide. 
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Sample Total integral 7-8 
ppm  
Sample Total integral 7-8 
ppm 
P11-13 578 P11-14 669 
P11-13 nanoHA 565 P11-14 nanoHA 654 
P11-13 Ca 600 P11-14 Ca 678 
P11-13 nanoHA Ca 813 P11-14 nanoHA Ca 660 
Table 5-2 Integral of the 7-8 ppm region of the 1H NMR spectra when 
normalised to the TMSP reference peak. Results suggest that the P11-
13 monomer, when in the presence of ionic calcium at a concentration 
of 6.5 mM, could enter in to surface mediated self-assembly on the 
surface of the nanoHA particles.  
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5.4 Discussion  
The use of self-assembling peptides P11-13/14 as a means of promoting and 
supporting the growth of hydroxyapatite crystals is a strategy which has been 
shown to be potentially applicable in the treatment of dentine sensitivity (Sayed, 
2013). To further assess and optimise the self-assembling peptide nanoHA 
hybrid material with respect to its ability to support the growth of the nanoHA 
crystals, the IVNCG assay was utilised (see Chapter 4). However, when used in 
the IVNCG assay, the hybrid material changed from a strong gel to white opaque 
liquid samples containing small amounts of gel like material. This observation 
was true for P11-13/14 samples with and without nanoHA seeding. The result 
was unexpected, as previous work by Sayed described the hybrid material as 
being capable of maintaining its self-supporting gel appearance after 4 days in 
the IVNCG assay (Sayed, 2013). The phosphate analysis of the P11-13/14 
samples following incubation in the IVNCG assay did not reveal sufficiently large 
amounts of phosphate to be present that would have accounted for the large 
amount of white precipitate, as the concentrations were below that of the positive 
control. The failure of the P11-13/14 samples to maintain their gel structure 
coupled with the formation of a white precipitate suggested that under the 
conditions experienced by the hybrid material samples in the IVNCG, the stability 
of the peptide material was compromised with respect to its solubility and that 
the white precipitate seen was the peptide material precipitating out of solution.  
Repeats of the experiment were undertaken using a 4-day test period to 
determine if the hybrid material was soluble at the shorter test period and the 
nanoHA seeding density was also decreased to 10 µg/mL to replicate the work 
carried out by Sayed (2013). The results produced similar white precipitation and 
loss of gel-like appearance as that seen in the 5-day test period. The phosphate 
concentrations of all the P11-13/14 samples following IVNCG were significantly 
low compared to the positive control in almost all cases, see Figure 5-5. 
One possible explanation for the failure of the gel to maintain its structure was 
the loss of monomer peptide from the sample well which could have caused the 
peptide fibrils to disassemble (though this would not explain the precipitate).To 
test this hypothesis, the dialysis membrane separating the sample from the 
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buffer reservoir in the IVNCG assay was changed for a benzoylated membrane 
which provides a smaller pore size and would theoretically limit the amount of 
peptide monomer which could diffuse away from the sample well. Although the 
SAP gels maintained a gel like structure , the introduction of benzoylated 
membrane proved to be unsatisfactory as the IVNCG assay was then unable to 
demonstrate a statistical difference between the positive and negative control 
(p>0.05), see Figure 5-6. The concentrations of phosphate in all samples, 
including the controls, were very low, approximately 200 ug/mL, suggesting that 
the benzoylated membrane was impeding the diffusion of buffer ions into the 
sample wells.  
To determine the cause of what was assumed to be precipitation of the peptide, 
further studies were therefore undertaken using a novel precipitation assay. The 
novel precipitation assay was developed to systematically analyse the 
precipitation behaviour of the hybrid material at varying peptide concentrations 
and under a variety of conditions (effect of adding IVNCG buffer solutions and 
the effect of calcium and phosphate concentration), see section 5.2.4. The effect 
of adding calcium-containing buffer or phosphate-containing buffer solutions, at 
the concentrations used in the IVNCG assay, was analysed. Decreased peptide 
concentration in the gel resulted in an increase in the rate and quantity of 
precipitation with a calcium-rich environment producing the most severe 
precipitation, see Figure 5-7. Interestingly, the P11-13/14 control sample (without 
the addition of nanoHA) also formed a small amount of precipitate after 5 days 
in a calcium-rich environment at IVNCG buffer concentration. Overall, the results 
showed that a decrease in peptide concentration resulted in an increase in the 
rate of peptide precipitation over the 5-day test period when in the presence of 
calcium-containing and phosphate-containing buffer solutions.  
The effect of decreasing the calcium and phosphate concentration in the buffers 
was also investigated using the precipitation assay and confirmed the findings 
above. The experiment also confirmed that as the concentration of calcium and 
phosphate decreased, the rate and quantity of precipitation also decreased. The 
calcium-containing buffer samples again produced the most severe amount and 
rate of precipitation with the calcium/phosphate-containing buffer producing less 
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severe precipitation. The cause of the precipitation in the presence of calcium 
ions with and without the addition of nanoHA can be explained through 
considering the surface chemistry of the self-assembled peptide hydrogel and 
nanoHA in a calcium ion rich environment. When considering the P11-13/14 self-
assembling material there is a background concentration of peptide in the 
monomer state. This concentration is equal to the critical SAP concentration 
called c* and is the concentration of peptide required to start the hierarchical self-
assembly process (Davies et al., 2006). Peptide monomer can be considered as 
a colloidal dispersion within the buffer solution. A potential cause of the 
precipitation when the system is changed through the addition of IVNCG 
calcium-containing buffer is that the solubility of the peptide is compromised due 
to the strong “salting out” efficacy of the calcium ion (Shaw, 1991) which 
competes with the peptide for its H2O hydration sphere. This competition for H2O 
results in the precipitation of the peptide monomer which in turn could result in 
the disassembly of the peptide-based fibrils due to the lack of monomer present 
in the surrounding solution. This would explain the liquid/broken gel appearance 
of the SAP samples after 5 days in the IVNCG assay. This would also explain 
the relationship between the peptide concentration and rate of precipitation if the 
difference in stability of the self-assembled fibrils within the lower peptide 
concentration and higher concentration is considered. The thickness of the SAP 
fibrils increases as peptide concentration increases which in turn increases the 
thermodynamic stability of the aggregates formed. When the smaller fibrils in the 
lower peptide concentration samples are exposed to an environment that is 
lacking in peptide monomer, they will disassemble more quickly compared to the 
thicker fibrils of the higher peptide concentration samples. 
The addition of nanoHA also caused an increase in the quantity and rate of 
precipitation, as can be seen in both the peptide concentration and IVNCG buffer 
concentration precipitation studies. The nanoHA has a similar effect to the 
addition of calcium ions as the particles are also a colloid suspension. The 
nanoHA particles will compete for solvation by H2O resulting in the same peptide 
precipitation described before. A further issue with the addition of nanoHA is that 
the addition of electrolyte, calcium ions, will result in the compression of the Stern 
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layer formed around the nanoHA particles, thereby increasing their tendency to 
aggregate (Shaw, 1991). 
To determine if the hybrid material was capable of maintaining stability at the 
lower calcium and phosphate concentrations experienced in the oral 
environment, the improved quantitative precipitation assay was developed using 
an artificial saliva (Eisenburger et al., 2001) as the added buffer, see section 
5.2.5. To quantify the precipitation behaviour of the hybrid material under IVNCG 
and artificial saliva concentrations, the precipitation assay was altered to include 
formazin standards which were used to provide a measurement of the turbidity 
of the samples through the measurement of absorbance. The use of formazin 
standards is common in the turbidity analysis of H2O sample to determine the 
H2O quality (Klein et al., 2012). The results of the assay provided a quantitative 
determination of precipitation, although 2 factors associated with the gels made 
the turbidity measurements complex and potentially inaccurate. One factor was 
the formation of bubbles within the samples, which had a large effect on the 
absorbance readings. The cause of the bubbles is unknown as they were not 
present on application and then developed on day 1 or 2 before slowly 
disappearing as the experiment progressed. One possible cause of bubble 
formation could be the peptide solution preparation during which the solutions 
were lightly shaken to aid dissolution of peptide, this may have resulted in small 
amounts of air being added into the samples which during the incubation period 
resulted in the formation of small bubbles seen during the initial stages of the 
experiment. The presence of bubbles made the comparisons to visual 
observations key to ensure large turbidity readings were not correlated to 
precipitation when no precipitation was present. The second factor which 
seemed to have an effect on the absorbance readings was the surface of the 
samples. Some of the samples developed a slightly uneven surface which could 
have been caused by the knocking of the assay while in the incubator or the 
removal of the coverslip prior to imaging and absorbance measurement. The 
effects associated with an uneven surface were most pronounced in the P11-
13/14 AS nanoHA sample with phosphate-containing buffer, Figure 5-11, which 
had extremely high turbidity readings, all above 1000 NTU, even though no 
precipitation or bubbles were visible in the images, Figure 5-9. Again, through 
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comparisons with the visible observations and images, it was possible to 
determine that the turbidity reading was not a result of the precipitation or 
bubbles within the sample and must be due to an uneven surface which could 
have resulted in diffraction of the light produced by the plate reader. The 
quantitative assay proved useful in the assessment of the hybrid material under 
various conditions but to improve the assay further, some simple developments 
would need to be undertaken. The first would be to ensure that repeats of each 
condition are undertaken to minimise the effect of bubbles and uneven sample 
surfaces if they occur. This would also permit the use of statistical testing to 
confirm significance. The assay plate should be kept in an incubator with minimal 
communal use to prevent the knocking of the plate and also the potential shaking 
due to the repeated opening and closing of the door. Finally, investigation into 
the cause of the formation of bubbles would be useful and, potentially, the use 
of degassed buffers and peptide solutions could address this issue. Taking the 
limitations of the quantitative precipitation assay into account, it can be 
concluded that the use of calcium-containing buffer and phosphate-containing 
buffer at AS concentrations appears to have very little effect, with regards to the 
precipitation of the hybrid material, with and without the addition of nanoHA, see 
Figure 5-9. The lower calcium and phosphate concentrations seem to be 
compatible with the P11-13/14 material which suggests that it may still be suitable 
as a material for the occlusion of dentine tubules through the growth of nanoHA 
crystals.  
To determine if the peptide monomers P11-13 and P11-14 interact with the 
nanoHA particles, a series of 1H NMR experiments was undertaken as described 
in section 5.2.6. Each of the peptide monomers was tested in 4 different dilution 
media at a fixed peptide concentration of 20 mM. The first medium used was a 
control of 150 mM HEPES, 150 mM NaCl, 0.125 mM TMSP. The integrals 
produced by the control samples in the 1H NMR spectra were used to produce a 
background value for the aromatic peak integral. The 3 conditions tested against 
the controls were 30 µg/mL nanoHA, 6.5 mM Ca(NO3)2 and 30 µg/mL nanoHA 
with 6.5 mM Ca(NO3)2. The only sample to produce a large increased integral in 
the aromatic region was the 20 mM P11-13 D2O, 150 mM HEPES, 150 mM NaCl, 
30 µg/mL nanoHA with 6.5 mM Ca(NO3)2. The increased aromatic region integral 
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of the P11-13 sample when in the presence of 30 µg/mL nanoHA and 6.5 mM 
ionic calcium suggested that the peptide molecules are in an assembled state. 
The lack of any large increased integral for any of the other samples suggests 
that the peptide molecules remain in a monomer state within the solution. The 
reason for the assembly of the P11-13 molecules in the presence of ionic calcium 
and nanoHA particles is not clear although a working hypothesis is that the 
addition of the calcium results in the assembly of the P11-13 monomer on the 
surface of the nanoHA particles, perhaps through ion bridging. The results of the 
1H NMR experiments suggest that the P11-13 assembly seems to occur only 
when both the nanoHA and 6.5 mM ionic calcium are present and does not occur 
when in the presence of either in isolation. A hypothesis to explain this result is 
that the P11-13 is binding with the surface cationic calcium of the nanoHA seed 
crystals. The widely accepted calcium bridging could then be occurring, similar 
to the effect seen in pellicle formation on enamel (Ash et al., 2014), whereby 
ionic calcium could promote further peptide aggregation resulting in layers of 
peptide covering the nanoHA seed crystal surface. This would not only explain 
the P11-13 aggregation inferred in the 1H NMR results but also why the positively 
charged P11-14 does not exhibit the same behaviour. The results of the 1H NMR 
experiments suggest that the P11-13 monomer, when in the presence of nanoHA 
and 6.5 mM ionic calcium, produces a self-assembled aggregate and a working 
hypothesis is that the peptide is undergoing a nanoHA surface mediated calcium 
bridging self-assembly producing multiple layers of P11-13 on the nanoHA 
surface. Further work would be required to test this hypothesis, although in 
relation to this work the interaction of the P11-13 molecule with the surface of the 
nanoHA crystals could be the cause of the failure of the IVNCG to produce 
increased mineral deposition within the sample wells. If the peptide is assembling 
on the surface of the nanoHA crystals, it may be preventing the diffusion of 
calcium and phosphate to the crystal surface, preventing mineralisation.  
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5.5 Conclusion 
The hybrid material, composed of P11-13/14 seeded with nanoHA crystals, was 
assessed with regards to its hydroxyapatite crystal growth supporting properties 
using the IVNCG. It was shown that the hybrid material was unstable with 
regards to its solubility when used in the IVNCG system. To determine the cause 
of the precipitation a novel precipitation assay was developed which enabled the 
variables of temperature, addition of calcium and phosphate-containing buffers 
and calcium/phosphate-containing buffer to be investigated. The results suggest 
that the hybrid material is not soluble when in the presence of calcium and 
phosphate ions at the concentrations used in the IVNCG system with the 
precipitation occurring at a faster rate when lower concentrations of peptide are 
used. The novel precipitation assay was further developed through a quantitative 
measurement of the precipitation using turbidity analysis. It was confirmed that 
the calcium and phosphate-containing buffers used in the IVNCG system 
resulted in the precipitation of the hybrid material, while the use of the lower 
calcium and phosphate concentrations in artificial saliva seem to have no effect 
on the precipitation of the hybrid material. The 1H NMR analysis seems to 
suggest that the P11-13 component of the hybrid material interacts with the 
nanoHA seed crystals which could be preventing their growth.  
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Chapter 6 – Application of Self-Assembling Peptide/Nano-
Apatite Hybrid Material to Dentine 
 
This chapter describes the addition of the self-assembling peptide/nano-
apatite (hybrid) material to human dentine and the subsequent 
determination of dentine tubule occlusion through the measurement of 
dentine permeability using a fluid filtration system. A fluid filtration system 
was designed, developed and validated to industrial standards for this 
purpose. Dentine disk samples were produced from human 3rd molars and 
the hybrid material applied. Fluid filtration measurements were taken to 
measure the change in fluid flow across the dentine disks before and after 
treatment and then after 7 days incubation in artificial saliva at physiological 
temperature. Scanning electron microscopy of the dentine surface was then 
undertaken along with imaging of the penetration of mineral into the dentine 
tubules. The hybrid material proved ineffective in promoting the growth of 
mineral within the dentine tubules and resulted in an increase in dentine 
permeability with respect to fluid flow through the dentine. In contrast, P11-
4 treated samples produced a reduction in fluid flow with mineral deposits 
observed 20 µm into the dentine tubules. We hypothesise that the P11-13 
monomer component of the hybrid material interacts with the dentine tubule 
wall, resulting in an increased wettability of the surface, increasing fluid flow. 
The hybrid material was found to be unsuitable for the use in the treatment 
of dentine sensitivity although the P11-4 self-assembling peptide produced 
encouraging results with respect to its ability to reduce fluid movement in 
dentine tubules.  
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6.1 Introduction  
The in vitro determination of a material’s ability to promote mineral deposition 
within the dentine tubules is an essential step in the development of new dentine 
sensitivity treatments. The current in vitro gold standard method used to 
determine a material’s potential to block the fluid flow in dentine is the fluid 
filtration method first developed by Reeder et al. (1978). This involved measuring 
fluid flow through the dentine before and after the application of citric acid (50 % 
w/v) (Reeder et al., 1978) . The method used the dentine disk model (Gillam et 
al., 1997) where a dentine disk sample is sandwiched between 2 rubber “O” rings 
to provide the test surface, see Figure 6-1. H2O held in a reservoir a minimum of 
20 cm above the sample was then used to provide a positive pressure of fluid 
which could produce fluid flow through the dentine samples. The fluid flow was 
measured by fluid displacement in a micropipette attached to the outlet of the 
chamber. The fluid flow was then measured and converted into hydraulic 
conductance units. This early study using the fluid filtration technique was able 
to demonstrate that as dentine disk thickness increased, the hydraulic 
conductance decreased, that as surface area increased so did hydraulic 
conductance and that etching the disks with 50% (w/v) citric acid produced a 32 
fold increase in hydraulic conductance (Reeder et al., 1978). This method 
provided a much improved system compared to others in development at the 
time (Polhagen and Brännström, 1971; Johnson and Brännström, 1974) as the 
standardised nature of the dentine disk model, although variations from donor to 
donor do occur, provided a controllable thickness of sample and a control test 
surface area. 
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Figure 6-1 Pashley (1984) dentine disk split chamber device, test area 
determined by rubber “O” rings (black) are forced against dentine disk 
through tightening of external sample holder (not pictured).  
The system was then used to assess the effectiveness of a variety of 
commercially available desensitising dentifrices to assess and compare their 
ability to reduce the fluid flow through dentine samples (Pashley et al., 1984). 
The dentifrices tested were “Promise” and “Denquel” which both contained 5% 
potassium nitrate as the active ingredient, “Sensodyne” and “Thermodent” which 
both contained 10% strontium chloride as the active ingredient, “Crest” which 
contained 0.2% sodium fluoride as the active ingredient and an experimental 
oxalate treatment which contained 2% potassium oxalate as the active 
ingredient. These treatments were applied in PBS at ratios of 1:3, 1:1 and 3:1. 
The active ingredients present in each dentifrice were also analysed 
independently at the same concentration as the commercial treatments to 
determine their effectiveness in reducing the fluid flow without the other dentifrice 
ingredients. The medium in which these controls were made was not stated 
although they were prepared fresh each day. A placebo for each commercial 
treatment was also tested which contained all of the treatment ingredients, 
except the stated active ingredient. The results of the study found that only the 
experimental oxalate-containing dentifrice was able to produce a statistically 
significant (p<0.01) decrease in fluid flow compared to the corresponding 
placebo dentifrices. The oxalate dentifrice was also found to produce larger 
reductions in fluid flow through dentine at all dilutions when compared to the 
other commercial treatments. This was explained through reference to previous 
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work which had shown ionic calcium within the dentine tubules reacting with the 
oxalate, resulting in the precipitation of calcium oxalate crystals (Greenhill and 
Pashley, 1981). 
The fluid filtration system was further developed by the replacement of the 20 cm 
high H2O reservoir with a pressure vessel which could be used to provide much 
higher pressures to enable the measurement of hydraulic conductance post-
treatment (Pashley and Galloway, 1985), Figure 6-2. The micropipette was also 
moved from the outlet of the split chamber to the inlet side with the movement of 
a trapped air bubble used to measure the flow. This modified method was used 
to measure the effect of oxalate treatments on hydraulic conductance of dentine 
before and after an acid challenge. The results showed that a 2-minute addition 
of (30% w/v) neutral di-potassium oxalate, (3% w/v) monopotassium-
monohydrogen oxalate or (30% w/v) dipotassium oxalate, followed by (3% w/v) 
monopotassium –monohydrogen oxalate produced a significant decrease in fluid 
flow compared to treatment with the KCl negative control (p<0.001). The study 
also explored the effect of acid etching after the application of oxalate treatments 
and found that the oxalate treated dentine was less permeable (20-30% increase 
in fluid flow depending on oxalate treatment) than the untreated dentine (400% 
increase in fluid flow). 
 
Figure 6-2 Schematic of the fluid filtration device developed with 
pressurised vessel to allow post-treatment fluid filtration 
measurements. Image reproduced with permission from Pashley & 
Galloway (1985)  
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The objectives of the following chapter were to develop and validate a fluid 
filtration system based on the Pashley and Galloway (1985) system shown in 
Figure 6-2. Once validated, the system would be used to assess the self-
assembling peptide/nanoHA hybrid material with respect to its ability to reduce 
fluid flow in dentine after treatment application and after 7 days in an artificial 
saliva (AS) solution.  
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6.2 Methods  
6.2.1 Dentine Disk Production  
All human teeth selected for preparation of dentine disks were obtained from the 
Leeds University School of Dentistry Skeletal Tissues Research Tissue Bank 
following full ethical approval (DREC ref: 010714/SW/137) and informed donor 
consent. The teeth were required to meet the following criteria: 
 Donor was healthy with no known systemic illnesses at time of extraction 
– prevent cofounding factors which may affect dentine permeability.  
 Donor must be aged 20-50 years when teeth were removed – age range 
when dentine sensitivity is commonly observed in the clinic (Rees, 2000)  
 Teeth must be 3rd molars – ensured large dentine disks were produced. 
 Teeth must be caries free – prevents any dentine disks being produced 
which contain damaged dentine which could affect permeability 
measurement. 
Selected teeth were hydrated in PBS (Lonza Bio Whittaker, Basel, Switzerland) 
containing 0.05% thymol (BDH Laboratory Supplies, Poole, UK) in a 7 mL plastic 
bijou tube. After 24 hours, the PBS was replaced and the teeth left to hydrate for 
at least 6 more days. Each tooth was then removed from solution and dried with 
lab towel. A small plastic cuvette was then cut approximately 1 cm from the base 
producing a 1 cm deep container which would hold the tooth during cutting. A 
small amount of Kemdent® simplex rapid powder (Swindon, England) was 
placed into a 7 mL bijou and approximately 1 mL of Kemdent® simplex rapid 
liquid (Swindon, England) was added and thoroughly mixed producing a viscous 
resin just capable of pouring. The resin was poured into the holder and the tooth 
added. While the resin was setting, the tooth was positioned to ensure that during 
cutting, the saw would cut perpendicular to the tubule direction. The initial cut 
position was determined by ensuring the widest parts of the tooth were in line, 
taking into account that parts of the tooth may well be worn through use, see 
Figure 6-3. If the roots of the tooth prevented its appropriate positioning, they 
were removed using files. Once the resin had set, the tooth was left for 15 
minutes to ensure the curing process was complete. The tooth was then mounted 
into the Accutom cutter (Struers Accutom-5, Ballerup, Denmark) fitted with a 
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diamond coated blade with settings of 3000 rpm, 0.05 mm per second feed rate. 
An initial transverse cut was made just below the widest part of the tooth. This 
was done to ensure that all the enamel from the fissures was removed producing 
an enamel-free dentine surface. This cutting procedure was continued until the 
pulpal horns were visible on the dentine surface. This section of dentine was 
chosen as it provides a dentine surface without enamel or pulpal horn 
holes/indentations which could produce a dentine like fluid flow. A total of 120 
dried teeth were sectioned to produce dentine disks, each with a thickness of 0.5 
mm. It was not uncommon for the disks to break during cutting but as long as the 
fragments were large enough to cover the 4 mm diameter sample holder used in 
the fluid filtration sample holder, they were deemed to be acceptable for use. All 
dentine samples were stored in PBS containing 0.05% thymol. At all times patient 
numbers were labelled on all samples in accordance with tissue bank guidelines.  
 
Figure 6-3 Picture of a molar tooth cast into holder prior to cutting. Tooth 
was positioned to ensure cut was as perpendicular to the long axis of 
the tooth (root to crown) as possible.  
6.2.2 Fluid Filtration Device 
A dentine fluid filtration device was constructed based on the system used at 
GSK (Weybridge, UK) and Intertek (Hooton, UK) and used during a collaborative 
industrial placement aimed at transferring the knowledge to Leeds. The device 
is not commercially available and was assembled using components from a 
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number of suppliers. An image of the device is shown in Figure 6-4 along with a 
schematic in Figure 6-5.  
 
Figure 6-4 Photograph of dentine fluid filtration device based on the work 
of Pashley (1984). 1) Micro syringe 2) Inlet pressure regulator 3) Test 
pressure regulator 4) Purge pressure tap 5) Test pressure tap 6) 
Pressure evacuation tap 7) Pressure vessel 8) Pressure vessel 
pressure gauge 9) Glass capillary 10) Sample holder 11) Buffer 
reservoir A) 3 way tap B) 3 way tap with on/off tap.  
 
Figure 6-5 Schematic of dentine fluid filtration device illustrated above. 
Black lines indicate gas system while grey lines indicate fluid system. 
Pressure is produced using nitrogen and regulated down to a purge 
pressure of 15 PSI or test pressure of 1 PSI. PBS is stored in pressure 
vessel and travels through the system and exits through the dentine 
sample (yellow rectangle in sample holder). The movement of the 
bubble within the glass capillary is used to record the fluid flow over 
the 5-minute test period.  
161 
 
The fluid filtration device was developed using the following materials: Pneumatic 
plastic push fittings and tubing (KELM, UK), Nitrogen cylinder (Boc gasses, UK), 
Hydraulic tubing and Luer fittings (Cole-Parmer Instrument Co Ltd, Eaton Socon, 
UK), Pressure Vessel and Pressure gauges (Fisnar, Ellsworth adhesives, EU) 
and Glass capillary (CM Scientific Ltd, 600 mm 0.5 mm internal diameter). The 
frame was produced in-house by the School of Dentistry workshop team. The 
sample holders were based on the design shown in Figure 6-2 and were custom-
made (Kirkstall precision, Leeds, UK). A cross-section of the sample holder 
assembly is shown in Figure 6-6. Once the system was assembled, a small piece 
of plastic was placed in a sample holder to determine if the system was watertight 
by ensuring that there was no movement in the bubble under test conditions. 
This system check was carried out daily when the system was in use to ensure 
that there were no leaks in the fluid part of the system. 
 
Figure 6-6 Schematic of sample holder assembly cross-section showing 
the dentine disk “sandwiched” between the 2 PTFE washers via the 
rubber “O” rings. Fluid flows through the inlet, through the dentine 
disk and then out of the outlet. Speed of fluid flow is dependent on the 
permeability of dentine disk and pressure of fluid (of which pressure 
is held constant). 
6.2.3 Fluid Filtration Validation 
Dentine disks produced previously, see section 6.2.1, were polished using 1200 
carbide paper followed by 2500 carbide paper to ensure that the surface was flat. 
Each sample was acid-etched in 10% citric acid for 2 minutes under shaking to 
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remove any smear layer producing during the cutting/polishing procedures. The 
disks were then rinsed thoroughly in DI H2O and mounted into a sample holder. 
An air bubble approximately 3 mm long was introduced into the capillary tube 
and positioned towards the capillary opening using the microsyringe. The test 
pressure (1psi) was applied and the flow controls opened to the sample holder. 
The initial position relative to the ruler was recorded in mm and the movement of 
the bubble measured over a 5-minute period. After the 5-minute test period, the 
bubble’s position relative to the ruler was recorded and the flow controls closed. 
The same bubble was then moved back to the capillary opening ready for the 
second measurement. The validation method used a negative control treatment 
of brushing the dentine surface with PBS and a positive control treatment of 
brushing with oxalic acid, 5% w/v, dissolved in DI H2O (98% Sigma-Aldrich St. 
Louis, MO, USA). Oxalic acid has been previously shown to be effective in the 
occlusion of dentine tubules (Pashley and Galloway, 1985) and is often used as 
a positive control in dentine permeability studies (Sauro et al., 2010). Each 
treatment was brushed on the dentine surface for 1 minute followed by a DI H2O 
rinse. After the application of a treatment, the permeability was measured again 
as described previously. The second measurement was then subtracted from 
the first measurement and then divided by the first measurement to produce a % 
reduction in flow. Each control treatment was tested on 10 dentine disk samples 
and a mean % reduction in fluid flow produced. The % reduction in fluid flow data 
was then imported into SPSS and a statistical test for normality followed by an 
independent t-test to determine statistical differences between the positive and 
negative control were carried out. 
6.2.4 Fluid Filtration Assessment of the Hybrid Material’s Tubule 
Occlusion Ability After 7 Days in Artificial Saliva.  
To determine the effectiveness of the addition of the hybrid material to dentine 
with respect to its ability to occlude dentine tubules through presumed promotion 
of nanoHA crystal growth, a series of fluid filtration experiments was undertaken. 
Each treatment group was assigned 10 dentine disks produced earlier, see 
section 6.2.1, with each dentine disk checked to ensure no visible cracks or 
pulpal horn indentations were present. Each dentine disk was then polished 
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using 1200 and 2500 carbide paper respectively. The disks were then placed in 
a 7 mL bijou with 5 mL of 10% citric acid added and then shaken for 2 minutes. 
The disk was then removed from the bijou and rinsed in copious amounts of DI 
H2O. The dentine disk was then mounted into the sample holder and connected 
to the fluid filtration system. The initial permeability of the dentine disk was 
measured by recording the initial position of the bubble at the beginning of 
exposure to the test pressure. A second measurement was taken after 5 minutes, 
producing a measurement of fluid flow in mm per 5 minutes for each dentine 
disk. The sample area of exposed dentine was then dabbed with a paper towel, 
to remove any fluid present on the surface, and a treatment applied as described 
in Table 3-1. After treatment application, the test surface was rinsed in DI H2O 
and the fluid flow was measured using the same method as that described for 
determination of the initial permeability. The initial permeability measurement 
(dentine disk permeability before treatment application) was then subtracted 
from the measurement after the treatment was applied and then divided by the 
initial measurement to produce a % reduction in flow. Once the test was 
complete, the dentine sample (including the holder to ensure the test area of the 
dentine disk remained the same) was placed in a 60 mL plastic beaker with screw 
lid and 40 mL of artificial saliva (AS) solution composition CaCl2 0.7 mM (Sigma), 
MgCl2 0.2 mM (Sigma-Aldrich St. Louis, MO, USA) KH2PO4 4 mM (BDH AnalaR, 
Poole, UK), KCl 30 mM (Sigma-Aldrich St. Louis, MO, USA) and HEPES 20 mM 
(Sigma-Aldrich St. Louis, MO, USA) with the pH adjusted to 7 using KOH 
(Eisenburger et al., 2001) added. The sample was then placed into the incubator 
at 37°C. Every 24 hours, the AS solution was removed and fresh AS solution 
added. After 7 days, the samples were removed from the incubator, attached to 
the fluid filtration system and the fluid flow was measured a final time as 
previously described. Once the measurement was completed, the sample was 
removed from the holder and left to dry overnight, covered. Once dry, the dentine 
sample was stored in a labelled 24 well plate. 
The treatments used, together with their corresponding method of application are 
summarised in Table 6-1. The negative treatment control for these experiments 
was a solution of 20 mM HEPES and 30 mM KCl. The negative control treatment 
acted as a control both for brushing and to ensure that the solution (which was 
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used to dissolve the test treatment materials) had no effect on dentine tubule 
permeability. The negative control was applied to the test surface using a Pasteur 
pipette (4 drops) and then brushed using a micro applicator brush (3M, 
Maplewood, Minnesota, USA) for 30 seconds followed by a 90-second pause to 
allow for the treatment solution to settle and permeate down into the dentine 
tubules. The sample was then lightly washed with DI H2O before taking the 
measurement. A nanoHA treatment of 30 µg/mL nanoHA in 20 mM HEPES, 30 
mM KCl was produced by weighing out 25 mg of batch 1 nanoHA, see Chapter 
3, into a 50 mL falcon tube and adding 25 mL of 20 mM HEPES 30 mM KCl in 
DI H2O. A second 1 mg/mL suspension of the previously synthesised nanoHA 
batch 3, see Chapter 3, was produced by weighing out 25 mg of batch 3 nanoHA 
into a 50 mL falcon tube and adding 25 mL of 20 mM HEPES 30 mM KCl in DI 
H2O. Both suspensions were vortexed for 30 seconds followed by 2 times 20-
second periods of sonic probe agitation (MISONIX model XL2010 with micro 
probe output 20 KHz). The 2 suspensions were then combined together in equal 
volumes to produce a 1 mg/mL nanoHA stock suspension of combined batches 
1 and 3. The suspension was then further diluted through addition of 20 mM 
HEPES, 30 mM KCl in DI H2O to produce a final solution of 30 µg/mL nanoHA 
combined batches 1 and 3 in 20 mM HEPES 30 mM KCl. The 30 µg/mL nanoHA 
combined batches 1 and 3 in 20 mM HEPES 30 mM KCl treatment was applied 
to the test surface using a Gilson pipette (50 µL) and then brushed using a micro 
applicator brush (3M, Maplewood, Minnesota, USA) for 30 seconds followed by 
a 90-second pause to allow for the effect of treatment to settle. The sample was 
then lightly washed with DI H2O before taking the measurement. 
A treatment solution of 20 mM P11-13/14 was produced by weighing P11-13 and 
P11-14 into separate 2 mL glass vials. A solution of 20 mM HEPES, 30 mM KCl 
in DI H2O was then added to the P11-13 and P11-14 powders producing individual 
solutions of 20 mM P11-13 and P11-14 in 20 mM HEPES KCl DI H2O. A small 
volume of 5M NaOH was added to the P11-13 solution to reach dissolution. Both 
suspensions were pH adjusted, P11-14 solution to pH 7 and P11-13 solution to pH 
8, using 2 M HCl and 5 M NaOH respectively. Both peptide solutions were 
sonicated for 5 minutes prior to use. The P11-13/14 treatment was applied to the 
test surface by adding 25 µL of the P11-14 solution which was then brushed using 
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a micro applicator brush for 15 seconds, followed by a 90-second pause to allow 
for the effect of treatment to settle. The 20 mM P11-13 was then added in equal 
volume and brushed for 15 seconds followed by a 90-second time to settle. The 
sample was then lightly washed with DI H2O before taking the measurement. 
A treatment of 20 mM P11-13/14 seeded with 30 µg/mL nanoHA was produced 
by weighing P11-13 and P11-14 into separate 2 mL glass vials. The peptide 
powders were then diluted with 20 mM HEPES, 150 mM NaCl seeded with 30 
µg/mL nanoHA of combined batches 1 and 3 to produce individual samples of 
20 mM P11-13 seeded with 30 µg/mL nanoHA and 20 mM P11-14 seeded with 30 
µg/mL nanoHA. A small volume of 5M NaOH was added to the P11-13 solution 
to reach dissolution. Both suspensions were pH adjusted, P11-14 solution to pH 
7 and P11-13 solution to pH 8, using 2 M HCl and 5 M NaOH respectively. Both 
peptide solutions were sonicated for 5 minutes prior to use. The P11-13/14 
seeded with 30 µg/mL nanoHA treatment was applied to the test surface by 
adding 25 µL of the 20 mM P11-14 seeded with 30 µg/mL nanoHA solution which 
was then brushed using a micro applicator brush for 15 seconds followed by a 
90-second pause to allow for the effect of treatment to settle. The 20 mM P11-13 
seeded with 30 µg/mL nanoHA was then added in equal volume and brushed for 
15 seconds followed by a 90 second-time to settle. The sample was then lightly 
washed with DI H2O before taking the measurement. 
A treatment of 20 mM P11-4 was prepared by dissolving a small amount of P11-4 
in 20 mM HEPES, 30 mM KCl. The P11-4 solution was then pH adjusted to pH 
7.4 and heated at 50 °C to prevent gelation. The 20 mM P11-4 treatment was 
then applied to the test surface using a Gilson pipette (50 µL) and then brushed 
using a micro applicator brush for 30 seconds followed by a 90-second pause to 
allow for the effect of treatment to settle. The sample was then lightly washed 
with DI H2O before taking the measurement. 
A control treatment of iBond® universal (Kulzer, Basingstoke, UK), was applied 
as per the manufacturer’s instructions. The iBond dentine bonding resin 
treatment was chosen to act as a positive control as the formation of a polymer 
resin on the surface of the dentine disk would prevent fluid flow. A micro 
applicator brush was placed into the iBond® resin and brushed on the surface of 
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the dentine for 30 seconds. An Elipar DeepCure-S dental curing light (3M, 
Maplewood, MN, USA) was then applied for 20 seconds to cure the resin after 
which it was allowed to settle for 90 seconds. The sample was then lightly 
washed with DI H2O before taking the measurement. 
Each treatment was applied to 10 dentine disks prepared and analysed as 
described above. The measurements were then imported into SPSS and 
statistically analysed using a one-way Anova Bonferroni test to determine 
statistical significance between treatment groups (p<0.05).  
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Treatment  
(dilution medium) 
Application – all brushing was completed using micro 
applicator brush (3M ESPE Disposable Micro 
applicators Brushes, USA) 
Negative control  
(20 mM HEPES 30 mM 
KCl) 
4 drops of solution were applied to dentine surface from 
a Pasteur pipette and brushed for 30 seconds, then left 
for a further 90 seconds. 
Positive control 
iBond Universal dentine 
bonding system  
Brush was dipped into resin and applied to dentine 
surface by brushing for 30 seconds then cured with 
blue light for 20 seconds (as per manufacturer’s 
instructions). After curing left for 90 seconds. 
20 mM P11-4 (20 mM 
HEPES 30 mM KCl) 
50 µL of treatment solution added to dentine surface 
and brushed for 30 seconds then left for 90 seconds.  
NanoHA 30 µg/mL (20 mM 
HEPES 30 mM KCl) 
50 µL of treatment solution added to dentine surface 
and brushed for 30 seconds then left for 90 seconds. 
20 mM P11-13/14 (20 mM 
HEPES 30 mM KCl) 
P11-14 solution (25 µL) added to dentine surface and 
brushed for 15 seconds then left for 90 seconds. Then, 
P11-13 solution (25 µL) added to dentine surface and 
brushed for 15 seconds then left for 90 seconds. 
20 mM P11-13/14 seeded 
with 30 µg/mL nanoHA (20 
mM HEPES 30 mM KCl) 
P11-14 nanoHA solution (25 µL) added to dentine 
surface and brushed for 15 seconds then left for 90 
seconds. Then, P11-13 nanoHA solution (25 µL) added 
to dentine surface and brushed for 15 seconds then left 
for 90 seconds. 
Table 6-1 Table detailing application procedure for each treatment tested 
using the fluid filtration device to determine any effect on dentine 
permeability. After application procedure, the test surface was rinsed 
with DI H2O and the test pressure applied. Each treatment was applied 
to 10 dentine disk samples with 3 fluid filtration measurements taken. 
The first measurement was taken before treatment application, the 
second directly after application and the final taken after 7 days in 
artificial saliva solution at 37 °C. 
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6.2.5 Scanning Electron Microscopy Imaging Assessment of 7-Day 
Fluid Filtration Study Treatment Groups 
To analyse the effect of adding the treatments to the surface of the dentine and 
the penetration of any mineral formed in the dentine tubules, a SEM study was 
undertaken. For the dentine surface analysis, 3 samples from each treatment 
group from the 7-day AS study were selected randomly, mounted onto SEM 
stubs using a carbon-coated disk and then sputter-coated in gold (Agar Auto 
Sputter Coater B3743, Stansted, UK). The dentine disk samples were then 
loaded into the SU8230 scanning electron microscope (Hitachi, Tokyo, Japan) 
and the test area was analysed (20 kV accelerating voltage, 113 µA emission 
current, secondary electron emission). For the dentine tubule penetration 
analysis, 3 dentine samples from each treatment group were chosen at random, 
placed in liquid nitrogen for 1 minute and then removed, snapped in half across 
the test area and mounted onto a SEM stub using Blu Tack (Bostik, Paris, 
France). The Blu Tack supporting the sample was then painted with conductive 
silver paint (Agar conductive silver paint AGG3790) ensuring the paint was 
brushed from the Blu Tack to the side of the sample to allow for proper 
conductivity. No silver paint was brushed onto the part of the dentine under 
investigation. Once the paint was dry the samples were sputter-coated in gold 
and then analysed using the SEM.   
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6.3 Results 
6.3.1 Dentine Disk Production  
A total of 120 human 3rd molars were sectioned to produce 500 µm thick dentine 
disks as described in section 6.2.1. The cutting resulted in only 58 of the total 
120 teeth successfully producing dentine samples of sufficient size for use in the 
fluid filtration experiments. On average, just under 3 dentine disk samples per 
tooth were produced from the 58 teeth resulting in 147 dentine disks produced 
in total. 
6.3.2 Fluid Filtration System Validation 
To validate the fluid filtration system, a validation experiment was run to ensure 
that the system was capable of determining differences in fluid flow when using 
a negative control (brushing the dentine surface with PBS) and a positive control 
(brushing with 5% oxalic acid). The fluid flow was measured before and after the 
application of negative and positive controls. The experiment was carried out as 
described in section 6.2.3. The results confirmed a statistically significant 
difference in fluid flow between the positive and negative controls (p<0.05) as 
can be seen in Figure 6-7. Application of the positive control of 5% oxalate 
produced a 98 ± 3 % reduction in flow while the negative control produced a -11 
± 19.0 % reduction in flow (negative reduction being an increase in flow) using 
the same application procedure.  
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Figure 6-7 Validation of fluid filtration device. Graph shows mean % 
reduction in fluid flow through dentine after application of positive 
control treatment (oxalic acid 5%) and negative control treatment 
(PBS) compared to the initial measurement (n=10). Statistical analysis 
using an independent t-test confirmed significant decrease in fluid 
flow in positive control compared to negative control. Error bars show 
2x standard deviation. * Statistically significant at least p<0.05. 
6.3.3 Effect of Application of Hybrid Material to Dentine Disks on 
Dentine Permeability After Initial Application and after 7 Days 
Incubation in Artificial Saliva Solution. 
To assess the hybrid material’s ability to occlude the dentine tubules and so 
reduce dentine permeability as measured by fluid flow, the study described in 
section 6.2.4 was undertaken. In brief, a dentine disk’s initial permeability was 
measured using the fluid filtration method, described in section 6.2.3, to produce 
an initial base line fluid flow measurement. A test treatment was then applied and 
the fluid flow was measured again, providing an initial % reduction in fluid flow 
value after treatment application. The treated disks were then stored in AS 
solution for 7 days, with the AS solution replaced every 24 hours. After 7 days 
the fluid flow was measured again, producing a % reduction in fluid flow after 7 
days in AS with respect to the initial baseline fluid flow measurement. The results 
of the change in fluid flow after the initial application of the treatments are shown 
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in Figure 6-8. On initial treatment application, the 20 mM P11-13/14 solution, 20 
mM P11-13/14 seeded with 30 µg/mL nanoHA and the iBond treatment groups 
all produced a statistically significant decrease in fluid flow compared to the 
positive control (p<0.05), with mean % reduction values of 69 ± 25%, 74 ± 20% 
and 60 ± 27% respectively. The 20 mM P11-4 solution treatment (no added 
nanoHA) resulted in a small mean decrease in flow of 12 ± 14%. Treatment with 
30 µg/mL nanoHA also produced a small increase in fluid flow of -22 ± 21 %, 
with neither treatment being statistically different to the negative control (p>0.05). 
 
Figure 6-8 Bar chart showing mean % reduction in fluid flow (dentine 
permeability) compared to fluid flow immediately after treatment 
application. A one-way Anova Test with post hoc Bonferroni 
correction showed that after initial application, there was no 
significant difference between the negative control (20 mM HEPES 
and 30 mM KCl), 20 mM P11-4 and 30 µg/mL nanoHA treatment groups. 
The P11-13/14, P11-13/14 seeded with 30 µg/mL nanoHA and iBond 
treatments were significantly more effective at decreasing fluid flow 
after initial application compared with the negative control and there 
was no significant difference between these 3 groups. Error bars 
show 2x standard deviation. * confirms statistically significant 
difference using one-way ANOVA Bonferroni test significance level of 
at least p<0.05 (n=10).  
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The fluid filtration experiment was then repeated on the treated dentine samples 
after 7 days incubation in AS solution (AS replaced daily). The results are shown 
in Figure 6-9. For statistical analysis, the results for the 20 mM P11-13/14 solution 
(no nanoHA), 20 mM P11-13/14 seeded with 30 µg/mL nanoHA and the 30 µg/mL 
nanoHA treatments were excluded due to the large standard deviations 
associated with these treatment groups, indicating very large variability of 
response. The 20 mM P11-13/14 seeded with 30 µg/mL nanoHA and the 30 
µg/mL nanoHA treatments produced such large increases in flow after 7 days in 
AS solution that only 6 and 8 samples respectively were able to provide usable 
readings before the end of the 5-minute measuring period, due to the bubble 
reaching the end of the capillary before this time.  
The dentine permeability produced after 7 days in AS by the treatments 20 mM 
P11-13/14 solution (no nanoHA), 20 mM P11-13/14 seeded with 30 µg/mL 
nanoHA and the 30 µg/mL nanoHA produced an increase in flow of -62 ± 100%, 
-70 ± 130% (n=8) and -162 ± 161% (n=6) respectively (a negative % reduction 
is an increase in flow). The negative control treatment (buffer solution only) 
produced a small mean increase in fluid flow (-13 ± 150%) after 7 days in AS. In 
the 20 mM P11-4 (no nanoHA) treatment group, 2 of the dentine samples from 
the group produced extremely large increases in fluid flow (data not shown). 
When one of these samples was removed from the sample holder it fell apart, 
while the other sample, on closer inspection, had a crack running through the 
test surface. These 2 readings were therefore removed from the statistical 
analysis as such defects would clearly have affected the results. Treatment of 
dentine with 20 mM P11-4 and subsequent incubation in AS resulted in a large 
decrease in fluid flow (57 ± 35%) which was smaller but not statistically different 
to the iBond control treatment (78  ± 13%) (p>0.05).  
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Figure 6-9 Bar chart showing mean % reduction in fluid flow (dentine 
permeability) and standard deviation  following a range of treatments 
and after 7 days incubation in artificial saliva. The 20 mM P11-13/14, 20 
mM P11-13/14 seeded with 30 µg/mL nanoHA and the 30 µg/mL nanoHA 
treatments (orange) were not considered due to their very high 
variability. After 7 days in AS solution there was a significant 
difference between the negative control and the 20 mM P11-4 and 
iBond treatment groups. There was no significant difference between 
the P11-4 and iBond treatments after 7 days in AS solution. Error bars 
show 2x standard deviation. * confirms statistically significant 
difference using one-way ANOVA Bonferroni test significance level of 
at least p<0.05 (n=10 unless stated different on graph).  
The initial post-treatment fluid filtration measurements and the measurements 
after 7 days in AS were then compared using an independent t-test to determine 
the effect of 7 days in AS solution on the treatments ability to occlude dentine 
tubules, see Figure 6-10. Both the 20 mM P11-13/14 solution (no nanoHA) and 
treatment with 20 mM P11-13/14 seeded with 30 µg/mL nanoHA resulted in a 
statistically significant increase in fluid flow after 7 days in AS compared to the 
fluid flow immediately after post treatment application (p<0.05). The 30 µg/mL 
nanoHA treatment produced an initial post-treatment increase in fluid flow and, 
after 7 days in the AS solution, there was a statistically significant increase in 
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fluid flow compared to the initial application (p<0.05). The 20 mM P11-4 treatment 
produced a statistically significant decrease in fluid flow after 7 days in AS 
solution compared to the initial post treatment fluid flow (p<0.05). 
 
Figure 6-10 Bar chart showing mean % reduction in fluid flow (dentine 
permeability) immediately after treatment application and after 7 days 
in AS solution. The 20 mM P11-13/14, 20 mM P11-13/14 seeded with 30 
µg/mL nanoHA and the 30 µg/mL treatment groups all produced 
significant increase in mean % fluid flow after 7 days in AS solution. 
The 20 mM P11-4 treatment group resulted in a significantly greater 
reduction in mean % fluid flow after 7 days in AS solution while the 
negative control and iBond treatments produced no significant 
change after incubation in AS solution. Error bars show 2x standard 
deviation. * confirms statistically significant difference using one-way 
ANOVA Bonferroni test significance level of at least p<0.05. (n=10 
unless stated different on graph). 
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6.3.4 Effect of Various Treatments on the Ultrastructural 
Appearance of Dentine  
To assess the effectiveness of the test treatments to not only reduce fluid flow 
but to also achieve tubule occlusion, a SEM study was undertaken. To assess 
for both the surface effects and tubule penetration, samples from each of the 
treatment groups in the study described above were used and split into 2 
assessment groups. The first group was used to examine the dentine surface via 
direct imaging of the surface onto which the treatment had been applied. The 
second group was used to image inside the dentine tubules to assess 
penetration. This was done by imaging treated dentine disks which had been 
placed into liquid nitrogen for 30 seconds and snapped in half across the test 
area providing access to the interior of the tubules.  
Imaging of the dentine surface of samples after 7 days incubation from the 6 
different treatment groups resulted in only the iBond treatment producing any 
apparent difference in appearance compared with the negative PBS control. It 
can be seen in Figure 6-11 D that only image D, which corresponds to the iBond 
treatment group appeared different, with the polymer-based resin seemingly 
filling the dentine tubules. All the other treatment groups show the same open 
dentine tubules with no evidence of mineral formation on the surface or within 
the dentine tubule openings themselves.  
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Figure 6-11 Scanning electron micrographs of dentine surfaces of samples 
taken from different treatment groups after 7 days in AS solution. A) 
Negative control (PBS) showed no deposits with open tubules. B) 
nanoHA control showed no differences compared to negative control. 
C) P11-4 produced no differences compared to negative control. D) 
iBond control produced a thick layer on the surface of the dentine with 
other areas showing resin filled tubules. E) P11-13/14 showed no 
differences compared to negative control. F) P11-13/14 with 30 µg/mL 
nanoHA showed no differences compared to negative control. 
The analysis of micrographs, taken from within the dentine using the fractured 
surfaces, confirmed the absence of any mineral deposits in the tubules of the 
negative control and samples from the 20 mM P11-13/14, 20 mM P11-13/14 
seeded with 30 µg/mL nanoHA and the 30 µg/mL nanoHA treatment groups. 
Samples treated with iBond showed a clear surface layer of resin but no evidence 
of tubule penetration, see Figure 6-12 D. The samples treated with 20 mM P11-4 
showed a layer of what looks like mineral approximately 20 µm from the dentine 
surface, with a thickness of 20 µm penetrating further down the dentine tubule. 
This layer was present across the test area only and was not seen in dentine 
proximal to the test area, see Figure 6-12 C. A higher magnification image, see 
Figure 6-12, clearly showed material which was apparently dislodged from inside 
the tubule spreading when splitting the disk. 
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Figure 6-12 Scanning electron microscopy images of dentine tubules in 
samples from different treatment groups after 7 days in AS solution. 
A) Negative control of PBS treated dentine showed no deposits with 
open tubules. B) nanoHA treated dentine showed no obvious 
differences compared to negative control. C) P11-4 treated dentine 
showed deposits 20 µm down the tubules with a deposit thickness of 
20 µm, see orange arrows. D) iBond treated samples showed a thick 
layer of material on the surface of the dentine, see white arrows, 
although very little penetration is visible down the tubules. E) P11-
13/14 treated samples showed no differences compared to negative 
control. F) P11-13/14 with 30 µg/mL nanoHA treated samples showed 
no differences compared to negative control. 
178 
 
 
Figure 6-13 High magnification SEM micrograph showing the deposits 
associated with P11-4 treatment of dentine disks after 7 days in 
artificial saliva. These deposits may have been the cause of the 
observed reduction in dentine permeability. These deposits localised 
to the test area approximately 20 µM away from the surface and were 
approximately 20 µm in thickness (deposit depth approximately 40 µm 
into dentine tubule at deepest point).  
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6.4 Discussion  
To test the hypothesis that the SAP/nanoHA hybrid material would occlude 
dentine tubules via its ability to promote/support the growth of nanoHA seed 
crystals, a quantitative means of measuring the change in dentine permeability 
was required. The use of a fluid filtration device is a common method to assess 
the potential of dentine tubule occlusion products (Pashley and Galloway, 1985; 
Ayad et al., 2009; Sauro et al., 2010; Wang et al., 2011; Thanatvarakorn et al., 
2013; Zhong et al., 2015).  
A study by Wang et al. (2010) used the fluid filtration method to assess the 
effectiveness of 3 commercially available treatments with respect to their fluid 
flow reducing properties (indicating decreased permeability and increased tubule 
occlusion) in a dentine disk model (Wang et al., 2010). The treatments assessed 
were all toothpaste formulations, including Novamin, Sensodyne, Freshmint and 
Colgate Sensitive. Controls of no treatment and distilled H2O were also tested. 
Initial dentine disk permeability was measured after etching with EDTA to provide 
a baseline reading and then a treatment was applied. Each treatment (1g) was 
applied using a toothbrush under constant loading of 150 g for 300 strokes per 
minute for 2 minutes after which the dentine permeability was measured again. 
Half of the samples from each treatment group then underwent an acid challenge 
(6% citric acid for 1 minute) with the permeability measured again. The remaining 
samples from each treatment group were then left in artificial saliva (1.5 mmol/L 
CaCl2, 50 mmol/L KCl, 0.9 mmol/L KH2PO4, 20 mmol/L Tris, pH 7.4) for 24 hours 
after which the permeability was measured. The results showed that the use of 
all treatments, including the distilled H2O control, resulted in a significant 
decrease in permeability compared to the no treatment control (p<0.001). The 
Novamin and Sensodyne treatments lowered the permeability significantly 
compared to distilled H2O (p<0.001) while Colgate Sensitive was not significantly 
different to the distilled H2O group. The ineffectiveness of the Colgate Sensitive 
treatment was perhaps not unexpected as this was developed as a nerve 
stabilisation treatment as opposed to a material that occludes tubules. 
Recently the fluid filtration system has been further developed to provide not only 
fluid flow measurements but also real time imaging using laser scanning confocal 
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microscopy (Williams et al., 2008). The new device used a modification of the 
Pashley methodology by employing a syringe pump which was configured to 
ensure a flow rate of 3 mL/h and measuring the pressure required to maintain 
this flow pre- and post-treatment. The fluid used to infiltrate into the dentine was 
10 µM rhodamine B, 20 mM HEPES buffer and 1 mM CaCl2. The dentine 
samples were placed under a confocal microscope during the fluid flow 
measurement and the fluid was then imaged within the dentine tubules due to 
the presence of the fluorescent dye, rhodamine B. The technique was used to 
test a commercial dentine resin, Cervitec® (Ivoclar Vivadent, Schaan, 
Liechtenstein) and an experimental alginate gel toothpaste (n=4) to 
simultaneously determine both their effectiveness in reducing fluid flow and to 
image the dentine surface during testing. The study concluded that the use of 
Cervitec resin produced a significant reduction in visible fluid flow which was 
supported by a linear increase in pressure, with a maximum of 13 kPa (1.88 psi) 
required to maintain the flow rate of 3 mL/h over the 120-second test period. The 
alginate gel toothpaste treatment produced a similar initial reduction in fluid flow 
but as the pressure increased to 6 kPa (0.87 psi), the fluid flow increased.  
The ability to image and measure fluid flow through dentine is a desirable 
combination as it could be used to determine the mode of failure, allow for 
imaging in its hydrated state minimising drying artefacts and also allow for 
increased understanding of the fluid flow through the tissue itself. With regards 
to its use as a measurement tool for dentine permeability to aid the development 
and assessment of dentine occlusion treatments however, it has a number of 
potential issues. The use of a constant flow rate which results in a varying test 
pressure is not ideal for all materials and, in effect, acts to provide a 
measurement of the failure pressure required to prevent the treatment working. 
The imaging of the fluid flow, although impressive with regards to it showing the 
increasing areas of fluorescence as the fluid leaves the tubules, does not have 
the required resolution to image the morphology of the dentine tubules or dentine 
surface. As such the use of traditional imaging, for example SEM or TEM, would 
still be required to assess the effect of the treatments at the ultrastructural level. 
No publications could be found which have used this technique to assess dentine 
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sensitivity treatments, which is most likely due to the lack of improvement in the 
data produced compared to the established fluid filtration technique.  
Another development which has been made to the fluid filtration experiment is 
the use of a Flodec device (De Marco Engineering, Geneva, Switzerland) which 
replaces the manual measurement of the bubble movement with the use of an 
infrared light to measure the bubble displacement (Pashley et al., 1996). This 
development removes the need for visual measurements as the Flodec device 
can be connected to a computer increasing the precision of each measurement. 
There have been a number of studies utilising the Flodec development to 
investigate a range of dentine permeability-related topics including, but not 
limited to, hydroxyapatite-containing toothpaste (Hiller et al., 2018), 
nanostructured bioactive glass treatment (Mitchell et al., 2011), and arginine-
containing toothpaste (Ayad et al., 2009) with the advantages of using the Flodec 
device not being discussed. To determine if there was any advantage of using 
the Flodec device, a study was undertaken by De La Macorra and Escribano 
(2002) to investigate if the Flodec device produced different results to the 
traditional visual measurements. The method measured fluid flow using both 
Flodec and visual measurement methods simultaneously. In total, 6 dentine 
samples were used with each sample being tested at fluid pressures of 0, 5, 10, 
15, 20, 25, and 29 cm H2O in sequence. The results of the study concluded that 
the use of a Flodec device did not produce results which were statistically 
different to the traditional method when compared using Passing and Bablok 
regression (p>0.1). The accuracy of the Flodec device, with its change in fluid 
volume detection limit of 10 to 20 nL (De La Macorra and Escribano, 2002), is 
much more accurate than the human eye but when we consider the experimental 
method, the main source of sample to sample variation is not caused by the 
visual measurement of the fluid flow but is a product of the inherent variability 
between dentine samples. Due to the lack of any real improvement in 
measurement or imaging quality, the fluid filtration device used in this thesis was 
based on the work of (Pashley and Galloway, 1985). There are currently no 
commercially available dentine disk fluid filtration instruments and so one was 
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developed as described in section 6.2.2 and was built to similar specifications as 
the devices used by GSK (Weybridge, UK) and Intertek (Hooton, UK).  
Validation of the fluid filtration device used here was undertaken using 5% oxalic 
acid as a positive control and PBS as a negative control (n=10). Oxalic acid was 
chosen as the positive control because desensitisers based on oxalic and/or 
potassium oxalate are considered the gold standard in the occlusion of dentine 
tubules due to the formation of acid resistant calcium oxalate crystals on the 
surface and within the dentine tubules, although the applications are limited due 
to potential toxicity (Sauro et al., 2010). The results of the validation experiments 
demonstrated unequivocally that the fluid filtration device developed for use in 
this thesis was capable of producing a statistically significant difference in the 
mean reduction in fluid flow through dentine between 5% oxalic acid and PBS 
(p<0.05), see Figure 6-7. The relatively small standard deviations produced by 
the negative and positive control treatments, ± 19 % and ± 3 % respectively also 
supports the validity of the system.  
The fluid filtration study where treatments were followed by 7 days incubation in 
AS solution involved 2 measurements of fluid flow reduction. The first 
measurement was taken directly after the treatment was applied and is referred 
to as the treatments’ initial application. The second measurement was taken after 
a 7-day incubation period in AS solution to determine the effect of the treatments 
in a biologically relevant environment and to allow the mineralisation process to 
occur within the dentine tubules.  
The data resulting from treatment with 20 mM P11-13/14 (no nanoHA) and 20 
mM P11-13/14 seeded with 30 µg/mL nanoHA might be explained as follows. 
These treatments resulted in an initial reduction in fluid flow of 74 ± 21 % and 69 
± 25 % respectively, immediately after application when compared to the initial 
fluid flow through the same untreated disks. This may be due to the formation of 
a SAP gel over the surface of the dentine or within the dentine tubules as per the 
hypothesis. After 7 days in AS solution, the 20 mM P11-13/14 (no nanoHA) and 
20 mM P11-13/14 seeded with 30 µg/mL nanoHA treatments produced very large 
increases in fluid flow (-62 ± 110 % and -70 ± 130 % respectively). The cause of 
this increase in fluid flow cannot be simply explained by the hybrid material 
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disassembling and diffusing out of the dentine tubules or off the dentine surface. 
In the case of the negative controls, there was no significant difference in fluid 
flow after the initial application of the PBS or after 7 days incubation in AS, 
suggesting that the hybrid material had actively increased the flow after 7 days 
in AS solution. A large increase in fluid flow measured following application of 
the hybrid material treatment and after 7 days in AS could potentially be 
explained by considering the fluid dynamics of the system.  
In Chapter 5 of this thesis, where the hybrid material was investigated using 1H 
NMR analysis, the data indicated that the P11-13 monomer was assembling on 
the surface of the nanoHA. It may therefore be that the P11-13 monomer interacts 
with the interior walls of the dentine tubule producing a monolayer covering in a 
similar manner. The interaction of the P11-13 monomer with the surface of the 
dentine tubule wall would result in the hydrophobic face of the monomer facing 
towards the fluid within the tubules, effectively producing a hydrophobic layer on 
the tubules’ surface. If we consider a single tubule as a channel with fluid running 
through it, we can then apply the widely accepted “non-slip” condition which 
concerns the fluid in contact with the surface of the channel. The non-slip 
condition is a condition which states that there is no relative motion between the 
wall and the fluid in contact with it (Day, 1990). The depth of the layer with respect 
to the distance between the tubule wall and the fluid which is immobilised by the 
non-slip condition is called the slip length (Priezjev et al., 2005). The non-slip 
condition has an insignificant effect when considering macroscale tubule fluid 
flow as it only affects a small proportion of the total fluid volume (the fluid in 
contact with the walls of the tube). However it has been recently shown that when 
we examine micro/nano tubes, the effect needs to be considered and may be 
significant (Nagayama et al., 2017).  
The formation of a self-assembled monolayer on the surface of the dentine tubule 
would produce a hydrophobic coating which would decrease the slip length. This 
is the distance of the fluid from the wall which is under the non-slip condition 
(Tretheway and Meinhart, 2002). The decrease in the slip length has a minimal 
effect on large channels as the channels already have a large area that is not 
affected by the non-slip region but when we consider dentine tubules, these are 
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very small channels (1-2 µm). It is therefore probable that a significant amount 
of intra-tubular fluid would be affected by the non-slip conditions resulting in an 
inhibition to fluid flow. Even a small reduction in the slip length could have a 
significant effect on the fluid flow dynamics, increasing the flow when under 
laminar pressure. Although this theory helps explain the increase in fluid flow 
produced in this work, a recent review considering fluid dynamics in micro 
channels and its deviation from macroscopic models was produced by Celata 
(2004) and concluded that due to the relatively large errors of the measurements, 
there was currently no consensus as to the fluid flow within micro channels. We 
were unable to determine the mechanism by which treatment with the 
SAP/nanoHA hybrid material resulted in an increase in fluid flow through dentine 
after 7 days in AS solution but compression of the slip length causing an effective 
increase in tubule diameter is a possible cause despite the theory being still 
debated.  
To summarise, the hypothesis is that the formation of a monolayer of P11-13 on 
the interior of the dentine tubules’ surfaces produces a hydrophobic layer. This 
hydrophobic layer decreases the slip length resulting in an increase in fluid flow 
under laminar pressure compared to the natural dentine tubule internal surface. 
However, the lack of agreed understanding of such fluid flow behaviour in the 
literature means that this remains a hypothesis only.  
NanoHA particles are increasingly being seen as a material with significant 
potential to increase the effectiveness of a range of dental and bone restoration 
treatments (Huang et al., 2009; Zhou and Lee, 2011; Hill et al., 2015b; Vano et 
al., 2018). These experimental treatments often use relatively large seeding 
densities compared to the 30 µg/mL used in this work. For example, an 
experimental treatment developed by Li et al. (2008) used a nanoHA seeding 
density of 10 mg/mL to promote the repair of tooth enamel (Li et al., 2008). This 
strategy of using nanoHA relies upon a relatively large concentration of nanoHA 
particles to produce a layer of nanoHA across the tooth surface to promote 
enamel repair. The use of nanoHA in this work was undertaken to provide seed 
crystals which would hopefully grow, supported by the SAP component, blocking 
the dentine tubules and reducing fluid flow (permeability) within the dentine 
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samples. The results of the investigation into the use of nanoHA in this way did 
not produce the desired effect and resulted in an increase in fluid flow within the 
treated dentine samples after 7 days in AS solution, see Figure 6-9. The increase 
in fluid flow suggests that not only are the nanoHA seed crystals not blocking the 
dentine tubules but they are also causing the dentine tubules to become more 
efficient at allowing the flow of fluid through them. The cause of this is unclear 
and was not explored further within this work although one hypothesis is that the 
low concentration of nanoHA present could result in the highly crystalline seed 
crystals growing at the expense of the natural mineral of the dentine tubules 
resulting in the increasing diameter. The dentine tubules walls are composed of 
peritubular dentine which is composed of 25 nm diameter crystals (Goldberg et 
al., 2011) while the nanoHA seed crystals are approximately 45 nm with respect 
to the longest axis, see Chapter 3. The aforementioned potential cause of the 
increase in dentine permeability after the application of the nanoHA seed crystal 
treatment could be due to the Ostwald ripening process which would result in the 
smaller, less thermodynamically stable dentine crystals dissolving and the larger, 
more thermodynamically stable nanoHA seed crystals growing (Vetter et al., 
2013). As previously discussed a small increase in diameter could result in a 
large increase in flow. There were no examples in the literature of nanoHA-based 
treatments which utilise µg/mL seeding densities of nanoHA but this work 
suggests that they may have a negative effect on dentine tubule mineralisation. 
The P11-4 SAP is a proven nucleator of hydroxyapatite (Kirkham et al., 2007) and 
has been developed into 3 clinical products of which it is the active ingredient, 
Curodont™ Repair, Curodont™ Protect and Curodont™ D’senz (Credentis, 
Windisch, Switzerland). The use of Curodont™ Repair has been shown to be 
effective in the remineralisation of early caries lesions (Brunton et al., 2013). The 
commercially available P11-4 Curodont™ D’senz treatment is applied with the 
peptide in the assembled state within a gel formulation, which means that there 
is little opportunity for the peptide to diffuse down into the dentine tubules. In this 
work P11-4 was used in its monomer state to act as a known nucleating agent 
which could be compared against the experimental hybrid material, in addition to 
exploring the use of P11-4 in its monomer state as a desensitising treatment. After 
initial application, the P11-4 treatment did not produce any significant mean % 
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reduction in fluid flow compared to the negative control (p>0.05), see Figure 6-8. 
The lack of any change in the fluid flow within the dentine is not unexpected due 
to the short length of time which had occurred before the testing of the fluid flow. 
The P11-4 treatment required exposure to the AS solution which would provide 
the ions required for mineralisation to occur and time for the mineral to grow. The 
large reduction in fluid flow (dentine permeability) measured after 7 days in AS 
solution in dentine samples treated with P11-4, see Figure 6-9, supports the 
nucleation and crystal growth supporting properties of P11-4. Further evidence of 
this mechanism was seen in the SEM images, see Figure 6-13, where small 
crystals can be seen forming a layer some 20 µm from the surface of the dentine 
tubules in samples treated with P11-4 and then incubated in AS solution. It is 
possible that these crystals represent some form of hydroxyapatite as predicted 
by previous studies showing the formation of hydroxyapatite by P11-4 (Kirkham 
et al., 2007).  The shape of the crystals is also indicative of hydroxyapatite 
(Sadat-Shojai et al., 2013).  
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6.5 Conclusion  
Apparatus for the measurement of fluid flow through dentine samples was 
developed and validated for these studies. Treatment of dentine surfaces using 
the P11-13/14 nanoHA hybrid material was shown to be ineffective in reducing 
dentine permeability as evidenced by the increased fluid flow in these 
experiments. The cause of this increase in fluid flow/dentine permeability 
associated with treatment with the hybrid materials is not known but appears to 
be related to the SAP component. A working hypothesis to explain the 
observations is that the P11-13 monomer interacts with the dentine tubule surface 
resulting in a decrease in the slip length, effectively increasing the diameter of 
the dentine tubule. The use of nanoHA at a seeding density of 30 µg/mL also 
resulted in an increase in fluid flow compared to the negative control. Again, the 
cause of this is unknown though the growth of the seeded nanocrystals at the 
expense of the dentine tubules may be a potential cause. Treatment of dentine 
surfaces with the SAP P11-4 proved to be an effective tubule occlusion agent 
after incubating samples in AS for 7 days, producing intra-tubular crystalline 
material 20 µm down the dentine tubule which acted to reduce the fluid flow 
significantly and was statistically comparable to the use of iBond resin. This may 
be attributed to the known nucleation properties of P11-4.  
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Chapter 7 - General Discussion 
The aim of this thesis was to develop, characterise and optimise a novel self-
assembling peptide/nanoHA hybrid material and assess its ability to support the 
occlusion of dentine tubules with a view to its potential use in the treatment of 
dentine sensitivity.  
The prevalence rate of dentine sensitivity varies depending on the population 
studied, with between 3.8% to 35% of people being affected by dentine sensitivity 
in the general population (Beddis et al., 2013). The large variation in reported 
rates of dentine sensitivity, as high as 74% (Rees and Addy, 2002), is often due 
to studies being based on populations seeking dental work or referred to 
university dental hospitals which can result in highly biased samples (Rees, 
2000). There are a number of factors which can increase the reported rates of 
dentine sensitivity. These include, but are not limited to, periodontal disease 
(Chabanski, 1996), gender (Splieth and Tachou, 2013), age (Rees and Addy, 
2002), higher social class (Chrysanthakopoulos, 2011) and consumption of 
dietary acids (O’Toole and Bartlett, 2017).  
A dentine sensitivity study produced by Clayton et al. (2002) investigated the 
prevalence and distribution of dentine sensitivity in a population of 17-58 year-
old serving personnel (228 participants) on an RAF base in the Midlands, UK. 
This population was chosen to remove the confounding factors associated with 
patients seeking clinical treatment or through referral to a university teaching 
hospital, with the study being completed through a self-assessment 
questionnaire.  
The results of the study revealed a prevalence rate of 50%, which was 
considered high compared to previous dentine sensitivity prevalence rates. The 
cause of this relatively high prevalence rate compared to other studies (Rees 
and Addy, 2002) was unclear, although a number of potential factors were 
discussed. A high percentage (26%) of study participants reported only brushing 
their teeth once or less per day which could suggest that other forms of dental 
pain, for example untreated caries, could be the cause. A second factor identified 
by the authors was a relatively large intake of dietary acid (through consumption 
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of fizzy drink or fruit juice) combined with twice daily tooth brushing. The intake 
of dietary acid has been shown to increase dentine sensitivity with the contact 
time between the dietary acid and tooth being reported as the main risk factor 
with respect to enamel erosion (O’Toole and Bartlett, 2017). The authors 
suggested that clinical assessment of the study participants would be required 
to establish if untreated caries was the cause of the high prevalence rate 
reported.  
No comparisons between gender were analysed due to the small number of 
females (Clayton et al., 2002) in the sample population. Dentine sensitivity is 
often reported to be more prevalent in the female population (Flynn et al., 1985; 
Chrysanthakopoulos, 2011) although a number of studies have reported no 
statistical difference when comparing males to females (Chabanski et al., 1997; 
West et al., 2013). One potential factor which has been cited as a reason for the 
reported difference is that women are more likely to seek treatment compared to 
males (Rees and Addy, 2002).  
The incidence of dentine sensitivity with respect to age can also vary depending 
on the population studied, although the range is often quoted as 20-49 years of 
age peaking at the 30-39 age bracket (Orchardson and Gillam, 2006).  
The increase in prevalence within the higher social classes (often defined as 
having a university education), who have been shown to maintain a high 
standard of oral health (Rees, 2000), suggests that a more varied diet containing 
increased dietary acids is causing increased levels of dentine sensitivity (Rees 
and Addy, 2002; Chrysanthakopoulos, 2011; Liang et al., 2017). The increase in 
relatively wealthy individuals reporting dentine sensitivity could result in a larger 
market for dentine sensitivity treatments and may lead to more expensive 
treatments, if they can produce a comparable reduction in painful symptoms to 
current treatments but provide a near permanent effect, more economically 
viable. 
Although the measurement of prevalence rates can vary depending on the study, 
dietary acid is a common factor reported in the literature which could pose issues 
in the future and make the development of new effective dentine sensitivity 
treatments essential. Dentine sensitivity prevalence studies on populations in 
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developing countries, for example China, are reporting dentine sensitivity as a 
result of a more varied diet containing higher amounts of dietary acid (Liang et 
al., 2017). The link between economic growth and a more acid rich diet could 
result in an increased number of potential dentine sensitivity sufferers world-
wide.  
The accurate measurement of the prevalence of dentine sensitivity is difficult to 
achieve and can depend on the country or population studied (West et al., 2013). 
When assessment is undertaken in a clinical environment, confounding factors, 
such as distorted population, can affect the resulting value. When using a self-
reported questionnaire, as described in the Clayton et al. (2002) study, the need 
for clinical evaluation is required to allow confirmation that dentine sensitivity is 
the true cause and not a symptom of untreated dental issues, for example 
untreated caries. 
There is a real clinical need for new dentine sensitivity treatments (Schmidlin and 
Sahrmann, 2013) as those currently available do not provide a satisfactory 
outcome as defined by the criteria of a gold standard sensitivity treatment. An 
ideal treatment should be: easily applied, rapid in action, non-irritant to the pulp, 
long-lasting, have no staining effects, be consistently effective and be relatively 
painless on application (Kimura et al., 2000). A further consideration, which is 
important with regards to the expensive peptide-based treatment investigated in 
this work, is that any treatment must be economically viable. The current range 
of available treatments, described in section 2.5, have at least one common 
characteristic which prevents them from being considered as a gold standard as 
defined above. This is that they are unable to provide a permanent relief from 
the painful symptoms of dentine sensitivity and so require repeated/frequent 
application. One reason for the lack of permanency of current treatments is the 
lack of tubule penetration achieved. To provide a permanent/more enduring 
solution, the P11-13/14 nanoHA hybrid material was developed in this thesis. The 
advent of a new generation of biomimetic materials with bioactive properties 
offers new potential avenues of research with regards to the treatment of dentine 
sensitivity.  
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The use of peptides in the treatment and prevention of dental diseases is a 
growing field of research with applications in tubule occlusion (Wang et al., 2010; 
Cao et al., 2014; Schlee et al., 2017) and caries repair (Kosoric et al., 2007; 
Kirkham et al., 2007; Melcher et al., 2016; Dogan et al., 2018). The use of 
peptides which can mimic the natural mineralisation process is desirable as they 
are able to effectively repair or replace the tissue which has been damaged or 
removed and can prevent further tissue damage or loss. The properties of the 
assembled peptides developed at the University of Leeds can be controlled 
through rational design of the monomer peptide amino acid sequence to provide 
optimal interaction with the enamel surface and sites for HA nucleation as well 
as prevent further demineralisation (Kirkham et al., 2007). 
The rationale behind combining the self-assembling peptides used in this thesis 
with nanoHA seed crystals in the hybrid material under investigation is that 
although the HA nucleation properties of the P11-13/14 self-assembled material 
per se are poor, it has been shown that it is effective in supporting the growth of 
embedded nanoHA seed crystals (Sayed, 2013). The complementary self-
assembling peptides P11-13 and P11-14 were developed at The University of 
Leeds as part of a portfolio of peptides offering a range of properties and so have 
similar design principles to P11-4, see section 5.1.  
P11-4 is a self-assembling peptide that is already commercially available and is 
the active ingredient in Curolox® technology which is the basis of the Curodont 
remineralisation, regeneration and demineralisation protection product range 
(www.curodont.com). P11-4 has been shown to be effective in the nucleation and 
support of HA crystal growth and in the repair of early caries lesions (Brunton et 
al., 2013).  
Unlike P11-4, which is designed to self-assemble in conditions of pH<8 and/or 
high ionic strength (Carrick et al., 2007), P11-13 and P11-14 were designed so 
that when dissolved separately in solutions at physiological pH and ionic 
strength, no self-assembly occurs. When P11-13 and P11-14 are combined in 
equimolar concentrations of above 10 mg/mL, self-assembly occurs 
spontaneously due to the complementary ionic bonding between the negatively 
charged P11-13 and positively charged P11-14 (Kyle et al., 2012), see section 
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5.1.The P11-13/14 self-assembled peptides have been investigated as potential 
scaffolds for tissue engineering and have shown excellent cytocompatibility 
when tested with primary human dermal fibroblast (Kyle et al., 2010).  
The hypothesised method of treatment application was that nanoHA would be 
incorporated into the individual P11-13 and P11-14 solutions and, when added to 
the surface of exposed and open dentine tubules, the monomeric non-Newtonian 
liquid would travel down into the tubules with the first solution and then the 
addition of the second peptide solution would trigger self-assembly. Due to the 
peptide acting as a carrier surfactant for the nanoHA, this would result in the 
nanoHA being present on the dentine surface and within the dentine tubules. 
NanoHA crystal growth would be supported by the SAP hydrogel. The hybrid 
material would then, in the presence of sufficient ionic calcium and phosphate, 
provide a source of mineral to occlude the dentine tubules from within.  
The novel feature of this treatment is that the trigger for self-assembly would 
occur only after the application of the second nanoHA seeded peptide solution. 
This would allow enough time for the first nanoHA seeded peptide solution to 
travel down into the tubule. On subsequent application of the second peptide, 
self-assembly would be triggered to provide a gel containing the nanoHA seed 
crystals within the dentine tubule. This is important as the growth of the seed 
crystals within the tubule would be difficult to remove via abrasive and attrition 
means, due to its position below the dentine surface, producing a long-lasting or 
permanent relief to the painful symptoms of dentine sensitivity as long as the 
crystals remain within the tubule. The ability to control self-assembly within the 
tubule itself through addition of the second complementary peptide solution is a 
key design feature to address what was suggested to be a potential 
disadvantage of using P11-4 in the treatment of dentine sensitivity as it would 
avoid premature assembly of the peptide at the tooth surface, prior to infiltration. 
To test this hypothesised SAP/nanoHA hybrid material treatment it was first 
assessed and optimised using the in vitro nucleation and crystal growth assay 
(IVNCG) developed by Sayed (2013) with respect to its ability to promote mineral 
formation under steady state conditions. The hybrid material and P11-4 peptide 
were then applied to the dentine disk model with the effect on dentine 
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permeability measured using a fluid filtration device after initial application and 
after 7 days incubation in artificial saliva (AS) followed by SEM analysis above 
and below the dentine surface.  
7.1 Development of an Optimised Hybrid Material for Dentine 
Tubule Occlusion  
To optimise the self-assembling peptide/nanoHA hybrid material, and provide a 
means to develop future potential treatments which rely upon the growth of 
hydroxyapatite mineral to produce dentine occlusion, a high throughput in vitro 
mineralisation method was required.  
The IVNCG method used in this work was first developed by Sayed (2013) and 
was based on work by Hunter and Goldberg (1993, 1994), see section 4.1. Once 
validated, see section 4.3.1, the IVNCG was used to optimise the seeding density 
of nanoHA with respect to its ability to produce a significant repeatable 
mineralisation-promoting effect while limiting the initial seeding density to reduce 
possible toxicity. This was of interest due to the poorly understood toxicity of 
nanoHA and to enable the use of the smallest seeding density of nanoHA in the 
hybrid material to mitigate this (Xu et al., 2009; Shi et al., 2009; Remya et al., 
2014).  
A nanoHA toxicity study produced by Xu et al. (2009) using a nanoHA seeding 
density of 10 mg/mL showed that on addition to osteoblast cells, their growth was 
significantly reduced. The nanoHA particles used were rod-shaped with a mean 
length of 80 nm. The effect on osteoblast growth was hypothesised to be caused 
by nanoHA dissolution resulting in elevated ionic calcium (Xu et al., 2009). The 
seeding density used in the Xu et al. study (2009) is significantly larger (10 
mg/mL) than the seeding density used in the hybrid material (0.03 mg/mL).  
We have hypothesised that the nanoHA in the hybrid material could undergo a 
similar dissolution behaviour before crystal growth could occur, see section 4.4, 
producing an increase in localised ionic calcium which could result in the same 
effect. An additional study which analysed the effect of nanoHA (20-30 nm) at a 
range of seeding densities (10 µg/mL, 100 µg/mL, 1 mg/mL and 10 mg/mL ) on 
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apoptosis in MC3T3-E1 cells confirmed that cell death was dose dependent even 
at 10 µg/mL (Wang et al., 2012). In contrast a study produced by Remya et al. 
(2014) investigated the effect of 800 µg/mL (below 50 nm) nanoHA on mouse 
mesenchymal stem cells isolated from bone marrow. The results showed that 
the nanoHA was compatible with mouse bone marrow mesenchymal stem cells. 
The conflicting results with regards to the toxicity of nanoHA depending on the 
cell line used, concentration of nanoHA used and size of nanoHA used, suggest 
that further research is required with respect to the clinical use of nanoHA. 
However, nanoHA is already used in dental products. The seeding densities of 
the currently available nanoHA based dental treatments are considerably larger 
than the densities used in this work. In a clinical trial investigating the 
remineralisation potential of a nanoHA toothpaste produced by Sangi Co 
(Apagard® nHAP toothpaste) containing 5% nanoHA (crystal size 30–84 nm) 
(Huang et al., 2009), the toothpaste was shown to have the same remineralising 
capacity as a fluoride dentifrice (Najibfard et al., 2011). Another clinical trial was 
reported by Vano et al. (2014) which used a 15% nanoHA toothpaste to treat 
dentine sensitivity but the size of the nanoHA was not reported. The study 
concluded that the use of paste containing 15% nanoHA provided relief from 
dentine sensitivity after 2 – 4 weeks (Vano et al., 2018). Both of these studies 
used significantly larger nanoHA seeding densities that what was used in this 
work. Published clinical trials therefore suggest that the use of nanoHA at 
significantly higher seeding densities than 30 µg/mL are acceptable despite 
published literature on in vitro data which suggests that this might not be the 
case, as described previously.  
To ensure that any toxicity due to the use of nanoHA was minimised, the 
minimum seeding density of the nanoHA seed crystals for further testing in this 
thesis was identified as described in section 4.3.3, with respect to mineral growth 
(measured as phosphate mass) in the IVNCG compared to the 10 µg/mL poly-
L-glutamic acid positive control. The results of this study produced a repeatable 
(n=3) minimal nanoHA seeding density of 30 µg/mL to increase the HA mineral 
mass present compared to the positive control (p<0.05). Interestingly, it was 
shown, through the use of TEM analysis on mineral recovered from the IVNCG 
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system, that when using a seeding concentration of below 30 µg/mL the 
morphology and composition of the mineral deposits formed within the agarose 
gels changed, see section 4.3.4. The mineral deposits formed when using a 
seeding density of 20 µg/mL or lower produced a small number of large spherical 
crystals, 400 µM diameter which had a Ca/P ratio and crystal morphology 
characteristic of OCP. In contrast, when using a seeding density above 30 
µg/mL, a much larger mass of mineral was formed, composed of a much larger 
quantity of smaller (2-5 µm) crystals with a Ca/P ratio and crystal morphology 
characteristic of hydroxyapatite.  
It is hypothesised that the cause of this transition in mineral morphology and 
composition was due to the seed crystals dissolving within the gels when lower 
concentrations of nanoHA were used and then recrystallising once the calcium 
and phosphate ions had diffused into the agarose gels from the buffers. The 
addition of 30 µg/mL nanoHA would also be expected to result in some nanoHA 
crystal dissolution but, significantly, not all would be dissolved. Once the calcium 
and phosphate buffers diffused into the agarose, it was hypothesised that the 
remaining nanoHA crystals underwent crystal growth producing a large quantity 
of small needle crystals (2-5 µm), see Figure 7-1.  
To my knowledge there are no publications which have observed this transitional 
behaviour with respect to the use of nanoHA crystal seeds and, although 
dependent on the salts and buffer composition, this behaviour may well be 
occurring in other nanoHA seeded systems and treatments which rely on 
nanoHA as a component and so could be of interest to this field of research. This 
result could also have implications for the formulation of future treatments which 
rely on concentrations of nanoHA similar to that used here (30 µg/mL and below) 
as maintaining nanoHA crystal seed stability with respect to dissolution must be 
considered.  
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Figure 7-1 Schematic describing the hypothesised nanoHA seeding 
density dependent transition from what is believed to be OCP (this 
could be tested using XRD), at 20 µg/mL or below nanoHA seeding 
density to HA, when seeded at 30 µg/mL or above after 5 days in 
IVNCG assay. At both nanoHA seeding densities the sample well is 
undersaturated with respect to HA causing crystal seed dissolution. 
When nanoHA seeding is below 20 µg/mL, all the seed crystals 
dissolve and then recrystallise when calcium and phosphate ions 
from buffer reservoir diffuse into the sample well forming large crystal 
aggregates of what we believe to be OCP, see SEM image A) (scale 
bar 200 µm). When nanoHA seeding is 30 µg/mL or above, nanoHA 
seeds dissolve but some remain which then go on to grow, producing 
a large number of what we believe to be small HA crystals as seen in 
the SEM image, (scale bar 10 µm). Schematic not to scale. 
The results of the IVNCG optimisation and assessment of the self-assembling 
peptide/nanoHA material proved disappointing with regards to its ability to 
support nanoHA crystal growth; this was due to the hybrid material precipitating 
out of solution within the hydrogel. The use of a novel precipitation assay, see 
section 5.3.4, confirmed that the rate of hybrid material precipitation increased 
as the concentration of ionic calcium increased. The cause of this relationship 
was hypothesised to be due to the strong salting out efficacy of the calcium ion 
(Shaw, 1991) which competes with the peptide assemblies for the sphere of 
hydration resulting in their precipitation. A similar result was produced when 
samples of nanoHA were added to the peptide gels although to a lesser extent 
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than addition of calcium ions. This was attributed to the same salting out process 
hypothesised for the calcium ions.  
A final series of experiments was undertaken using 1H NMR to identify if the 
peptide monomers were interacting with the nanoHA with or without the 
presence of ionic calcium, see section 5.2.6. The results showed that the P11-13 
monomer, when in the presence of 6.5 mM of ionic calcium and 30 µg/mL 
nanoHA, was subject to aggregation. When in the presence of 6.5 mM of ionic 
calcium or 30 µg/mL nanoHA in isolation, no peptide aggregation was detected. 
A working hypothesis to explain this observation is that P11-13 was assembling 
on the surface of the nanoHA through the widely accepted calcium bridging 
process, similar to the effect seen in pellicle formation on enamel (Ash et al., 
2014). The interaction of ionic calcium with the P11-13 peptides assembled on 
the surface of the nanoHA could promote further peptide aggregation resulting 
in layers of peptide covering the nanoHA seed crystal surface. Further 
experiments would be required to confirm this hypothesis which could include 
further 1H NMR experiments to investigate the P11-13 and ionic calcium 
concentration effect on P11-13 aggregation. 
The IVNCG assessment and optimisation of the hybrid material proved 
unsuccessful as none of the IVNCG assay experiments resulted in the hybrid 
material exhibiting any efficacy with respect to supporting the growth of the seed 
crystals as evidenced by a significant increase in phosphate mass compared to 
the positive control. Further analysis of the hybrid material with respect to its 
precipitation under the IVNCG conditions, through the use of a novel precipitation 
assay, suggested that it is unsuitable for testing the SAP component of the 
material, see section 5.3.4. Although the hybrid material was unsuitable for 
testing in the IVNCG, this did not exclude it from being tested using the dentine 
disk model as the conditions used in the fluid filtration study were of lower ionic 
calcium concentration (0.7 mM) which could prevent or reduce the surface-
mediated SAP aggregation hypothesised above. Comparisons with the 
published literature are difficult due to the lack of publications that use self-
assembled peptides or other materials combined with sub 100 µg/mL nanoHA 
used in this work, in the field of dentine sensitivity or caries repair. 
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7.2 Suitability of SAPs for Use as Dentine Occlusion 
Treatments  
The in vitro assessment of the hybrid material provided a more detailed 
understanding of the material’s behaviour, including its unsuitability for use in 
IVNCG system. The next step was to apply the hybrid material to its intended 
substrate – human dentine. The hybrid material was compared throughout the 
human dentine studies with P11-4 without the addition of nanoHA as this peptide 
has already been brought through to clinical use, albeit not yet for infiltration of 
dentine tubules. In order to evaluate efficacy of tubular occlusion experimentally, 
both the hybrid material and P11-4 were applied to human dentine and fluid flow 
reduction assessed using the fluid filtration device first developed by Reeder et 
al. (1978), see Chapter 6. The fluid filtration device is the gold standard method 
for the measurement of dentine tubule permeability in vitro (Al-Jadaa et al., 2014) 
and is used extensively for the assessment of dentine sensitivity treatments 
(Pashley et al., 1984; Sauro et al., 2006; Wang et al., 2011; Hiller et al., 2018), 
including the development of new formulations for commercial use.  
The application of the P11-13/14 to human dentine with and without the addition 
of nanoHA produced a surprising result. Instead of reducing fluid flow as 
hypothesised, the application of P11-13/14 to human dentine resulted in an 
increase in dentine permeability with or without the nanoHA seed crystals after 
7 days incubation in AS solution. 
A hypothesis for this result is that the large increase in fluid flow was due to the 
interaction of the charged face of P11-13 with the dentine tubule wall, producing 
an effectively hydrophobic dentine tubule surface. The previous results using 1H 
NMR that led to the suggestion of calcium bridging of P11-13 peptide to nanoHA 
crystals, described in section 5.4, support the hypothesis explaining the 
observed increase in fluid flow. In the dentine permeability study, the interaction 
of the peptide with the dentine tubule wall would reduce the non-slip length, 
causing an effective increase in the circumference of the tubule with respect to 
the area of fluid which could flow (Day, 1990). If this hypothesis is correct, then 
the application of the hybrid material to dentine would cause the tubule to 
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become more permeable to fluid movement. This is exactly what was observed 
in the fluid filtration study, see Figure 7-2.  
Further experimental work would be required to confirm this hypothesis. This 
could include a fluid filtration study using varying concentrations of SAP which 
could provide a dose-response with respect to fluid flow and confirm the SAPs 
active role in affecting fluid flow in dentine. Further analysis could be undertaken 
using P11-14 (positively charged) as a negative control as this would not be 
expected to interact with the dentine tubule wall. P11-8 (negatively charged at 
physiological pH) could also be assessed which would be expected to interact in 
a similar manner to P11-13 with respect to the P11-8 interaction with the tubule 
wall (Maude et al., 2011). Comparisons with the literature are not possible due 
to the lack of published work relating to this behaviour in dentine studies or more 
generally in micron size channels. As previously discussed, see section 6.4, the 
effect of hydrophobic coating on the non-slip condition within microchannel is a 
poorly understood phenomena and further analysis was not within the scope of 
this thesis.  
 
Figure 7-2 Schematic cross section of dentine tubule (not to scale) 
depicting the hypothesised decrease in non-slip length (dark blue) 
when hydrophobic SAP layer (magenta) assembles on tubule wall. 
The increase in diameter of D1 to D2 results in an increase in fluid not 
under non-slip condition (light blue) which, when under laminar 
pressure, would result in increased fluid flow.  
In contrast to the increase in fluid flow reported for the hybrid material, P11-4 
proved to be the most effective SAP material in reducing fluid flow through 
dentine after treatment, producing a statistically significant reduction in fluid flow 
(57 ± 34%, n=8) compared to the negative control (p<0.05) after 7 days 
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incubation in AS solution. SEM examination of the treated dentine samples 
revealed a lack of any obvious surface deposits and the presence of small 
needle-like crystals (5 µm) within the dentine tubules some 20 µm from the 
surface. This observation suggested that the fluid flow reducing properties 
associated with P11-4 treatment were produced by nucleation of crystals de novo 
by the P11-4 peptide within the dentine tubule, see Figure 6-13. The formation of 
these crystals within the dentine tubules suggests that application of P11-4 as a 
monomeric (solution) could be investigated further as a treatment for dentine 
sensitivity as the deposits could be difficult to remove due to their location within 
the dentine tubule. The nature of the crystals formed within the dentine tubules 
by P11-4 would need further analysis to be able to draw conclusion with regards 
to their permanency. The reduction in fluid flow after 7 days incubation in AS is 
a positive result with regards to the effectiveness of the P11-4 treatment but does 
not confirm its ability over a longer timescale of more than 7 days. 
Additionally, the fluid filtration study undertaken in this work does not fully 
replicate the conditions present in the clinic. One major issue which was not 
investigated was the positive pressure exerted by open dentine tubules in a 
“living” tooth. In a “living tooth”, there is a positive pressure exerted by the pulp 
which results, when the dentine tubules are open, in a constant flow through the 
dentine tubules in the pulp to dentine surface direction. The treatments in this 
study were applied to a dentine surface with no fluid pressure applied to the 
dentine disk model through the tubules, which might have enabled a more 
efficient diffusion of the P11-4 into the dentine tubule when compared to a “living 
tooth” as the peptide would not have to diffuse against a positive flow of fluid. 
Application of the P11-4 in a clinical trial would be required to determine if the P11-
4 peptide could diffuse into a dentine tubule, and once there, if it could promote 
the formation of the crystals seen in the SEM dentine study. 
When the fluid filtration results are compared to a similar study presented in the 
literature, the results of P11-4 seem promising. A dentine fluid filtration study 
reported by Zhong et al. (2015) investigated the effect of using novel bioactive 
glass-ceramic HX-BGC (SiO2-P2O5-CaO-Na2O-SrO), to reduce dentine tubule 
permeability after initial application, 1-day submersion in AS solution and after 7 
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days of daily treatment applications with submersion in AS between treatments. 
The effectiveness of HX-BCG was assessed, in both its powder form and also 
as part of a toothpaste formulation, and compared to a control treatment of 
distilled water and Sensodyne Repair toothpaste which contained the bioglass 
NovaMin®. The fluid filtration device used was based on the original device 
produced by Reeder et al. (1978) utilising a reservoir of H2O held at 20 cm above 
the dentine sample holder to provide a constant pressure.  
There are similarities between the study produced by Zhong et al. (2015) and 
the fluid filtration study presented in this thesis which make a comparison 
between the studies relevant. Both used the fluid filtration method to assess 
dentine tubule occlusion after initial application and after 7 days incubation at 37 
°C in AS solution. Both studies also used 10 dentine disks per treatment group. 
Although similar, there are some differences in the study methodology used that 
need to be taken into consideration. The AS solution in the study by Zhong et al. 
was 1.5 mM CaCl2, 0.9 mM KH2PO4, 130 mM KCl, 5 mM NaN3 and 20 mM 
HEPES with pH 7.4 (stabilised with NaOH) compared to the AS solution used in 
this study which was CaCl2 0.7 mM, MgCl2 0.2 mM, KH2PO4 4 mM, KCl 30 mM 
and HEPES 20 mM with the pH adjusted to 7 using KOH (Eisenburger et al., 
2001). The effect of different AS solutions could have a significant effect on the 
performance of the test materials due to the availability of ionic calcium and 
phosphate for HA mineralisation. Another difference was the measurement after 
1 day in AS solution which may have had an effect on the resulting dentine 
permeability measurement at day 7 although this cannot be confirmed without 
further measurements. Although differences between the 2 study methodologies 
exist, a comparison of the results seems reasonable. The original results of this 
study were presented as a percentage of the original flow compared to the initial 
reading (initial reading being 100%); this has been converted to % reduction to 
enable comparisons with the fluid filtration study produced in this work and is 
shown in Table 7-1. 
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Time point  Distilled 
H2O control  
Sensodyne 
Repair ® 
(Bioglass) 
HX-BGC 
Toothpaste  
(Bioglass) 
HX-BGC 
Powder 
(Bioglass) 
P11-4 
monomer 
treatment 
After 
treatment  
12 ± 11.8 % 43.4 ± 10.1 
% 
51 ± 8.8 % 20.3 ± 11.9 
% 
12 ± 14% 
1 day of AS 
immersion 
27.6 ± 14.1 
% 
53.9 ± 20.1 
% 
58.3 ± 16.1 
% 
59.7 ± 15.8 
% 
no data 
7 days of 
daily 
treatment 
28 ± 10.7 % 71.7 ± 14 % 78.7 ± 10.1 
% 
79 ± 9.3 % 57 ± 34 %* 
Table 7-1 Dentine fluid filtration measurements (converted into % reduction 
± SD) after application of a novel bioglass HX-BGC formulated into a 
toothpaste and as a powder compared to Sensodyne repair 
(Novamin®) and distilled H2O control. Treatments were assessed after 
initial application, 1 day of submersion in AS solution and after 7 days 
of daily treatment application followed by AS submersion (Zhong et 
al., 2015). The fluid filtration % reduction for the P11-4 monomer 
treatment produced in this work is shown in bold. * No repeated daily 
application of P11-4 was done after initial application. 
When comparing the % reduction in fluid flow for the P11-4 treated dentine 
samples after initial application (12 ± 14 %) to the treatments used in the Zhong 
et al. study (2015), the performance of the bioglass treatments (all above 70%, 
see Table 7-1) is more effective with respect to their ability to reduce fluid flow. 
This P11-4 treatment was found not to be statistically different to the negative 
control (20 mM HEPES and 30 mM KCl) in the dentine fluid filtration study in this 
thesis (p>0.05), and when statistically compared to the bioglass treatments 
produced significantly lower reductions in fluid flow (p<0.05) which confirms the 
poor performance of the P11-4 monomer treatment after initial application with 
respect to the reduction of fluid flow through dentine. The limited effectiveness 
of monomer P11-4 on application is not surprising considering it requires time and 
the availability of ionic calcium and phosphate to allow the mineral nucleating 
properties of P11-4 to promote crystal formation, and so tubule occlusion. When 
the reduction in fluid flow after 7 days incubation in AS solution of the HX-BGC 
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toothpaste (78.7 ± 10.1% ), HX-BGC powder (79 ± 9.3 %), and Sensodyne 
Repair (71.7 ± 14 %) was statistically compared to the P11-4 treatment (57 ± 34 
%) using an independent t-test it was found that there was no statistical 
difference between the P11-4 treatment and any of the treatment groups listed 
above (p<0.05). When one considers that the P11-4 treatment was applied only 
once, compared to the daily repeated treatments of the bioglass material over 7 
days, then the single application of P11-4 treatment produces an impressive 
decrease in fluid flow after 7 days incubation in AS. The repeated application of 
the P11-4 treatment would be required to determine if any further fluid flow 
reducing effect could be achieved.  
A recent clinical trial compared the assembled P11-4 gel formulation Curodont 
D’Senz (concentration and dispersion medium not stated) to a 8% arginine and 
calcium carbonate [ACC] toothpaste. Patients in the P11-4 gel treatment group 
were instructed to rub a small amount of P11-4 gel treatment on the affected teeth 
twice a day for 1 week only. The ACC treatment group were instructed to use the 
ACC toothpaste for the duration of the 90-day trial twice a day. The patients were 
then assessed using Visual Analogue pain Score (VAS) and Verbal Rating Scale 
(VRS) pain scores which were recorded over the 90-day study at time points of 
day 3,7,30,90 (Schlee et al., 2017). Interestingly, no data was collected after the 
initial treatment application; this could have been an important piece of data as 
it would have determined if relief from the symptoms of dentine sensitivity was 
decreased instantly on application. The results from the study determined that 
both treatment groups experienced an improvement in the VAS and VRS scores 
as a function of time with no significant difference between the 2 treatment 
groups at any time point (p<0.05). A significantly higher proportion of subjects in 
the P11-4 treatment group reported that they were pain-free at the 7-day and 90-
day time points compared to the ACC treatment group. The finding that the P11-
4 treatment group experienced the same level of dentine sensitivity symptom 
suppression upon receiving the application of P11-4 treatment for only 7 days, 
when compared to an effective desensitising toothpaste used for the full 90-day 
trial, is significant as it suggests that the P11-4 treatment is not only effective but 
also effective over a long period of time after treatment application. A SEM study 
was undertaken alongside this study and confirmed that the P11-4 treatment 
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produced a layer on the surface of the dentine although it was stated by the 
author that no evidence of it penetrating down into the tubule was available, see 
Figure 7-3.  
 
Figure 7-3 SEM images of A) the control dentine disks (after preparation, 
cleaning and without application of any agents); B) dentine disks 
treated with ACC toothpaste and C) dentine disks treated with P11-4 
gel product. Image reproduced with permission from Schlee et al. 
(2017). 
The results reported in this thesis, see sections 6.3.3 and 6.3.4, suggested that 
application of 20 mM P11-4 as a monomeric solution onto the surface of exposed 
and open dentine tubules promoted de novo mineralisation inside the dentine 
tubules, see Figure 6-13, at a distance of 20 µm from the surface. This would 
resist abrasion by tooth brushing or attrition removing the protective mineralised 
layer with a consequence of the painful symptoms of dentine sensitivity returning. 
As such, treatment with P11-4 monomer could lack of immediate benefit after 
initial application which could be improved (see below).  
A recent in vitro study by Chen et al. (2014) investigated the dentine permeability 
reducing properties of a range of desensitising treatments including Curodont 
Protect which contained assembled P11-4 as its active ingredient. Dentine disks 
were acid-etched (n=5 per treatment group) and then split in half with one half 
acting as the control. Treatments were brushed onto the surface of the dentine 
disks for 2 minutes followed by fluid filtration measurement. The treated samples 
were compared to the control samples to determine the difference in fluid flow 
after treatment application. The results showed that the Curodont Protect treated 
samples had a mean decrease of 55.1 ± 12.5 % which was a significantly larger 
decrease (p<0.05) than that produced by UltraDex Recalcifying and Whitening 
(26.4 ± 7.6%) and Colgate Sensitive Pro Relief (27.6 ± 6.8%). Curodont Protect 
treated samples were not statistically different to the Sensodyne Repair and 
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Protect (64.9 ± 18.5%) or the Sensodyne Rapid relief (39.1 ± 17.1%) treated 
samples (p>0.05). This suggests that Curodont Protect is effective at reducing 
fluid flow in dentine after initial application but, due to the design of the study, 
does not assess the nucleation and crystal growth potential of Curodont Protect. 
To assess this, the treated samples would require incubation in an artificial saliva 
solution so that the active ingredient (P11-4) can nucleate and support HA growth 
over a number of days, as discussed with regards to the Zhong et al. (2015) 
study above. The Chen et al. (2014) study only assessed how well the Curodont 
Protect gel can plug the tubules and prevent fluid flow without the formation of 
any mineral. That being said, if we compare Curodont Protect’s fluid flow 
reducing properties (55.1 ± 12.5%, n=5) after initial application to the P11-4 fluid 
flow reduction after initial application (12 ± 4, n=8), it appears much more 
effective on initial application.  
The need for a dentine sensitivity treatment to be rapid in action is one of the 
dentine sensitivity treatment gold standard requirements (Kimura et al., 2000). 
For this reason, an almost instant alleviation of painful dentine sensitivity should 
be the goal of any treatment and the P11-4 monomer treatment did not achieve 
this, as determined in this thesis. The issue with the application of P11-4 in a 
monomer form is that it takes time for gelation to occur within the dentine tubule. 
The kinetics of P11-4 have not been studied at short time scales although a self-
supporting gel can be achieved within minutes when in a 5 mL glass vial with 5 
mL volume. Once gelation has occurred it would take longer for the treatment to 
nucleate mineral to the extent that a reduction in fluid flow in dentine tubules 
occurred. The exact kinetics of P11-4 nucleation under the conditions used in the 
fluid filtration study are currently unknown but this study confirmed that after 7 
days, the dentine tubules had mineral-like deposits present after P11-4 
application. A study by Kirkham et al. (2007) showed that 15 mg/mL P11-4 gels 
incubated in a mineralising solution produced deposits of poorly crystalline HA 
throughout the gel after 7 days incubation at 37 °C, similar to the conditions used 
in this work.  
A potential solution to the inability of P11-4 monomer to produce immediate 
results after application to the dentine, which was not tested in this thesis, would 
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be to combine the application of monomer P11-4 solution followed by treatment 
with Curodont Protect. This could produce an effect similar to the hypothesised 
mode of action of the E8DS treatment described previously, see section 2.9. This 
could result in the penetration of P11-4 monomer down into the dentine tubules 
promoting the formation of crystals occluding the tubules seen in this study, while 
the addition of Curodont Protect (P11-4 in its assembled gel state) could provide 
the instant fluid flow reduction properties and provide dentine surface 
mineralisation over time.  
For any P11-4 based dentine sensitivity treatment to become commercially viable, 
the resulting dentine occlusion would have to be permanent or require infrequent 
(potentially annually) reapplication due to the associated costs of manufacture 
and the requirement for clinical application. The application of P11-4 (monomeric) 
treatment is not as simple as a desensitising toothpaste and would require a 
dental healthcare professional to apply the solution. Previous studies (discussed 
above) have shown that patients are able to apply the D’senze treatment (this is 
identical to Curodont Protect and contains P11-4 in its assembled gel form) 
themselves (which, at the time of writing, was € 16.80 per treatment) but the 
application of a P11-4 solution would, due to the cost of treatment and precise 
application, require clinical application to the affected area. Unless the 
production of peptide-based treatments significantly decrease in cost through 
increased usage and become applicable by the patient, frequent application of 
P11-4 may be prohibitively expensive and therefore ineffective compared to the 
current range of desensitising treatments already on the market. The clinical 
application of a P11-4 solution followed by a repeated patient applied Curodont 
D’senze gel treatment could potentially be a more economically viable treatment 
method. 
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Chapter 8 – Summary and Conclusion  
8.1 Summary  
The main aim of this thesis was to assess and optimise a novel self-assembling 
peptide/nanoHA hybrid material with respect to its ability to occlude dentine 
tubules. The optimisation work was undertaken using the IVNCG while the 
assessment of the P11-13/14 nanoHA hybrid material and P11-4 was undertaken 
using a dentine fluid filtration study. 
Hydrothermal synthesis and characterisation of nanoHA was successfully 
achieved. Optimisation of the nanoHA seeding density in agarose with respect 
to phosphate mass (indicative of crystal growth) compared to the poly-L-glutamic 
acid positive control was determined as 30 µg/mL. The IVNCG assay proved 
capable of reliably determining the minimum nanoHA seeding density required 
to statistically increase the mass of mineral formed compared to the poly-L-
glutamic positive control as 30 µg/mL when seeded in 1% agarose. This seeding 
density was then taken forward and combined with the self-assembling peptide 
component to create the hybrid material. 
The IVNCG was then used to optimise the hybrid material with respect to its 
mineralisation potential. In contrast to the nanoHA seeding optimisation 
experiments, the use of the self-assembling peptide/nanoHA hybrid material in 
the IVNCG assay was found to be inappropriate and was unable to provide any 
experimental evidence that the hybrid material was capable of supporting the 
growth of the nanoHA crystals. Further experimental work using a novel 
precipitation well plate study suggested that the hybrid material was precipitating 
out of solution in the hydrogel when exposed to the conditions of the IVNCG 
assay, with the 6.5 mM concentration of ionic calcium being the main driver of 
hybrid material precipitation.  
The analysis of the hybrid material components using 1H NMR revealed that the 
peptide monomer P11-13 was forming aggregates only under conditions of 
6.5 mM ionic calcium and 30 µg/mL nanoHA. It was hypothesised that the 
formation of this aggregated P11-13 was the result of surface mediated self-
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assembly on the nanoHA seed crystals which resulted in the precipitation of the 
hybrid material when used in IVNCG experiments. It was concluded that the 
IVNCG assay technique was unsuitable for the optimisation of the hybrid 
material. 
A dentine fluid filtration study was then undertaken with 2 peptide materials being 
assessed; the P11-13/14 nanoHA hybrid material and P11-4, the latter being a 
known nucleator of HA. The results for the hybrid material 7 days after treatment 
application and incubation in AS solution showed a significant increase in fluid 
flow through dentine of 70 ± 130%. The cause of this increase in fluid flow was 
hypothesised to be due to interaction of the charged face of the P11-13 peptide 
monomers with the walls of the dentine tubule. This interaction would be 
expected to produce a hydrophobic coating on the tubule surface which would 
result in a compression of the “non-slip” layer. The compression of the “non-slip” 
layer would, due to the 1-2 µm diameter of the tubule, effectively increase the 
tubule volume susceptible to fluid flow producing increased dentine permeability.  
The results for the P11-4 treatment produced a significant 57 ± 34% reduction in 
fluid flow through dentine after 7 days incubation in AS solution compared to the 
negative control (p<0.05). A SEM study concluded that the dentine surface 
remained clear of any visible mineral deposits but when the dentine samples 
were split and the tubules imaged, a 10 µm thick layer of crystals was visible 20 
µm down the tubule. This suggests that the P11-4 peptide is capable of forming 
mineral inside the dentine tubule; this would be an advantageous place with 
respect to treating dentine sensitivity due to it being difficult to abrade away 
through tooth brushing or similar processes. Comparisons with current P11-4 
based treatments in the literature suggest that the mineral deposition within the 
dentine tubules below the dentine surface is a new finding not previously seen 
in the use of P11-4. The ability of monomer P11-4 to penetrate the dentine tubules 
and promote sub-surface crystal growth makes it a candidate for further 
investigation and opens up the possibility of potentially combining it with 
Curodont D’Senze (gel-based P11-4 desensitising agent) which has shown to 
decrease dentine permeability and promote dentine surface mineralisation 
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although lacks tubule penetration. Together, these 2 treatments could offer both 
immediate and enduring benefits for the treatment of dentine sensitivity.  
8.2 Future work  
 Determine if the IVNCG has the potential to be used as a high throughput 
for the assessment and optimisation of mineral nucleation and crystal 
growth with respect to other dentine sensitivity treatments that aim to 
produce mineral deposits to occlude dentine tubules. Further experiments 
with materials which can function in the IVNCG conditions would be 
required to test this.  
 The use of P11-13/14 as a material for the support of hydroxyapatite 
crystal growth requires further analysis to determine the interaction of the 
peptide material with hydroxyapatite. No crystal growth supporting effect 
was seen in any technique used in this thesis.  
 Although the results of this thesis suggest that P11-13 may not be suitable 
for the applications described here due to its interaction with crystal 
surfaces and effect of increasing fluid flow through the dentine channels, 
it may be a candidate for use in other applications, for example as a 
potential internal coating for micro catheters and indwelling peripheral 
intravenous cannulae or as a mineral stabiliser/inhibitor of calcification. 
Surface modification chemistries for attachment of the P11-13 peptide to 
the required surface would have to be investigated.  
 Further analysis of the P11-4 treatment on dentine. Multiple time points, 
for example testing every day, would provide more insight into how the 
P11-4 treatment develops over time with respect to fluid flow reduction and 
mineralisation and provide insight in to mineralisation kinetics.  
 Possible combination of P11-4 treatment in a monomer state followed by 
application of self-assembled P11-4 treatment may produce a dual effect 
of producing mineral deposits in the dentine tubule and promoting surface 
mineralisation. This hypothetical treatment could be investigated using the 
fluid filtration device.  
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8.3  Conclusion 
In conclusion, this study has determined that the SAP/nanoHA hybrid material 
treatment was ineffective at reducing dentine permeability but has revealed new 
insight into the interaction of the individual peptides with calcium ions and HA 
crystal surfaces, as well as illustrating potential applications for P11-13 in 
facilitating fluid flow in micro-channels. The P11-4 treatment was shown to be 
effective in reducing dentine permeability 7 days after application and may be a 
promising candidate for further development as a dentine sensitivity treatment. 
Clinical trials would be needed to fully assess the effectiveness of the P11-4 
treatment with respect to treating dentine sensitivity. 
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